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SUWARY
The host cell, probably plays an import:ant role in neutralization 
but previous work on influenza virus neutralization used 
dedifferentiated cultured cells derived fro« tissues which are not the 
natural target of the virus. The aim of this investigation was to 
study the mechanisms of neutralization of influenza virus by different 
antibody isotypes using fully differentiated, ciliated epithelial 
cells of tracheal organ cultures. Tracheal organ cultures derived from 
the mouse were used together with mouse pathogenic strains 
(A/FPV/Roetock/34 (adpFPV/R) and A/PR/8) and mouse antibodies, so that 
all the participating components came fro« the same species. Parallel 
experiments were performed using cultured EH< cells and erythrocytes 
to enable comparison between different cell types. As previous worie 
had used only a single saturating amount of antibody I decided to use 
a range of antibody concentrations with a constant amount of virus. 
Three potential mechanisms of neutralization were investigated: 
aggregation of virus, inhibition of virus attachment to cells and 
inhibition of virus internalization fcy cells.
Each isotype (IgG. IgM and IgA) aggregated influenza virus (by EM 
determination) when used in sub-saturating amounts. Increasing the 
amount of antibody reduced aggregation and at higher antibody 
concentrations, the virus was monodisperse. Sub-saturating amounts of 
IgG monoclonal antibody partially inhibited the attachment of adpFPV/R 
to tracheal organ culture cells. EH< cells and erythrocytes. Together, 
aggregation and inhibition of virus attachment by IgG accounted for 
more than a 90% loss of infectivity. although this was usually less 
than the amount of neutralization observed. It is argued that these 
represent potentially important mechanisms of neutralization. 
Increasing the IgG concentration increased neutralization and 
increased attachment of virus to tracheal organ culture and EH< cells 
but not to erythrocytes. Therefore when there is a high ratio of IgG 
to virus, neither aggregation or inhibition of virus attachment 
accounted for any loss of infectivity. Under these conditions. IgG did 
not prevent internalization of virus that had attached to tracheal 
organ culture or BKK cells and it was concluded that inhibition of an 
intracellular stage of the virus infectious pathway was the major 
mechanism of neutralization.
Polyclonal IgM partially inhibited attachment of virus to organ 
culture cells, EH< cells and erythrocytes. Increasing the amount of 
IgM did not increase virus attachment to any of the cell types. 
Internalization of IgM-neutralized virus that had attached to tracheal 
organ culture and EH< cells was blocked, confirming earlier 
observations when a single saturating concentration of IgM was used.
Neutralization of A/PR/8 by sub-saturating amounts of monoclonal 
polymeric IgA also inhibited virus attachment to EHK cells and 
erythrocytes. There was no rise in attachment when the amounts of IgA 
were increased and internalization of attached virus was inhibited. 
Suh-saturating amounts of IgA also greatly reduced virus attachment to 
tracheal organ culture cells. However increasing the relative IgA 
concentration resulted in increased attachment. The highest 
concentration of IgA used enhanced virus attachment by more t^ ian 
five-fold compared to infectious virus but this was accompanied by no 
increase in infectivity. Enhanced attachment was neuraminidase- 
resistant and was possibly mediated via an IgA-specific Fc receptor.
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Influenza viruses belong to the Crthoayxoviridae and are divided into types 
A, B or C depending on the antigenicity of the nucleocapsid (NP) structural 
virus protein. Type A influenza viruses are the meet important fro« the 
stand-point of morbitity and aortal ity in «an and are the subject of this 
thesis.
Using an electron microscope, influenza viruses appear as highly 
ple-cnorphic. spiked particles (Figure 1.1a). The size and shape of the 
particles varies considerably depending on the virus strain and the method 
of isolation used. Spherical particles (80-ieOmn diameter) are coomonly 
found in virus preparations that have been repeatedly passaged in 
chorio-allantoic membrane of fertile eggs whereas freshly isolated virus 
preparations have a more filamentous morphology (Home et al.. 1960).
The detailed structure of the influenza virus particle (reviewed by Lamb, 
1983) is shown in a stylized form in Figure 1.1b. The envelope is acquired 
by the virus during the process of maturation as the progeny virus 
particles bud through the host cell membrane (Compare & Dimmock. 1969). The 
lipid composition therefore closely reflects that of the host cell membrane 
fro« which the virus was derived (Klerk & Choppin. 1968). A higher
tproportion of phosfiatidic acid has been found in the virion compared to the 
cells (Kates et al.. 1961), suggesting that the virus incorporates newly 
synthesized lipids as well as those lipids already present in the host cell 
at the time of infection.
Fig. 1.1a. An electrcmmicrograph of an influenza virus 
particle visualized by negative staining (x335,000). 
Courtesy of Dr.S.J.Armstrong (University of Warwick).
HA
Fig. 1.1b. A schematic diagram of the structure of the
influenza virion. The coding assignments of the 
8 RNA segments are also illustrated. The diagram 
is not drawn to scale (Lam b, 1983).
Into the envelope are inserted two types of virus-coded transmemfcrane 
glycoprotein spikes; haemagglutinin (HA) and neuraminidase (KA) (Laver & 
Valentine, 1969). It is against these two surface glycoproteins that the 
host's humoral lianune response is mounted during infection. There are 
approximately 700-1000 spikes per virion with a ratio of roughly five 
haemagglutinin spikes to every neuraminidase spike (Webster et al.. 1962). 
The haemagglutinin spikes are evenly distributed over the virus surface and 
extend approximately 13.5nm from the envelope. They are trimers and have a 
cylindrical, rod shape with a triangular cross section. The haemagglutinin 
is the virus attachment protein (VAP), and also mediates virus penetration 
and fusion steps during the infectious process. The neuraminidase spikes 
are tetramers and are clustered in discrete patches on the virus surface 
(Murti & Webster. 1966). The major functions of the neuraminidase includes 
the prevention of self-aggregation (Palese et al.. 1974), improving virus 
mobility by freeing virus bound to respiratory tract mucous and freeing 
progeny virus from the host cell surface (Palese & Schulman. 1974). The 
detailed structures of both the HA and NA have been resolved using X-ray 
crystallography and are described in greater detail below.
Influenza virus 'cores’ (diameter of roughly 65nm) are prepared by removing 
the envelope and surface glycoproteins (Schulze, 1972). The most abundant 
protein in the virion is the matrix protein (Ml) (Compans et al.. 1970) and 
this forms a 3-4nm thick shell (Reginster & Nermut. 1976). Ml is a type 
specific (Schild et al.. 1962) but sub-type variable influenza antigen 
(LeCompte & Oxford, 1961). It is a hydrophobic protein (Lenard et al..
1974) which gives it a great avidity for lipid bilayers (Davis & Bucher. 
1961; Karadaghi et al.. 1964). A specific fragment (5kD) of Ml embeds in 
the lipid bi layer (Gregoriades, 1961) and may allow interactions to take
place between the virus surface glycoprotein spikes and the virus core 
(Basak et al.. 1964). Joassin et al. (1987) demonstrated M protein epitopes 
on the outer face of the viral envelope using monoclonal antibodies, 
indicating that it is a transmeatrane protein. Positive cooperation between 
the NA and Ml does occur and enhances NA incorporation into lipid bilayers 
(Davis & Bucher. 1961). It is thought that the spike/core interactions 
result in a clustering of both HA and NA on the infected cell surface and 
the asymmetry of the interaction causes a local curvature of the membrane, 
facilitating the budding of progeny virus (Karadaghi et al.. 1964). This is 
disputed by Patterson et al. (1968) who found that there was little Ml on 
the cytoplasmic suface of infected cell membranes. They thought that virus 
cores formed in the cytoplasm before migrating to the cell surface. The 
progeny budded rapidly once the cores and the glycoproteins came together. 
Others have also found Ml evenly distributed between the cytoplasm and 
nucleus of infected cells (Steith et al.. 1967). The Ml protein inhibits the 
transcriptase activity of the virus, indicating that it is also closely 
associated with the ribonucleoprotein (RNP) complexes which lie within the 
virus core (Zvonarjev & Ghendon. I960; Mikhejeva & Ghendon. 1963).
A second matrix protein (M2) is also coded for by the virus in a reading 
frame that overlaps with that for Ml. This small (Mr15,000) protein was not 
thought to be present in the virion (Lamb & Choppin. 1981; Zebedee et a l . . 
1965; Hay et al.. 1965). although it is present in large quantities 
inserted into infected cell membranes (Lamb et al.. 1985; Staith et al..
1967). It has an integral membrane anchor domain with at least 18 residues 
external and a role in organising virus assembly has been proposed (Lamb et 
al.. 1965). Recently M2 has been found in small quantities in the virion 
structure (Zebedee & Lamb. 1968).
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The r 1 bonuc 1 eoproteln (RNP) complexes (90» protein; 10» RNA) lie inside the 
'core' shell and are composed of four different proteins (IP. PA. PB1 and 
PB2) and eight single-stranded RNA segments of negative polarity. The RNP 
complexes are rod shaped structures with terminal loops and helical 
mid-sections (Pons et al.. 1969). They can be separated ir.'-o five size 
classes, each class reflecting the different size of RNA segment contained 
(Rees & Dismock. 1961).
The nucleocapeid protein (NP) is the most abundant protein in the RNP 
(Compans et al.. 1970). Each NP contacts 20 base pairs of RNA and interacts 
with itself. PA. FBI. PB2. possibly Ml but not HA (Rees & Diamock. 1961; 
Patterson et al.. 1968). It is a group specific antigen (Skehel & Schild, 
1971) with at least five distinct antigenic determinants in three 
non-overlapping sites (van Wyke et al.. I960). These sites do undergo some 
antigenic variation, but one is common to all strains. Monoclonal —  
antibodies against two of the sites inhibit transcription of viral RNA in 
vitro, which implies that IP is an integral part of the transcriptase 
complex (van Wyke et al.. 1981). Others disagree with this suggestion, 
Scholtissek et al. (1971) found RNA transcription in the absence of NP.
PB1. PB2 and PA together make up the virus transcriptase enzyme (Palese et 
al.. 1977; Braam et al.. 1963; Detjen et al.. 1987). PB1 and PB2 are 
involved in mRNA synthesis, with PB1 initiating transcription (Ulmanen et 
al.. 1961 & 1963) and PB2 binding the cap of host mRNA (Penn et al.. 1962; 
Ulmanen et al.. 1981; Blaas et al.. 1982; Braam-Markson et al ■. 1985)). The
role of PA is less clear but may be involved in mRNA prising and RNA 
transcription (Nichol et al.. 1981). All RNA synthesis occurs in the 
nucleus (Shapiro et al.. 1987).
Although the host s humoral response is primarily directed against the 
virus surface spikes, the internal structural proteins of the influenza 
virus 'core1 are important antigens far cell-mediated immunity. Cytotoocic T 
lymphocytes (Tc or CIL) recognise NP and Ml determinants in association 
with the target cell major histocompatabi 1 ity complex (KHC) class I 
antigens OtC class I restricted) (Townsend et al.. 1984; Gotch et al..
1987). The major influenza virus antigen is iff» which has at least three 
distinct Tc epitopes. These are different frcm those recognised by 
antibodies because anti-NP does not inhibit Tc recognition. It is thought ~  
that the Tc epitopes are presented in a processed form in a manner similar 
to that found for )tiC class II restricted presentation to T helper (Th) 
cells and that the H C  class I receptor can influence which epitope is 
presented (Townsend et al.. 1985).
The influenza genome comprises eight single-stranded RNA segments (MW 
0.27-1.00 xlO4) with negative polarity (Desselberger & Palese, 1978). The 
RNA segments code for the eight structural proteins described above plus 
two (possibly three) other non-structural proteins (Reviewed by Palese.
1977; McCauley & Mahy, 1983). The segmented nature of the influenza virus 
genome allows recombination events to occur during mixed infections leading 
to the phenomenon of 'antigenic shift* described below.
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The virus-coded non-structural proteins. MSI and NS2, are made in large 
amounts in the infected cells (Ccopans et al.. I960) and are found to 
accumulate in the polysomes and nucleolus (Dimmock. 1900; Shaw & Compare.
1978; Davey et al.. 1905). The functions of these proteins have not been 
established but MSI may be involved in host-cell protein shut-off and NS2 
in vRNA synthesis (Wolstenholme et al.. I960). A third possible 
non-structural protein (M3) has yet to be found and it exists only as an 
open-reading frame within the virus genome.
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1,1 : A n u q e o ic  d r i f t '  and a n tig e n ic  s h i f t 1 o f  type A in flu e n za  v iru se s
The segmented nature of the influenza virus genome allows the virus to 
undergo recombination events through the exchange of segments during a 
mixed infection. When new HA or NA segments are acquired from an 
antigenically unrelated type A virus this is termed antigenic 'shift'. 
Variation in the HA and NA also arises by the progressive acc^isition of 
point mutations, termed antigenic 'drift' . Together these mechanisms of 
genetic alteration combine to create one of the most striking features 
of influenza epidemiology, that is emergence of new. distinct virus strains 
which can differ in antigenicity, virulence, host range and
Type A influenza viruses can be divided into subtypes on the basis of 
serological cross-reactivities to HA and NA. To date thirteen HA 
(designated H1-H13) subtypes and nine NA (designated N1-N9) subtypes are 
known (WHO memorandum. i960). All the subtypes are found in birds whereas a 
more limited repertoire is found in higher animals, such as man. horses and 
swine. In man only three HA subtypes (HI. H2 and H3) and two NA sub-types 
(N1 and N2) have been found this century. A nomenclature system is used to 
identify influenza virus strains (WHO memorandum. I960) which designates 
the host of origin (except for human viruses). the geographical origin, the 
strain number and the year of isolation. The antigenic description of the 
virus is given in parenthesis e.g. A/Hong Kong/1/68 (H3N2) is a type A 
influenza virus of human origin isolated in Hong Kong in 1968. the strain 
number is 1 and it possesses the H3 haemagglutinin and N2 neuraminidase.
1 ;  t n t i i w i ' r  - d r i f t  ■ w i t h i n  F h .  i  n ,  n  »n rt  n . ^ l n , d . »  r ~ ,n ~ .
Antigenic drift arises from the gradual accumulation of point mutations 
within the HA or NA gene. A virus strain then arises which is of the same 
subtype but that can be serologically distinguished from its predecessor 
e.g. the A/Bangkok/79 (H3N2) strain is related to. but differs from A/Hong 
Kong/68 (H3N2) strain. Antigenic 'drift1 has been well documented for both 
HA and NA subtypes, and phylogenic relationships calculated (Webster et 
al.. 1982; Martinez et al.. 1983; Col man et al. . 1983; Wiley et al.. 1981; 
Young et al.. 1979; Cox et al.. 1988; Laver et al.. I960; Wang et al.,
1966; Robertson. 1987).
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In vitro, antigenic 'drift1 can be forced using monoclonal and polyclonal 
antibodies (Laver & Webster. 1968; Wiley et al.. 1981; Webster et al.. 
1982). Mutations arise, usually point autations. which cause the resulting 
virus strain to escape either the neutralizing or neuraminidase inhibiting 
effects of the eliciting antibody but not other antibodies to different 
antigenic sites. A single amino acid substitution is sufficient to evade 
the adverse effects of a monoclonal antibody and occur with a frequency of 
roughly 10* (ItehBtor & Laver. I960; Colean et al.. 1983; Webeter et al.. 
1982). On the HA molecule these mutations cluster into distinct antigenic 
sites (Gerhard & Webster, 1978; Laver et al.. 1979; Wilson et al.. 1981) 
whereas on the NA molecule the mutations cover almost all the exposed 
surface of the spike head (Colman et al.. 1983). In neither case do the 
mutations arise in the receptor binding or catalytic pockets of the 
respective molecules. It is thought that the mutations occur at the site of 
antibody binding and observations using electron microscopy support this 
view (Wrigley et al., 1983).
Selection of variants by immunological pressure allows the mutants to 
escape neutralization (Laver & Webster, 1968). In vivo substitutions need 
to arise within each of antigenic sites on the HA molecule for a natural 
mutant strain to arise because the hosts serum is polyclonal (Wiley et al.. 
1981). Therefore the frequency of new strains occurring should be very low 
and in support of this, no escape mutants have been successfully produced 
in vitro using polyclonal sera. Natali et al. (1981) dispute the fact that 
mutations need to occur in each of the antigenic sites to give a viable 
variant in nature. Variants of A/Texas/77 (H3N2) produced in vitro were 
tested against the sera of patients positive to the parental strain. They 
found 40» of the patients sera failed^react against such variants, even
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though only a single antigenic site was altered. It is also argued that not 
all the sites are e^ially immunogenic and that one site nay be 
immunodominant (Webster & Laver, 1960). There are also non-immune selection 
pressures in vivo where the host oell exerts an effect. Viruses isolated 
from eggs have an anti g em cal ly different HA from viruses isolated in HXX 
cells (Schild et al.. 1983. 1904; Katz et al.. 1967; Rott et a l .. 1964; 
Robertson et al.. 1967. Cbcford et al.. 1967). The haemagglutinin genes for 
H3 viruses isolated from wild ducks are conserved compared to those 
isolated over the same time period from man (Kida et al.. 1967) . The 
mutations that had occurred were randomly distributed throughout the 
molecule and not confined to antigenic sites.
1.3- Antiasnis vt Uw haagw ivtim n  and neur<niTH<v>r» <rnw
Antigenic shift arises from a re assortment event between RNA segments in 
dual infections and leads to a strain in which the HA or NA is 
serologically unrelated to the strain immediately preceding it. The 
antigenic 'shifts' recorded this century in man are H1N1 (1910-1957). the 
H2N2 (1957-1968) and H3N2 (1960-present day).
Antigenic 'shift' can be demonstrated in vitro by carrying-out mixed 
infections and selecting for recombinants using either monoclonal or 
mono-specific polyclonal antibodies. The origin of new influenza subtypes 
in nature is far less certain. Considerable evidence indicates that the 
emergence of new subtypes may arise by recombination between human and 
animal viruses in nature, with a tendency to acx^iire the HA of the more 
virulent parent virus (Kilbourne. 1974; Webster et al.. 1973 & 1971). 
Non-human hosts have glycoproteins similar to the human HI. H2 and H3
haemagglutinin subtypes (Laver & Webster. 1973- 1979; Austin & Webster.
1906). and the N1 and N2 neuraminidase subtypes (Webster & Pereira. 1960; 
Schlld & Newman, 1969). The human H3 subtype possibly cooes from an animal 
source, either duck or equine (Scholtissek et al.. 1970; Laver et al..
1973).
An alternative explanation for the emergence of new subtypes in nature is 
that a subtype is recycled after lying dormant in some unknown way and 
re-emerges at a later date e.g. H1N1 reappeared in 1977. twenty seven years 
after the last occurrence but has none of the expected evolutionary changes 
of 27 years replication (Nakajima et al.. 1978; Scholtissek et al.. 1979; 
Yeung et al.. 1979; Bean et al.. 1900). No explanation as to how this 
occurs has been found.
1,4, Structure of the haemaqqlutinin glycocrotein.
The structure and functions of the influenza virus haemagglutinin has been 
extensively researched, it is possibly one of the best understood proteins 
(Reviewed by Wiley & Skehel. 1907).
The haemagglutinin is translated as a single polypeptide chain and inserted 
into the endoplasmic reticulum membrane where the N-terminal signal 
sequence is removed. As the HA progresses through into the 4olgi apparatus 
it is glycosylated and cleaved into HA1/HA2 before it reaches the plasma 
membrane (Reviewed by Gething et al.. 1906).
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The structure of fcrcoelain digested haemagglutinin of A/Hong Kong/68 (K3N2) 
has been determined by X-ray crystalography (Wilson et al ■. 1901) and is 
reproduced in Figure 1.2. It is thought likely that the haemagglutinins of 
other subtypes have a similar structure because many of the important 
structural amino-acid residues (especially proline and glycine) are 
conserved, as are the disulphide bonds (of which there are five in the H3 
subtype). The haemagglutinin spike is a trimer (Hr 224.640) of HA1/HA2 
dimers linked by a single disulphide bond. The spike extends 13.5rm from 
the memtrane and has a triangular cross section. There are two structurally 
distinct regions within each HA1/HA2 dimer: (i) a stem region which extends 
7.6nm away from the virus envelope. This region is composed of both HA1 and 
HA2 polypeptide chains and is centred on two anti-parallel alpha-helices; 
(ii) a globular head region which sits on top of the stem. The head is 
composed entirely of HA1 polypeptide folded into eight anti-parallel 
beta-structures. It is the head region that contains the antigenic sites 
and the receptor binding site.
Each HA1/HA2 diner of H3 has seven glycosylation sites, all of tfiich are 
utilised, and carbohydrate makes up 19% of the HA molecular ««eight (about 
Mr 13.000). The carbohydrate is mainly located on the lower half of the 
haemagglutinin and covers 17-20% of the spike surface. The glycosylation 
sites on the HA2 polypeptide are highly conserved and are possibly involved 
in trimérisation (Klenk & Schwarz. 1907). The glycosylation sites and 
carbohydrate moieties on HA1 are more variable (Klenk & Schwarz. 1907). lut 
are import.ant as they can mask antigenic sites (Skehel et al.. 1904).
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Fig. 1.2. A stereo drawing of the alpha— carbon tracing of the
H3 haemagglutinin m onom er. The receptor binding site 
is at the distal (top) end of the molecule and 
the positions of the carbohydrate moieties 0  ) 
are also shown. (Wilson et ol.. 1981).
1 5
The trimeric spike Is stabilised by non-covalent interactions between the 
HA1/HA2 diner units. Moot interaction occurs between the stem regions which 
twist together to fern a triple-stranded helix. This stabilises the triner 
by hiding a 3.6ro hydrophobic domain on the top half of the sten structure. 
The memtrane anchor domains may also be important in triner stabilisation 
(Doms & He 1 emus. 1906). There are fewer interactions between the globular 
head regions, the contact between the heads is not extensive but a 
carbohydrate moiety attached to anino acid residue 165 of HA1 does span the 
interface and nay provide some stabilization.
The cell receptor for influenza virus is sialic acid bearing glycoproteins 
or glycolipids. The influenza viruses isolated from man have a specificty 
for *0 (2 .6 ) linked sialic acid whilst strains isolated from equine or avian 
hosts shew a specificity for *42.3) linked sialic acid (ft-itchett et al.. 
1907). These workers were able to block the binding of virus to 
erythrocytes using sialosides of known linkage. The human A/Memphis/102/72 
strain was only slightly inhibited by«x(2.3) linked aialosides butoo(2.6) 
linked si aloe ides (especially branched forms) blocked binding very 
efficiently. The influenza receptor binding pocket isA highly conserved 
depression at the distal end of the H3 haemagglutinin (Wilson et al..
1901). Weis et al. (1900) examined by X-ray crystallography the the same H3 
haemagglutinin, together with various mutants, complexed with a 
trisaccharide analogue of sialic acid (sialyllactose). The sialic acid 
binds to the HA with one face downwards in the depression and 66% of the 
sialic acid molecule surface is buried upon binding. There is no evidence 
conformational changes take place in the HA upon binding. Both the
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•«(2.3)- and the *(2.6)-linked sialic acid bind in essentially the sane way 
to the haemagglutinin. When leucine at position 226 of HA1 is changed to 
¿glutamine then a two-fold reduction in affinity for «e(2.6)-linked sialic 
acid compared to *(2.3)-l inked occurred (Weis et al.. 1906; Naeve et al.. 
1904; Rogers et al.. 1963). This is thought to be due to small 
conformational differences rather than altered binding. This conformational 
change is minor and did not alter the antigenic sites which surround the 
receptor binding pocket (Daniels et al.. 1907). Interestingly if residues 
224 to 230 of HA1 were deleted (completely removing the left side of the 
pocket), the virus was still viable but only had altered binding 
characteristics (Weis et a l .. 1968). Also in nature, avian viruses which 
replicate in the intestinal tract and have a higher affinity for 
«¿(2,3)-linked sialic acid, have a glutamine instead of leucine at position 
226. If mutants of A/Duck/Ukraine/63 were produced with an affinity for 
•<(2.6)-linked sialic acid, then glutamine was found to be altered to 
leucine at position 226 (Rogers et al.. 1905).
Recently considerable interest has focussed on the point of cleavage 
between the C-terminal of HA1 and N-terminal of HA2. Wilson et al. (1961) 
showed the ends of the HA1 and HA2 chains are 2.lnm apart which implies a 
considerable structural rearrangement occurs on cleavage. The N-terminal 
region of HA2 is highly conserved and is glycine rich. This causes a series 
of four reverse turns which is an uncommon protein conformation. This 
region of the HA is therefore strongly non-polar and highly flexible, and 
has been strongly implicated in the lew pH induced fusion of viral and 
cellular memfcranes (discussed in more detail later).
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Cleavage is also important in the internalization of attached influenza 
virus by cells. Scholtissek (1966) found that influenza viruses with 
uncleaved haemagglutinin adsorbed to cells but were not internalized. 
Viruses with uncleaved HA. in contrast to viruses with cleaved HA. remained 
accessible to removal or destruction by pH2.5 treatment. Cleav**ge of HA is 
also an important determinant of virulence. This has been reported for 
various HA subtypes :3osch et al.. 1979; Rott et al.. 1980; Chuchi et al.. 
1969). Influenza viruses with uncleaved HA were found be non-pathogenic and 
although they replicated they failed to spread from the site of infection, 
unlike those with cleaved HA which spread rapidly and were pathogenic (Rott 
et al.. I960; Scholtissek et al.. 1968). Kawaoka et al. (1967) compared the 
HA of avirulent A/Duck/113/83(H5N8) and a highly virulent virus strain. 
A/TUrkey/1378/83(H5N8). Genetically the viruses were very similar, with 
only a 16 base and 4 amino acid difference between the HA's. The HA of 
the avirulent virus was not cleaved whereas the virulent form was. 
indicating that cleavage was important in determining virulence. In the 
connecting peptide region of the HA there was only a single arginine in 
avirulent virus whereas virlent strains has at least a pair of basic amino 
acids. They concluded that HA cleavage is determined by the connecting 
peptide and is important in virulence. Additional factors were also 
involved in determining the virulence of inf luenzaTbecause tt»®»® workers 
found that if they infected wild ducks with the virulent strain, then 
replication occurred but no disease. Virulence may be linked to the 
distribution of trypsin-like enzymes in tissues of the host and it is 
possible that in wild birds such enzymes have a restricted distribution.
The host trypsin-like enzymes may result from co-infection with bacteria, 
the strain of co-infecting bacteria has been shown to affect the cleavage 
of HA and influenza virus pathogenicity (Tashiro et al.. 1967). Wild
acpjatic fowl may met as a 'reservoir' for influenza viruses which are 
virulent for domestic poultry (Kawaoka et al.. 1987; Nestcrowicz et al..
1987). It is also worth noting that both of the above viruses occurred very 
close together in geographic origin and tise. and is good evidence of the 
spread of virus fro* wild to domestic birds. Also Kawaoka et al. (1987) 
were able to demonstrate a divergence of the H5 subtypes by following 
either the North American or European flight paths of wild aquatic fowl.
1 5 - 7T* antiremc n m  on the h«>awinUnin,
The antigenic sites on two haemagglutinin subtypes (H3 and HI) have been 
extensively investigated.
¡•5-1. The H3 hasiwqglviU n in PMfrtyre,
Using monoclonal antibody generated variants of A/Memphis/1/77(H3N2),
Webster & Laver (1980) found at least 3 non-overlapping antigenic areas lay
icomparing haemagglutination-inhibition titres to a panel of 30 monoclonal^ . 
These antigenic sites were designated I. II and III. The frequency of 
variation within each antigenic site varied but averaged log^-5.3 and could 
be as low as log^-7.3, indicating that differences exist within single 
antigenic areas. When two monoclonal antibodies directed to different 
antigenic areas were used in combination, the frequency of escape mutants 
fell to less than log*-6.0. Only one escape mutant (in site II) could be 
differentiated from the parent using polyclonal, hyperiamune sera, 
suggesting that most of the variants created would not have had a selective 
advantage in nature. The fact one did occur indicates that a change in a 
single site may have epidemiological significance. The epidemiology of
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natural H3N2 variants was examined. the first changes occurred in site II, 
then site III (in roughly 1972) and lastly in site I (in roughly 1977).
These workers also found two different H3H2 lineages. A/Hong Kong/1/68 
which spread to Europe and A/Aich1/2/68 which spread to the USA. but they 
were uncertain as to whether the viruses originally came from the same 
source.
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Breschkin et al. (1961) used A/Memphis/102/72 (H3N2) variants to map the 
antigenic sites, but instead of mapping the positions of nutation they 
studied the competition in binding of monoclonal antibodies by RIA. Four 
distinct antigenic regions were found: (i) There was one major region to 
which all neutralizing and HI antibodies bound. These had differing strain 
specific and cross-reactive patterns and therefore they concluded that 
there were many overlapping/adjacent epitopes. This region agreed with 
group III site of Webster & Laver (1960). (ii) Two of the other regions 
were distinct but not remote to that described above, to which 
non-neutralizing and non-HI monoclonals bound. These would not be found by 
Webster & Laver (1960) as escape mutants would not have been produced.
(iii) The last region was remote from others to which again 
non-neutralizing, non-HI monoclonals bound.
When the H3 structure was resolved (Wilson et al.. 1961). it became 
possible to map mutations to their position on the HA molecule. Wiley fit 
al. (1961) used A/Hong Kong/68 (H3N2) bromelain cleaved HA (EHA) and 
located 4 distinct antigenic sites by mapping both natural and laboratory 
generated mutants (Figure 1.3a). Site A was a 'loop' structure (HA1 
residues 140 to 146) which protruded O.Snm from the rest of the HA monomer. 
This is believed to be the iamunodominant site described by Webster & Laver
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a b
Fig. 1.3. Diagram of the neutralizing antigenic sites on 
the H3 (a ) and H1 (b ) haemagglutinin trimers. 
Also shown are the carbohydrate attachment 
sites ( V )  and the receptor binding sites. 
(Caton et ol., 1982).
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(1980). Site B was defined only by natural H3 variants and lay on the edge 
of receptor-binding pocket (HA1-187 to 196). Site C was a bulge 6ns from 
distal tip, at S-S bond (cystine residues at 52 and 277). Site D occurred 
at the trimer interface. A further putative antigenic area was proposed, 
site E. but this was masked by carbohydrate on the A/Hong Kong/68 virus. 
The H3 antigenic sites were confirmed to be the actual sites of antibody 
binding by observation using the electron microscope (Wrigley et al..
1983). It was also found that the angle of the antibody arm and the 
haemagglutinin was varied according to the site to which it was bound. The 
HI sites were mapped using the H3 structure. These were similar but not 
identical (see below).
1.3.2. The HI htwaonlutinin subtype.
Gerhard et al. (1981) used monoclonal antibodies to produce escape mutants 
of A/FR/8/34 (H1N1) and constructed an operational (rather than physical) 
antigenic map of the HA using RIA. They found four antigenic sites, two of 
which were 'strain specific* (designated Sa and Sb) and two that were mare 
'cross reactive* (designated Ca and Cb) (Figure 1.3b). There was some 
linkage between Sa and Sb. indicating that they may possibly be close 
physically. The designation of 'strain specific* versus 'cross reactive* 
arose because it was thought that antiviral immune mechanisms exert 
stronger selection pressure on Sa.Sb than on Ca.Cb. There was no greater 
inherent mutability of these sites but antibodies to Sa and Sb neutralized 
ten-fold better in vitro than those to Cb. They found anti-Ca antibodies 
neutralized relatively well compared to anti-Sa and anti-Sb, they suggested 
that man produced an insufficient quantity of anti-Ca antibody, thereby 
reducing the immune selection pressure on the Ca antigenic site.
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Caton et al. (1982). also using A/PR/8/34 compared the positions of 
mutations to where they lie on the H3 structure found by Wiley et al.
(1981). The HI had low total homology with the H3 but alsost all U» 
mutations lay on the predicted surface of the HA. The monoclonal antibody 
mutants clustered into distinct groups on^-D model. Previously Gerhard 
al ■ (1981) had found 4 sites on A/PR/8/34 HA and designated them 
Sa.Sb.Ca.Cb. Caton split the Ca site into Cal and Ca2 but found a strong 
linkage between them. Other linkages were found between antigenic sites 
e.g. Sa-Cal and possibly Cb-Ca2. Although mere than 50% of variants mapped 
exclusively to distinct sites, it was found that as the number of mutants 
examined was increased, then sites became less distinct. They concluded 
that it was best to view the HA head as a large contiguous antigenic area 
with 5 immunodominant regions.
Lubeck & Gerhard (1982) demonstrated synergistic binding between the Sa and 
Ca antigenic sites, giving roughly ten-fold enhanced binding. This 
enhancement was not due to antibody-antibody interaction and was maximal 
when the other antibody saturated its antigenic site. The synergism was 
only reflected in antibody binding by RIA and was not apparent by 
haemagglutination-inhibition. unfortunately they did not assay 
neutralization. It was concluded that the binding of antibody induced a 
conformational change in the HI haemagglutinin. It should be noted that 
they meotired binding to HA lunobi 1 lsed on plastic by RIA. It has been 
argued that the binding of HA to plastic induces gross conformational 
changes in the HA. similar to that found induced by low pH (Nestorowicz et 
al.. 1985).
Drescher et al. (1967) prepared polyclonal antibodies to A/a-azi 1/11/78 
(MINI) in chickens and rabbits, and separated the antibodies so that they 
were either directed against strain specific (SSA) or common (CAA) 
antigenic sites. These polyclonal antibody preparations seemed to represent 
the corresponding mixtures of monoclonal antibodies (i.e. pcSSA competed 
with Sa/Sb and pcCAA competed with Ca/Cb). Also SSA and CAA did not differ 
in avidity for their respective sites, all sera either (SSA.CAA) or 
(Sa.Sb.Ca.Od) recognised roughly 1.000 epitopes per virion.
ÇqnfçreWiqml tfwnreg indue«! in ttw «ntiatnis a i t »  it
hawwal u t i m n  by lei m t r a n e  tuaion.
Daniels et al ■ (1963) treated the X-31 (H3N2) (which is derived from 
A/Aichi/68) EHA at pH 5.0 which causes fusion of viral and cellular 
membranes. This also lead to a conformational change in the N-terminal 
region of HA2. The antigenic changes were observed by reaction with 
monoclonal antibodies with defined specificities, fln treatment at pH 5.0.
EHA became aggregated and susceptible to tryptic digestion. The latter 
resulted in two fractions, the 'tops' of HA1 monomers, and aggregates of 
HA2 plus some HA1 (residues 1 to 27). This would suggest that the HA heads 
separate at pH 5.0. Daniels et al. (1963) found monoclonal antibodies to 
sites A.C or E still recognised the EHA at pH 5.0 (with or without tryptic 
digestion). Whereas monoclone Is to sites B or D failed to recognise or 
recognised poorly pH 5.0 EHA. This indicates that a conformational change 
has altered the antigenicity of these sites. Some antibodies to site B (to 
HA1 residues 157 and 193) still recognised pH 5.0 EHA and therefore site B 
can be split into 2 regions (residues 156,156.196 versus residues 157,193).
2 3
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There was no alteration of site B (site D was not done), when uncleaved EHA 
was exposed to pH 5.0. Conformational change and antigenic alteration 
therefore depends on cleavage of the HA.
Webster et al. (1963) used both untreated and pH 5.0-treated virus to 
generate monoclonal antibodies. The virus strains used were A/Meaphis/2/71 
(H3N2) and X-31 (H3N2) (which is closely related to A/Memphis). The 
irreversable conformational change in the H3 HA following exposure to pH 
5.0 resulted in the generation of new, non-neutralizing antigenic regions. 
These monoclonal antibodies inhibited haemagglutination only after pH 5.0 
treatment of HA. There was a concomitant loss of the previously defined 
antigenic sites at the tip (site B) and interface (site D). hence 
conformational changes caused by fusion are primarily located in these 
regions. The sites at the loop (site A) and bulge/hinge (site C) are not 
affected by pH5.0 treatment. The binding of antibody specific for HA at 
neutral pH was not sufficient to prevent the change in HA taking place 
following exposure to acidic conditions. Vino* pre-treated at lew pH bind 
to erythrocytes and haemagglutinate, but have no inf activity and do not 
cause haemolysis. Virions that have attached before the acid-shift do 
haemolyse. It was surprising that antibodies to neutral pH HA inhibited 
haemolysis whereas those to acid-treated HA did not. It is possible that 
the process of conformational change at the erythrocytic surface is 
responsible for the HA penetrating the lipid memfcrane. This taken together 
with the fact that monoclonals to the acid-treated HA did not neutralize 
indicated that in the normal infection the HA alters its conformation at a 
location where it is inaccessible to antibody i.e. in endosomes. Therefore 
virions with acid-modified HA are not capable of initiating infection.
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Kostolaneky et al. (1968) used monoclonal antibodies prepared against 
either HA1 or HA2 to assess the low pH-induced conformational changes in 
the HA. The antibodies recognised epitopes outside the major antigenic 
sites and neither inhibited haemagglutinationaor neutralized the virus.
They found some of the antibodies, both anti-HA 1 and anti-HA2. had improved 
binding. Indicating that both subunits of the HA underwent a conformational 
change at acid pH. If polyclonal antibodies were used then no differences 
in binding were observed.
Yewdell et al. (1983) found pH 5.0 treatment of A/PR/B/34 (H1N1) lead to 
widespread and irreversible conformational changes of the antigenic sites. 
Antibodies against Sa and Sb had reduced HI activity whereas those to site 
Cb had increased HI activity. Antibodies against site Ca varied in their 
alteration, some with improved activity and others decreased activity. They 
support the view of Caton et al. (1962) that site Ca should be split into 
two close but distinct sites. Cal and Ca2. Comparison of the data using HI 
haemagglutinin with those using the H3 subtype revealed differences in the 
pH-induced alterations in conformation, suggesting that each HA subtype mayfe 
affected differently.
1.6 flt.nirtiir. nf th . n«vr» .lnjslM .  ™lwyyotcin.
The N2 neuraminidase structure has been resolved using X-ray crystallography 
(Varghese et al.. 1983). The spikes are mushroom shaped and tetrameric.
Each monomer has a slender, flexible stalk and a box-shaped head composed 
of six anti-parallel beta sheets. There are five potential glycosylation 
sites on the N2 neuraminidase, four of which are linked to carbohydrate.
The tetramer has a four-fold axis of symmetry and is possibly stabilised by
one of the carbohydrate moieties free each monomer. The memfcrane 
orientation of the neuraminidase is unusual for a tranememfcrane 
glycoprotein as it is anchored via the N-terminal rather than the usual 
C-terminal.
Neuraminidase (acylneuraminyl hydrolase EC 3.2.1.18) enzymatically 
hydrolyses glycosidic bonds of N-acetylneuraminic acid (sialic acid) to 
release either D-galactose or D-glucose (Gottschalk. 1957). Each monomer 
has a large, highly conserved pocket at the end distal to the virus surface 
and therefore each spike has four catalytic sites (Varghese et al.. 1963).
The N9 neuraminidase subtype Is unusual as it also has a high 
haesagglutination activity (Air et al.. 1967). They suggest that the two 
activities reside at separate sites on the N9 molecule because an inhibitor 
reduces the neuraminidase activity but has no effect on haemagglutination. 
Gene and protein sequence analysis of this neuraminidase showed no 
significant homology to either influenza virus haemagglutinin or the HN 
glycoprotein of the paramyxovirus. SV5 (Air et al.. 1965).
Neuraminidase mutants can be selected using monoclonal antibodies 
mggesting a possible role for neuraminidase in disease and selection 
(Webster et al.. 1962). The antigenic sites on the N2 subtype overlap and 
form a nearly continous surface covering the top of each monomer, 
encircling the catalytic pocket (Colman et al.. 1963). The N9 subtype has 
also been analysed and has a very similar structure, it is also one of the 
few antigens to have been miccessfully crystal lsed with bound Fab' antibody 
fragments (Laver et al.. 1967; Col man et al.. 1967). Unlike lysozyme (Amit 
et al.. 1965). the N9 neuraminidase undergoes conformational change when 
Fab' fragments are bound and there is a shift of up to 3& at the centre of
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the epitope (Colean et al.. 1987). The Fab' nay also alter its conformation 
and Col man et al. (1987) liken the character of antibody binding to a 
'handshake'.
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Antibodies to neuraminidase are non-neutralizing (except at very high
concentrations) and may attenuate illness (Rott et al.. 1974) and give
protection against lethal infection (Webster et al.. 1968). They inhibit or
reduce the substrate activity of the enzyme, possibly by displacing
arginine at position 371 from the catalytic pocket (Colman et al.. 1987).
The size of the substrate influences the antibody affect, the cleavage of
large substrates (e.g. fetuin) is inhibited but not smaller substrates and
the antibody possibly acts by steric hindrance (Jackson & Webster. 1982).
Antibodies also reduce the budding and release of progeny virus frcm the
infected cell surface (Webster & Laver. 1967; Kilboume et al.. 1968;
Dowd le et al.. 1974). The valency of the anti-neuraminidase antibodies is
important because bivalent (Fab’)2 fragments inhibit both NA activity and
virus release, whereas monovalent Fab’ fragments only inhibit substrate
activity (Becht et al.. 1971). These workers argue that anti-neuraminidase
antibodies act by forming a lattice between the released virus and the NA
in the host cell membrane, thereby reducing the release of virus from the
cell. Others believe the anti-NA antibodies act by preventing the NA
cleavage of host cell receptors; the progeny virus particles re-attach to
these receptors and are not released into the culture medium (Klenk et al..
1970; Seto & Rott. 1966; Cohans et al.. 1969; Palese et al.. 1974).
♦
Anti-NA antibodies may also inhibit influenza virus-induced low pH membrane 
fusion to H *  cells (Huang et al.. 1981) and erythrocytes (Huang et al.. 
1985). Liposomes only fused if either they contained cleaved HA and NA
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together; or if they contained cleaved HA alone plus additional soluble NA 
(Huang et al.. 1980). This indicated an enzymatic role for the NA within 
the fusion process, and these workers argue that in vivo the NA cleaves the 
HA 1-receptor bond, allowing the HA2 to insert into the lipid membrane, 
resulting in fusion. The anti-NA antibodies sterically block the NA 
activity and inhibit the membrane-fusion. Fusion activity could be restored 
by the addition of extra soluble REE (receptor destroying enzyme, a 
bacterial neuraminidase from Vibrio cholerae). The role of NA in 
virus-induced membrane fusion is disputed by White et al. (1982) who showed 
that cells transfected solely with the haemagglutipin gene of influenza did 
fuse efficiently at acid pH and demonstrated that the presence of
neuraminidase is not essential.
2 9
2- Intlyjyga intwttw mi twwij,
2,1. Clinical aanitegtotione of diaeaae in »an.
In nan, influenza is a predominantly an upper respiratory tract (URT) 
infection with occasional lung involvement and rarely viraeaia (reviewed 
by Kilboume, 1967). The severity of the illness varies considerably, some 
influenza viruses produce subclinical infections whereas others produce 
acute illness which may prove fatal. The symptoms commonly associated with 
influenza include nasal discharge, cough, fever, headache, myalgia, 
anorexia, malaise and depression; occasionally gastrointestinal and 
neurological effects are seen. Secondary bacterial infections are common 
and are major contributors to influenza complications and mortality. 
Influenza infection is frequently associated with acute respiratory disease 
which can lead to hospitalization (Glezen et al.. 1987). In the U.S.A. 
during the pandemic years 1968-69 the economic impact of influenza virus 
was estimated as between $1.7 to »3.9 billion (Kilboume. 1987).
The data on the relative virulence of different strains of influenza virus 
in man mainly come from clinical observation of either natural epidemics or 
volunteer trials. Interpreting data from epidemics is complicated by 
socioeconomic factors e.g. the mortality rate of the 1918 pandemic was 16 
times higher than that in 1957 which might suggest that the 1918 virus 
strain was much more virulent (Sweet & £taith, I960). However this could be 
equally due to the poor primary health care in 1918. lack of availabilty of 
antibiotics to control bacterial pneumonia and the low socioeconomic 
conditions which prevailed at the end of the Great War. Volunteer trials 
attempt to overcome the variations in epidemiological studies of morbidity
and mortality by using a defined sample population. Most trials involve a 
limited number of healthy adults and therefore fail to reflect the sections 
of society for whom influenza is a serious problem i.e. the old and those 
with cardio-pulmonary problems (Sweet & Smith, I960).
2,2.- Aniwl isflslg gf infiuwga inircticn in ian.
The complications associated with interpreting data involving human 
populations has lead many groups to explore the use of animal models. 
Influenza infection of laboratory animals can studied at two levels; The in 
vivo effects on the whole animal and the in vitro effects on isolated 
respiratory tissue explants i.e. organ cultures.
2:2.1; 7T* in yiyg inftrtiqn vt an lie Is fry influenza virus,
Most in vivo investigations of influenza virus pathogenesis have utilised 
the ferret because intranasal inoculation of human influenza virus isolates 
leads to a non-fatal URT infection with symptoms similar to those in man 
i.e. sneezing, nasal discharge, listlessness, pyrexia, and anorexia (Sweet 
& Smith, 1980). Infection is not fatal even though ferrets are slightly 
more susceptible to infection than man (Campbell et al ■. 1979). The 
relative differences in virulence observed in man agree well those observed 
in ferrets (Toms et al.. 1976; 1977; Sweet et al.. 1977; Fenton et al..
1977; Campbell et al.. 1979).
In-bred strains of mice can be infected and have proved important in the 
study of the immunological responses to influenza virus infection and this 
will be discussed later. In-bred mice produce no overt disease when
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inoculated intranasal ly with freshly isolated human influenza viruses 
although infection of the respiratory tract does occur (FYankova, 1975). 
Passage of virus through in-bred sice increases virulence (Sugiura & Ueda, 
I960; Rudneva et al.. 1906). The infection is primarily of the lower 
respiratory tract (LRT) with gross lung pathology (FVankova. 1975). The 
infection can become systemic leading to infection of many internal orgarm 
and is often fatal (Frankova & Rychterova. 1975). The strain of mouse used 
also influences the infection, mice bearing the Mx gene survived infection 
by a neurotropic influenza virus whereas »be negative mice died (Spriggs,
1906; Krug et al.. 1905; Staeheli et al.. 1906). Virulence in mice does not 
correlate well with that found in man <a#eet & Staith. 1900) and therefore 
mice are not as good a model of human infection as ferrets, although the 
involvement of the LRT is similar to that occasionally found in man.
2 .2 .2 . 1»» organ c u ltu re  ttctim au e.
The aim of the organ culture technique is to maintain fully differentiated 
cells in a histologically and functionally intact state. Crgan cultures 
have been prepared from a wide range of tissues e.g. palate, nasal 
turbinate, trachea, lung, skin, cartilage, fallopian tube, gut, brain etc. 
Most attention has focused on those tissues that have ciliated epithelium, 
particularly nasal and tracheal tissue of the URT. because the cilia can be 
seen beating using light microscopy (Hoorn, 1966) and this provides an easy 
method of assessing the functional activity of the tissue. The technique 
used to prepare tracheal organ cultures, the most commonly used source of 
organ cultures, is discussed later in the thesis (section 6.2.2.) and 
therefore will not be dwelt on here. The range of animal donors from which
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organ cultures have been prepared is equally as wide and this is discussed 
below. Organ cultures have been used for almost a century and their use in 
virology can be roughly divided into the pre-1970 and post-1970 phases.
The early history and usage if organ cultures is reviewed by Hoorn (1966). 
Before 1970 organ cultures were used to isolate new virus strains (Hoorn & 
Tyrrell. 1965; Almeida & Tyrrell, 1967; Harnett & Hooper. 1960) and observe 
the pathogenic effects of a wide range of respiratory viruses (Hoorn & 
Tyrrell. 1966a; 1966b). Comparisons were made between unrelated viruses but 
little attempt was made to compare closely related viruses of differing 
virulence and this is one of the features that distinguishes pre-1970 work 
from later work. The second distinguishing feature of the early work is the 
animal sources used for organ culture preparation. CTgan cultures were 
prepared from human foetal and adult post-mortem tissue and the animals 
used tended to be either large and expensive or limited in supply e.g. 
calf, dog. pig and monkeys. Tracheal organ cultures were prepared by 
longitudinal sectioning (Hoorn. 1966) rather than by transverse sectioning 
which has been more commonly used since 1970.
The development of live, attenuated influenza virus vaccine strains in the 
1970's changed the use of organ cultures. Many groups now used organ 
cultures, mainly prepared from ciliated respiratory tissues, to assess and 
compare the virulence of closely related virus strains. Most research has 
focused on influenza virus (discussed below) but other viruses and 
pathogens have been studied. Chick embryo tracheal organ cultures were used 
to study the pathogenesis of infectious bronchitis virus (IBV) (Cherry & 
Taylor-Robinson. 1970; Derbyshire et al.. 1979; Cavanagh et al.. 1906). The 
relative virulence of sexually transmitted diseases has been assessed using
human fallopian tube organ cultures, which also possess ciliated epithelium 
(McGee et al.. 1976). The pathological effects of virulent mycoplasm» have 
been determined using tracheal organ cultures from ferret (Hu et al.. 1975) 
and chick emfcryo (Cherry & Taylor-Robinson. 1970).
Marry different groups have used tracheal, and to a lesser extent nasal 
turbinate, organ cultures as model to assess influenza virus virulence. The 
most striking feature of the data is the lack of a uniform technique. Each 
group has tended to use different maintenance conditions and different 
methods to assess pathological damage (discussed in Methods 2.2. and 2.3.). 
Attempts have been made to resolve the differences concerning medium 
(Blaskcrvic et al.. 1973) and whether cultures should remain stationary or 
be kept mobile (Cherry & Taylor-Robinson. 1970), but the results have had 
little impact on the field of organ cultures. New techniques have been 
explored and abandoned; for example the combined tissue culture and organ 
culture system (Blaskovic et al.. 1972b) or the use of tetrazolium-trypan 
blue staining (IT test) to demonstrate histological damage (Herbst-Laier, 
1970b).
The animal source used to prepare organ cultures also changed in the 
1970 s. Herbst-Laier (1970a) compared tracheal organ cultures prepared from 
a wide range of animal sources (human, monkey, dog. ferret, rat, pig, 
hamster and mouse) as a model system to evaluate the efficacy of 
anti-influenza virus drugs. She found the limited supply of human foetal 
and dog trachea together with their variable quality restricted the 
potential use of these animals. Pig tracheal organ cultures were also 
rejected because they had poor susceptibility to influenza virus infection. 
Hamster and mouse organ cultures suffered necrotic damage during sectioning
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because of the snail trachea size, which resulted in a shorter effective 
lifespan far such cultures. It was concluded that the most suitable animal 
models were the ferret and rat. These findings have been largely either 
ignored or refuted by others. Human embryo tissue continued to be used 
(Moetow & Tyrrell. 1973; Hara et al.. 1974) but the use of smaller animals 
became mare coonon. Ferrets were employed predominantly but other animals 
have also been used successfully.
When comparing the known virulence in man to that on organ cultures, two 
criteria have been investigated: virus multiplication and destruction of 
cilia activity. Virus multiplication has proved to be a poor measure of 
virulence using both human, ferret and hamster tracheal organ cultures, 
with little or no difference between virulent and avirulent strains (Moetow 
& Tyrrell. 1973; Hara et al.. 1974; Moetow et al.. 1979; Abou-Donia et al.. 
1980; Heath et al.. 1983). However the destruction of ciliary activity on 
tracheal organ cultures has correlated very well with virulence using 
tissue from humans (Moetow & Tyrrell. 1973; Hara et al.. 1974). ferrets 
(Hara et al.. 1974; Fenton et al.. 1977; Boudreault. 1979; Diaz-Rodriguez & 
Boudreault. 1982). rats (Ali et al.. 1982a). hamsters (Ali et al. . 1982b; 
Heath et al.. 1983), mice (Westerberg et al.. 1972) and chick embryos 
(Blaskovic et al.. 1972a; 1972b). Many factors have been found which 
influence the rate of destruction of cilia activity; Increasing the amount 
of virus in the inoculum accelerates the rate of damage and shortens the 
time at which virus multiplication is detected (Hoorn. 1966). Hara et al. 
(1974) compared tracheal organ cultures from humans and ferrets. In both 
systems virulence correlated very well with the destruction of ciliary 
activity. The destruction of ciliary activity on ferret tissue was 
considerably slower than found on human tissue (i.e. a 50% reduction in
activity occurred by day 12 in ferret tissue compared to day 4 in human 
tissue). The age of the donor animal may also influence the rate of damage 
observed as has been found using hamsters, where cultures from old animals 
were less susceptible to infection and suffered less cilia damage (Schiff, 
1974). The serostatus of the donor has an effect as Edwards et al. (1966) 
demonstrated using human adenoid organ cultures. The passage history of the 
particular virus strain may influence the apparent virulence. Virus that 
had been repeatedly passaging in eggs showed reduced multiplication on 
organ cultures and damaged cilia less than similar virus that had been 
passaged a few times through organ cultures (Hoorn, 1966; Gorev, 1975).
2.3. Pathogenicity of influenza viruses.
Pathogenicity describes the mechanism by which the virus produces illness 
and is a result of complex interactions between the virus and the host 
organism (reviewed by Sweet & Smith, I960).
In ferrets, the detection of viral antigens by fluorescent antibody 
demonstrates that the infection tends to spread down the respiratory tract,
(Sweet et al.. 1981; Husseini et
al.. 1983). Nasal turbinates are the major site of influenza virus 
replication in ferrets (Sweet et al.. 1981). Some in vivo studies have 
demonstrated that avirulent viruses could be distinguished from virulent 
strains because they multiplied over a longer period and gave lower nasal 
wash virus titres (Toms et al.. 1977; Sweet et al.. 1977; Fenton et al..
1977; Campbell et al.. 1979. Heath et al.. 1986). Other studies have 
reported no appreciable differences in nasal wash virus titres (£*/eet et 
al.. 1981; 1984) and this parameter does not appear to be reliable. The
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trachea is also a primary site of infection. Using fluorescent antibodies, 
influenza antigens were detected with* 24 hours of intranasal inoculation 
and were maximal at 40 to 72 hours (Husseim et al.. 1903). It was observed 
that infection was focal and did not encompass the entire epithelium; 
goblet cells in addition to epithelial cells were infected. This contrasts 
with the findings of Dourmashkin & Tyrrell (1970). who did not observe 
virus attaching to mucus secreting cells of guinea-pig trachea. No 
differences in virus multiplication. ciliary destruction or histology were 
found between the upper/middle/lower sections of the trachea (Hara et al.. 
1974). The pattern of infection in the bronchi is similar to that of the 
trachea and both these tissues release virus more efficiently than the 
nasal turbinates (Hussein! et al.. 1963). Viruses of differing virulence 
could be distinguished both by cilia damage and virus sultiplication using 
ferret bronchi (»#eet et al.. 1904). In the lungs, both the bronchioles and 
the alveolar cells show few signs of infection in the ferret (Husseini et 
al.. 1903). The nasal turbinates of ferrets produce 10-fold more virus on a 
per cell basis than lung alveolar cells and release into the medium a 
greater proportion of the virus produced (Cavanagh et al.. 1979; Husseini 
et al.. 1903). If alveolar organ cultures were maintained for 24 hours 
before inoculation then higher virus titres were obtained in the 
medium (Kingsman et al.. 1977a; 1977b; Cavanagh et al.. 1979). in contrast 
maintenance of nasal and tracheal organ cultures did not increase virus 
titres appreciably. Kingsman et al. (1977a) found that maintained lung 
organ cultures were more susceptible to infection and underwent marked 
histological changes which included the appearance of necrotic zones and 
vacuolization. The maintained alveolar organ cultures did not have a 
different amount of surfactant (Kingsman et al.. 1977b) . It was observed 
that 2- to 3-fold more virus particles bound to maintained cells but a
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similar observation was made using nasal turbinate organ cultures, 
suggesting that this is not an important factor in tissue maintenance. 
Cavanagh et al. (1979) found that maintenance did not increase either the 
number of cells infected or the total virus production but that the amount 
of virus released by cells had increased by 20- to 100-fold. The reasons 
why maintained tissue released more virus is unknown and is not due to 
proteolytic cleavage of HA because both fresh and maintained lung cultures 
produced virus with cleaved HA. They concluded that the poor virus release 
in the lungs explained why influenza virus produced an URT rather than LOT 
infection. It was suggested that the poor virus release may be due to 
alveolar cells having either small numbers of ribosomes and mitochondria 
(type I alveolar cells) or little smooth endoplasmic reticulum (type II 
alveolar cells), both of which are important in the formation of progeny 
virus.
The first barrier to infection of the URT is the mucociliary blanket which 
covers the epithelial surface. The virus particles become 'entangled* in 
the mucus blanket by attaching to N-acetyl neuraminic acid residues present 
in the mucus secretion (Dourmashkin & Tyrrell, 1970) and the rate at which 
the virus penetrates this barrier is affected by its thickness and 
viscosity (Blaskovic et al.. 1972a). These workers suggested that virus 
attachment to tracheal organ cultures should be studied at physiological 
temperatures because at 4*C the viscosity of the mucus increased, greatly 
slowing virus penetration to the epithelial cells. The viral neuraminidase 
may be important at this stage of infection by releasing virus that has 
attached to the mucus and possibly also decrees^ viscosity (Gottschalk,
1957). Influenza virus may also reduce mucociliary clearance by infecting 
the subepithelial mucus-secreting glands. Gentry et al. (1988) have
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demonstrated that primary cultures of feline tracheal glands do undergo a 
productive non-lytic infection by influenza. When the virus particles have 
penetrated the mucus blanket they attach to the epithelial cells and in 
particular adhere to the cilia (Dourmashkin & Tyrrell. 1970). Westerberg 
al. (1972) observed by EM that virus attachment caused the cilia of mouse 
tracheal organ cultures to clump and suggested that this might reduce 
mucociliary clearance of the virus. The significance of these findings is 
doubtful because every other group that has used ciliated organ cultures 
have found that the cilia appear to beat normally after inoculation of 
virus. The virus enters the cells by viropexis and replication proceeds, 
this will be discussed later. The pathogenic damage caused to the ciliated 
epithelium of organ cultures is usually recorded as a reduction in ciliary 
activity and disorganisation of the synchrony of cilia beating, often 
referred to as ciliostasis. As discussed previously the reduction in 
ciliary activity correlated with the relative virulence of the virus 
strain, suggesting that a similar mechanism has a major role in influenza 
pathogenesis. At the cellular level cytopathic changes precede ciliostasis 
(Dourmashkin & Tyrrell. 1970; Westerberg et al.. 1972; Schiff. 1974). Hu 
a). (1975) used ferret tracheal organ cultures to examine the destructive 
effects of virulent mycoplasma on ciliated epithelium. Metabolic changes 
occurred in the cells prior to ciliostasis. including reduced uptake of 
galactose and amino acids together with reduced cellular RNA and protein 
synthesis. Blaskovic et al. (1972a; 1972c) detected influenza viral 
antigens in the epithelial cells of chick embryo tracheal organ cultures at 
12 hours post-infect ion (p. i.), and budding of progeny virus also started 
at this time. At 24 hours p.i. considerable vacuolization and dehydration 
of the epithelial cells w *  seen, and the epithelial layer progressively 
became flatter and less columnar in appearance. At 48 hours p.i. the
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ciliary activity of the cultures began to fall, large numbers of epithelial 
cells had a rounded-up morphology and were eventually shed fro« the culture 
surface. Cells continue to be shed fro« the surface of cultures and 
eventually this strips the organ cultures, revealing the basal membrane. 
Frequently the cells that had been shed fro« the cultures still had 
actively beating cilia. Weeterberg et al. (1972) observed very similar 
cytopathic changes using mouse tracheal organ cultures and in addition 
found that the infection was restricted to the epithelial layer, the 
sub-epithelial tissues remained normal in appearance. The appearance of 
lesions and ciliostasis on tracheal organ cultures leads to a concomitant 
fall in virus multiplication but low levels of multiplication may persist 
for up to 2 months indicating that influenza virus ww*. repl lcatjoj in 
subepithelial tissue (Hoorn. 1966).
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Influenza virus stimulates a full range of immune responses in the infected 
host (reviewed by Mims & White. 1964; Couch & Kasel. 1963; Mitchell et al..
1965; Yewdell & Hackett, 1967). These responses combine to aid recovery 
from the illness and prevent re-infection of the host by the same strain of 
virus. Influenza virus can abortively infect most resting cells of the 
lsmune system (Rodgers & Mims. 1962; KUbourne. 1967; Mims. 1966; van 
Campen et al.. 1989). with various adverse affects e.g. reduced IgG and IgM 
synthesis (Casali et al.. 1964). Iunune responses can be conveniently split \
into cell-mediated and humoral.
As previously discussed influenza virus infection results in considerable 
damage to URT ciliated epithelium. The infection, together with the 
resulting cell debris, stimulates PMN and macrophage cells to migrate in 
large numbers to the site of infection (Toms et al.. 1977; a#eet & Smith. 
1960). These cell types are highly phagocytic and actively digest and 
degrade cell debris and virus particles. Both PMN and macrophage cell 
membranes have Fc-receptors and if virus-specific antibodies are also 
present, as found in a secondary rather than primary infection, then 
phagocytosis is enhanced.
Antibody-dependent cel 1-mediated cytotoxicity (ADCC). which is also 
mediated via Fc receptors, plays an important role in influenza infection 
(Shore et al.. 1976). Macrophages, PMN and non-T.non-B (K) lymphocytes are 
all capable of performing ADCC (reviewed by Fanger et al ■. 1989). Hash 1 moto 
et al. (1963) demonstrated that ADCC by human peripheral blood was 
influenza subtype specific but variant cross-reactive, and was mediated by 
both anti-HA and anti-NA antibodies. They also found ADCC cell lysis to be 
greater than that caused by cytotcocic T lymphocytes (Tc or CTL). Very low 
levels of antibody are required for ADCC which can be detected at dilutions 
below that required for haemagglutination-inhibition (Greenberg et al.. 
1977; Hashimoto et al.. 1983). Murakami & Matsuyama (1988) found that PMN 
released reactive oxygen species when influenza infected MDCK cells were 
encountered. These behaved as strong mutagens on the replicating virus and 
lead to an increase of 7 to 10-fold in the frequency of production of 
influenza HA antigenic variants. By increasing the rate of variant 
production, PMN cells may aid the generation of influenza viruses that can 
escape neutralization by antibody.
Macrophages release interleukin 1 (IL-1) which is a molecule that is 
involved in T-cell activation. Soluble factors (cytokines) such as 
interleukines and interferons (IFN) are important modulators of the immune 
response and are vital within numerous feed-back loops. During the early 
stages of influenza virus infection the release of alpha-IFF! and beta-IFN 
is vital, these two IFN species are similar. Probably all infected cells 
produce and secrete alpha- and beta-IFN. which then binds to specific 
receptors on other cells close to the site of infection (Morris, 1988). The 
binding of alpha- or beta-IFN to cells stimulates the expression of class I 
major histocompatibility complex (NIC) antigens and the importance of this.
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especially with respect to the action of Tc cells, is discussed below. 
Cells stimulated with IFN also become refractory to infection by viruses 
via induction of enzyme systems which prevent the synthesis of viral 
proteins (Morris. 1966).
3 1 2 .  *ntn»n b w m i h i  and a -tw n taticn  to m c-re g tricte d  T lv ic h o c y t« .
M C  antigens are coded for by the H-2 loci in the mouse and HLA in man. and 
are divided into class I (H-2 D.K or L in mouse; HLA-A.B or C in man) and 
class II (la in mouse; D in man) (reviewed by Roitt et al.. 1965; Mims & 
White. 1984). MJC antigens are expressed on the surface of cells and their 
structures suggest that they belong to the immunoglobulin ‘superfamily' 
(Williams, 1984; 1985). T lymphocytes recognise foreign peptide antigens in 
association with a particular class of PHC antigen on the surface membranes 
of the other cells, i.e. MIC restriction. Class I MIC antigens are present 
on most nucleated cells, although in variable amounts. Class II MIC 
antigens are present on macrophages and lymphoid cells although class II 
can be induced on other cells, such as astrocytes, by gamaa-IFN. The 
classical view of class I MIC-restriction (as found with Tc cells which are 
CD6+) was that the intact foreign antigen interacted with the MIC-I antigen 
and required no processing. This was based on the fact that Tc cells seemed 
to be specific for membrane glycoproteins of viral origin. Recent work has 
radically altered this perception and this work is discussed in further 
detail below. For some time it has been known that foreign antigens 
presented by class II MIC-bearing cells are processed before being 
presented to CD4+ T lymphocytes (Schwartz. 1985; Mills. 1986). The 
processing and presentation functions are performed by antigen presenting 
cells (APC). There are three requirements for an APC (i) to express MC-II
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antigens Cii) to process foreign antigen (iii) to synthesis and release 
IL-1 Macrophages are the most studied and possibly most important class of 
APC and therefore have a central role within the lunune system. Dendritic 
cells. B cells. Langerhans cells and astro^tes can also express m e  class 
II determinants and act as APC's (Unanue. 1964; Morris. 1908). Dendritic 
cells have been found associated with the basal membrane of rat tracheal 
organ cultures and protrude through to the epithelial surface (Holt & 
Schon-Hegrad. 1967). This would be a favourable position for an APC to be 
situated during a respiratory tract infection and suggests they may play a 
role in the immune responses to influenza virus. Antigen processing by 
class II bearing cells (reviewed by Unanue. 1964; Germain. 1966) involves 
the internalization of the foreign antigen, which is then degraded in an 
acidified intracellular compartment; this is the processing stage.
(Braciale et al ■ (1967) have called this the exogenous pathway, it differs 
from the endogenous processing pathway which presents foreign antigen with 
class I IMC antigens. A comparison between the two pathways will be made 
later). Exogenous antigen processing is therefore time-dependent and 
sensitive to lysosomotropic agents (e.g. chloroquine) which raise the 
lysosomal compartment pH (Germain. 1966; Eisenlohr et al.. 1987). The 
processed antigen is then cycled to the APC surface where it is recognised 
in conjunction with the MHC-II antigen. How. and when, the processed 
antigen interacts with the class II antigen is currently a matter of heated 
debate (reviewed by Pamham. 1964; I960). Analysis of small peptides 
involved in presentation has lead to the suggestion of a basic structure 
for the presented antigen i.e. a region of nonpolar amino acids next to a 
region of polar amino acids that differ from those of self-proteins. X-ray 
cystolography of the class I ItK  antigen has revealed the presence of an
unknown peptide bound in a large groove at the distal end of the ItIC
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molecule (Bjorkman et a1.. 1967a; 1967b). They suggest this is the binding 
site for processed foriegn antigen. This evidence would argue far a complex 
with the molecule rather than a loose association resulting fro® random 
collision on the APC surface membrane. The presentation of foreign antigen 
is modulated by the level of itC-II expression on the APC surface (reviewed 
by Unanue. 1984) and APC situated at different locations in the body 
express differing amounts of MC-II. Gamma-IFTJ is produced by lymphocytes, 
particularly Tc, and up-regulates both class I and II >HC expression 
(Morris. 1968). whilst prostaglandin E. alpha-fetoprotein and glucocortoids 
down-regulate expression (Unanue, 1964).
aa,3, Htlcw T IvmwCTt« cm) rwpgnae.
Th cells (CD4+) recognise foreign antigens in conjunction with >HC-II 
antigen on the surface of APC and are stimulated by IL-1 (Kappler &
Marrick, 1976). As their name suggests, the primary role of Th is in aiding 
other isoune responses. Th cells are required for a potent Tc population 
(Zinkemagel & Doherty. 1979) and they are vital for antibody production by 
stimulating B lymphocytes (Mims & White. 1964; Riott et al.. 1965). Moot of 
the functions of Th cells are mediated by the synthesis and release of 
lymphokines (including IL2-5 and gamma-IFh) and on the basis of different 
interleukine synthesis Th cells can be sub-divided into Thl and Th2 
(Mosmann & Coffman, 1967).
Curing influenza virus infection Th cells are important in the host for 
both recovery and protection fro® further infection. Lightman et al. (1967) 
found adoptive transfer of Th cells to monoclonal antibody-Th-ce 11 -depleted 
mice resulted in the clearance of a persistent X31 (H3N2) infection within
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6 days. The type of antigen is important in the stimulation of Th cells. 
Eisenlohr et al. (1967) found UV-inactivated influenza virus stisulated Th 
proliferation 1000-fold better than either denatured protein, protein 
fragments or synthetic peptides of HA, »» and M proteins. The fact that Th 
cells can recognise both internal and surface influenza proteins explains 
why both sub-type specific and cross-reactive Th cell clones exist (Lasb & 
Green. 1963; Andes et al.. 1961). HA-. M- and »»-specific Th cells all 
st l an late anti-HA antibody production (a Th cell-dependent response) in 
nude sice equally well upon stimulation using whole virus; the phenomenon 
of 'cross-help'. With »»-specific Th cells only the IgM isotype was 
produced whereas with HA- or M-specific Th cells class switching occurs 
leading to IgA or IgG (Scherle & Gerhard. 1966). Using adoptive transfer of 
Th cell clones into nude mice. Scherle & Gerhard found an accelerated 
antibody response and reduced fatalities upon infection by influenza virus. 
They also demonstrated that the Th cells interacted directly with B 
lymphocytes (cognative help) rather than by a general lyaphokine release 
mechanism (non-cognative help).
Some of the antigenic sites on the HA molecule recognised by Th cells are 
known (Hackett et al ■. 1963; 1965). Thomas et al. (1967) demonstrated that 
the HA of X31 (H3N2) with a single mutation which alters glycine to 
arginine (HA1 residue 135) no longer stimulated proliferation of some Th 
cell clones. This mutation lies within antigenic site A (Wilson et al.. 
1961) and therefore in this instance both Th and B cells appear to focus on 
the same region of the HA molecule. It should be noted that no correlation 
was found when Th cells were tested with natural mutants in this region. 
Brown et al. (1968) isolated Th cells from spleens of A/Meaphis/71 (H3N2) 
infected BALB/C and C57BL mice. The proliferative responses of the Th cells
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were assessed fcy stimulation with natural and laboratory-generated variants 
with known amino acid substitutions and monoclonal antibody reactivities. 
They found 4 overlapping epitopes centred on residues 60 and 63 of HA1 i.e. 
antigenic site E on H3, and they concluded therefore that this site was 
also a major antigenic region recognised by Th cells. Also sequence 
analysis of one HA variant showed that a carbohydrate moiety was linked to 
the HA at site E. they suggested that this either masked the site or 
prevented the proteolytic fragmentation of the HA during APC presentation.
Th cells can mediate de 1 ayed-type hypersensitivity (COH) response 
(reviewed fcy Liew & Russell. I960) but this response is more coomonly 
associated with Td lymphocytes which are also itC-II restricted and express 
the CD4 marker (Miller & Jenkins. 1965). Adoptive transfer of Td cells into 
mice Increased lung infiltrates and resulted in no reduction in influenza 
virus titre (Fedson et al.. 1971; Couch & Kasel. 1983). suggesting that Td 
have a deleterious effect during infection. Inactivated influenza gave a 
greatly enhanced UTH response compared to live influenza. Liew et al.
(1979) found the ETTH response in mice, measured in terms of foot-pad 
swelling, could be elicited within 24 hours of challenge stimulation. The 
CriH could be enhanced by pre-treating with cyclophosphamide which is 
thought to act by inhibiting suppressor T lymphocyte (Ts) maturation. If 
whole virus was used as the ismunizing antigen then the EOH response showed 
extensive cross-reactivity, responding to influenza B and Sendai viruses. 
This was thought to be due to host cell components in the viral envelope 
because allantoic fluid could also elicit a DTH response. If purified M 
protein was used as an immunogen then the response was type-specific and if
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purified HA was used then the response was subtype-specific but variant 
cross-reactive. This suggested that Td cells recognised different epitopes 
fros those utilised by the humoral response.
3.1.4, Crtgtoftic T lychggytf ITcJ r w s f a i .
In san the Tc (CE8+ cells) response, detected by ItC-I restricted 
cytotoxicity against influenza virus-infected target cells, peaked after 
approxisately 1 week during a natural infection or isnunization with live 
vaccine (Greenberg et al.. 1978). and between days 3 to 7 using an 
inactivated vaccine. Cytotoxicity returned to baseline levels after 1 month 
but persisted for longer if the subject had been pre-expoeed (i.e. had a 
detectable serum antibody titre). The appearance of a Tc response 
correlated with the onset of recovery- Ehnis (1981a) reported similar 
findings and found that the route of inoculation (i/n or i/m) was not 
important in generating a Tc response. Interestingly, it was also found 
that certain of host HLA groups (Al. A9 and BB) generated a lower cytotoxic 
T lymphocyte response than did others. The significance of this is not 
clear but dependent presentation has been found for class-II antigen 
processing (Puri et al.. 1986).
The primary role of Tc cells is to lyse virus-infected cells which reduces 
the amount of virus shed and results in the clearance and recovery from 
infection (McMichael et al.. 1983; Mitchell et al.. 1985). Most work has 
focused on Tc cells isolated from the spleen of mice, a T lymphocyte-rich 
organ, but the virus-specific Tc cells can also be stimulated and isolated 
at the local site of infection e.g. pulmonary lymph nodes (Cambridge et. 
al.. 1976). Peyers patches (London et al.. 1987), bronchus (Waldman et al..
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1972). or peripheral blood (McMichael et a l .. 1963). The major sites of 
action for influenza-specific Tc cells are the respiratory surfaces. The 
cytolytic activity of Tc cells say cause the characteristic lung pathology 
found in influenza infection of Bice but does ultimately lead to virus 
clearance (Wells et al.. 1961). These workers found that influenza virus 
infection of 'nude' sice (which lack T lymphocytes), caused a high 
mortality rate, a persistent infection of the lungs and a slower 
development of lung pathology. A greater proportion of normal mice survived 
infection, the lung pathology developed more rapidly and the incidence of 
lung pathology correlated with increased Tc activity in the lungs.
Protection is also partially mediated by cellular immunity and does not 
solely result from the action of antibodies. Adoptive transfer of 
influenza-specific Tc cells does protect mice from lethal doses of 
challenge virus (Sullivan et al.. 1976; Yap et al.. 1978; Yap & Ada,
1978a). although seme have found that Tc cells are not protective (Taylor & 
Askonas. 1963; Liew et al.. 1964). That there is a Tc anamnestic response 
with a memory ranging from 6 months (Ehnis, 1962) to years (McMichael 
al■. 1963) would suggest a protective role, even if it is short-lived. 
Adoptive transfer of cloned Tc cells leads to passive protection. This also 
correlates with the gamma-IFN level (Morris et al.. 1962). which is 
released on contact with infected cells. UV-inactivated virus did not 
induce gamma-IFN. Gamma-IFN limits virus spread by establishing an 
antiviral state, modulates other immune responses (particularly M< 
activity) and up-regulates both class I and class II )tHC-expression 
(Morris. 1966).
The virus-specific Tc cells recognise viral antigen in a class I 
ItC-restricted manner. It was believed that the influenza virus 
glycoproteins, in particular the HA, were the target antigens recognised by 
Tc populations (Cambridge et al.. 1976) and that Tc cells recognised intact 
antigen in association with MC-I. The work pioneered by Townsend's group 
has radically altered our understanding of which influenza proteins are 
antigens for Tc cells and also how antigens are presented in a M4C-I 
restricted manner to Tc cells (reviewed by Germain. 1966; Long & Jacobson, 
1969). It had been long recognised that Tc cells were composed of both 
type-specific and cross-reactive populations (Zweerink et al.. 1977;
Doherty et al.. 1977; Wraith. 1967) and assumed that Tc were recognising 
either a common epitope on different HA subtypes which is different to 
those recognised by antibodies, or an internal viral component (Zweerink et 
al.. 1977; Yap & Ada, 1978b). The second possibility was confirmed when a 
cross-reactive Tc clone was found which was influenza type-specific but 
failed to recognise either the HA or NA glycoproteins (Townsend & Skehel,
1962; Townsend et al.. 1964a). Comparison of the reactivities of this clone 
with cells infected with different influenza virus strains found that it 
recognised a viral determinant which had undergone an antigenic change 
between 1943 and 1946. The probable candidate was the NP protein. Townsend 
et al. (1964b) used transfected L cells expressing different influenza 
proteins to investigate the specificities of different polyclonal Tc lines. 
They found only a minor subpopulation of cells recognised the expressed HA 
and were subtype-specific, whereas the majority of cells recognised NP and 
were cross-reactive. Further, NP could not be detected on the transfected 
cell surface using monoclonal antibodies and this suggested that the NP was 
not presented in its native form but had undergone processing, possibly 
similar to that for itiC-II restricted Th cells as previously discussed.
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This hypothesis was explored (Townsend et al.. 1905; 1906) by using 
truncated forms of NP expressed in transfected cells. Both the N- and 
C-termini were independently transported to the cell surface and were 
recognised by Tc in a »C-I restricted manner. Anti-NP antibodies were 
unable to block Tc recognition. It was found that the ItC haplotype helped 
to define the epitope which was recognised by Tc because Tc cells from ChA 
(H2k) mice recognised an epitope in region 1-130 whilst C57BL (H2b) 
recognised an epitope residing in the region 328-306. This selection by the 
itC class I haplotype is not absolute as C3H (H2k) Tc cells recognised the 
region of NP from 328-306. These findings confirmed the processing 
hypothesis. However chlaroquine failed to inhibit recognition indicating 
that the processing did not involve endosomal degradation. The discovery 
that immunization using inactivated virus could generate a ItlC-II 
restricted Tc population (Jacobson et al.. 1984; Kaplan et al.. 1984; 
Maimone et al ■. 1986; Mills et al.. 1908) has allowed the differences 
between itiC-I and itC-II processing to be explored using the same APC 
system (reviewed by Ek-aciale et al.. 1987a). »HC-II processing utilises a 
ch 1 oroquine-sensitive lysosomal route to degrade input antigens; the 
"exogenous pathway". >MC-I processing requires de novo virus protein 
synthesis and does not involve lysosomal compartments (Wraith & Vessey. 
1986) but does present viral antigens in a non-native form.
Although most interest has concentrated on Tc recognition of NP. Tc 
subpopulations can recognise all other influenza virus proteins, in 
addition to the HA as mentioned previously e.g. Ml (Gotch et al.. 1987). 
Also the subtype-specific Tc populations that recognise HA are not limited 
to recognising epitopes in the HA1 polypeptide as antibodies tend to be 
(Braciale et al.. 1904; 1987b; Gould et al.. 1987).
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3.1,5, Natural Killer IMP cell response.
M< cells kill virus infected cells and tuaqr cells by spontaneous 
cytotcocicity which is not virus-specific (Couch & Kasel. 1963) and is 
up-regulated by gaama-IFN. When studying influenza infection of nan. Ehnis 
et al. (1961b) found that M< activity was maximal on day 3 and correlated 
with the rise in IFN. virus shedding and onset of symptoms. Adoptive 
transfer into infected 'nude' mice did not result in virus
clearance unless >HC-I restricted T lymphocytes^* Iso transferred (Efriis, 
1962). N< cells are found in epithelial-associated lymphoid tissues such as 
Peyers patches (London et al ■. 1967), suggesting that they might have an 
early role in infection.
3,3. Antibody rwocpBea.
Infection by influenza virus elicits a humoral response in the host 
involving the three major immunoglobulin classes: IgG, IgM and IgA. Murphy 
et al. (1962) studied the primary serum and nasal wash anti-HA antibody 
responses of children inoculated intranasally (i/n) with live attenuated 
H3N2 and H1N1 influenza virus strains. A serum IgM response was found in 
all but one of the subjects and peaked at 2 weeks p.i. before declining. 
Oily two-thirds of the subjects developed a serum IgA response; this had a 
lower titre than that found for serum IgM but followed similar kinetics.
All the subjects developed a serum IgG response which reached high titres 
between 4 to 7 weeks p.i. . In contrast, the predominant immunoglobulin 
class in the nasal wash samples was IgA which occurred in over
three-quarters of the subjects. The nasal IgA response appeared at 2 weeks
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p.i. and rose to high titres at 7 to 9 weeks p.i.. A similar number of 
subjects developed a nasal IgM response, which peaked at 2 weeks p.i.. IgM 
titres then declined rapidly and were negligible at 7 to 9 weeks p.i.. Only 
half the subjects developed a nasal IgG response with titres considerably 
lower than that found for IgA. This peaked at 4 to 6 weeks p.i. and 
persisted upto 7 to 9 weeks in a few individuals.
During an acute primary influenza infection of a naive host, the virus 
titre peaks within the first few days of infection and by the end of the 
first week is declining (Murphy et al.. 1973; Char & Ogra, 1965). The fact 
that the detectable humoral response appears during the second week of 
infection has led to the suggestion that the role of antibody in the 
recovery from a primary influenza infection is minimal (Mims & White.
1964). The fact that antibody cannot be detected does not mean that 
antibody is not present during the early phases of infection merely that 
there is an excess of antigen. In mice at 3 days p.i. there is a rise in 
the numbers of IgA and IgM plasma cells in the sub-epithelial respiratory 
tissues and a few days later there is a rise in the number IgG plasma cells 
(CVens et al.. 1961). This indicated that antibody production could be 
occurring earlier than the findings of Murphy et al. (1962) would suggest. 
As previously discussed, antibody in low amounts, undetected by other 
assays is capable of mediating ADCC.
Antibodies are the host's main line of defence against re-infection by the 
same or closely related influenza virus strain (reviewed by Couch & Kasel. 
1963). The mechanisms by which antibody can mediate host resistance to
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re-infection include opsinization for phagocytosis, complement fixation, 
ADOC (discussed previously) and neutralization, which will be discussed 
later.
Protection is conferred mainly by neutralizing anti-HA antibodies and 
passive transfer of neutralizing anti-HA antibodies to naive mice protected 
against a subsequent challenge infection (Virellzier. 1975; Ehnis. 1962; 
Ehnis et al., 1962). The role of anti-NA antibodies is less clear. As 
previously discussed (section 1.4.), anti-NA antibodies are 
non-neutralizing but inhibit progeny virus release frcs Infected cells. 
Reports that anti-NA antibody was rarely demonstrable following primary 
infection may reflect the insensitivity of the neuraminidase-inhibition 
(NI) test, together with the fact that the NA represents a smaller 
antigenic mass compared to the HA (Couch & Kasel. 1963). The anti-NA 
response of inmunized subjects is suppressed by the anti-HA response when 
challenged with a homologous virus strain and is greater when challenged 
using a virus with a heterologous HA subtype (Johansson et al.. 1967a),
This suppression operates at the Th cell level, the homol^ous challenge 
generates fewer NA-specific Th cells than does the heterologous HA 
challenge, which suggested that antigenic competition between the virus HA 
and NA existed (Johansson et al.. 1967b). The poor anti-NA response is not 
due to poor antigenic properties of the NA glycoprotein because Johansson 
et al. (1969) demonstrated that mice inoculated with equal amounts of 
purified HA or NA gave equivalent antibody responses, indicating that both 
viral glycoproteins are equally immunogenic. If an HI titre of greater than 
1:16 was produced by immunization with purified HA, then the mice were 
completely protected from challenge infection. Immunization with purified 
NA did not protect the mice from challenge infection (all mice were
infected) but did reduce the amount of pulmonary virus in proportion to the 
amount of antigen administered. This confirms the infection-limiting, 
rather than protecting, role of anti-NA (Schulman. 1969). Humoral responses 
are also generated against the internal M and NP virus proteins (Cretescu 
et al.. 1978) but these are not protective (Oxford & Schild. 1976).
Although it is clear that antl-HA antibodies protect against re-infection, 
there is debate how this protection is mediated. Infection by influenza 
virus stimulates both systemic and secretory immune responses as 
demonstrated by Murphy et al. (1982). Stimulation of the systemic immune 
system results in a predominantly serum IgG response and some groups have 
found that this response showed the best correlation with protection (Couch 
& Kasel. 1983; Potter & Oxford. 1979; Couch et ml.. 19791. In contrast, 
others have found protection to correlate better with local antibody levels 
(Waldman et al.. 1968; Liew et al.. 1984) and there is a considerable body 
of evidence (discussed below) which demonstrates that the secretory 
response are. if not more, important than the systemic response.
Local immunity is mediated by the gut-associated lymphoid tissue (GALT) and 
the bronchus-associated lymphoid tissue (BALT), both of which are linked 
and when stimulated produce predominantly IgA antibodies (reviewed by 
Underdown & Schiff. 1986; Mestecky, 1987). The human IgA immunoglobulin 
class can be s*?lit into two: serum IgA which is mainly (>80%) monomeric and 
secretory IgA which is mainly (>90%) polymeric (the different 
immunoglobulin structures are discussed later). Murphy et al. (1982) 
compared the specific activities for each antibody class in nasal wash 
samples to those in the serum (i.e. ELISA anti-HA titre/RIA antibody 
concentration) and found that both IgA and IgM antibodies in the nasal wash
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samples were secreted locally and did not merely reflect the sens antibody 
concentrations. The fact that these antibody classes are secreted locally 
does not necessarily mean that their production occurred at the b u c o m I 
surface. The mucosal epithelium actively transports secretory IgA from the 
basolateral cell surface to the apical cell surface and hence into the 
external secretions, therefore the increased concentration of IgA in 
secretions may result from selective transport of serum IgA produced at 
distant sites of the body. The transepithelial IgA transport pathway is 
reviewed by Underdcwn & Schiff (1966). They concluded that very little of 
the IgA in external secretions came from the circulating pool of serum IgA 
and that the transepithelial IgA transport pathway was dedicated to 
transport of IgA from surrounding, local IgA producing cells. There was 
some inter-species variation; blood to bile transport was found to occur 
efficiently in the rat. the rabbit and the chicken but not in all other 
species so far studied, including both man and mouse. Local antibody 
production (not just the IgA class) has been demonstrated during influenza 
virus infection. Jones and Ada (1966) intranaMlly (i/n) inoculated mice 
with influenza virus and examined different tissues for evidence of 
antibody secreting cells (A9C). A9Cs were found in the mouse lungs that 
secreted each of the major iamunoglobulin classes: IgA, IgM and IgG. More 
IgA ASCs were found in the lungs than the spleen, and they persisted for a 
longer period (more than 11 month p.i.) than did the spleen AdCs which were 
more transient. Edwards et al. (1966) isolated lymphocytes from human 
adenoidal organ cultures and found only those from seropositive donors 
could be stimulated in vitro to produce antibody, with IgM and IgA antibody 
classes produced in greater <*iantities than IgG. Tracheal organ cultures 
from seropositive ferrets required approximately 100-fold more homologous 
influenza virus to become infected than did those from seronegative animals
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(Cogllano & Small. 1978). Once infected the organ cultures continued to 
shed virus for over 60 days, suggesting that protection fro* infection was 
due to local immune mechanisms whilst recovery from infection required 
factors not present in the tissue explants, presumably originating from the 
systemic response. Payer's patches are also a site rich in IgA-committed 
ASCs and these cells can be stimulated by intragastric (i/g) inoculation of 
virus (London et al.. 1987). Chen et al. (1987) i/g inoculated mice with 
influenza virus and these had 13-fold more IgA than IgG in the lungs. 
Lymphoid cells isolated from Payer's patches produced predominantly IgA 
whilst those isolated from the spleen produced IgG. The presence of IgA in 
the lungs persisted for 3 to 5 months and protected the mice against a 
subsequent l/n challenge with a lethal dose of homologous virus. Partial 
protection was given against antigenic variants of the same HA mibtype 
(Chen & Quitman. 1988). The ability to generate a BALT immune response by 
stimulating the GALT demonstrates that the two immune systems are closely 
linked and others have demonstrated the migration of GALT and BALT-primed 
ASCs between different mucosal sites (Hestecky, 1987; Dahlgren et al ■. 
1987).
If protection is primarily due to a local immune response, then the 
immunization regime (local immunization versus systemic immunization) 
should radically alter the immune response generated by varying the site of 
antigen delivery and the nature of the antigen presented. Snyder et al, 
(1986) demonstrated that intranasal (i/n) inoculation stimulated an 
equivalent immune response in squirrel monkeys when compared to aerosol 
Inoculation. In man Johnson et al. (1986) found that i/n inoculation with a 
live attenuated influenza virus vaccine gave protection (determined by 
amount of virus shed) against a challenge infection that was similar to the
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protection found in subjects who had prior exposure to natural infection by 
a virus of the same subtype. Both groups had detectable pre-challenge nasal 
IgA titres. In comparison, intramuscular (i/m) vaccination with an 
inactivated virus gave poor protection and these subjects lacked a 
pre-challenge nasal IgA titre. Local IgA was produced upon challenge 
suggesting that i/m vaccination did prime the local immune system. Waldman 
et al. (1968) demonstrated that i/n inoculation of human volunteers with 
inactivated virus (H2N2) generated a much greater response, with both serum 
and nasal wash antibody detected, than did sub-cutaneous (s/c) inoculation 
which only produced a serum antibody response. IgA was found to be the 
predominant immunoglobulin class in nasal secretions. When the specialty of 
the serum and local anti-HA antibodies were compared it was found that 
whereas the serum antibody was sub-type specific, the local antibody 
cross-reacted with a heterologous (H1N1 and H3N2) influenza viruses 
(Waldman et al.. 1970). This suggested that the IgA antibody was less 
specific compared to the serum antibody. Liew et al. (1964) found that mice 
inoculated using an aerosol of live recombinant A/Rec31 (H3N1) (derived 
from A/Qig 1 and/939/69 and A/PR/8/34) were completely protected against 
challenge infection using a different H3 virus strain, A/Victcria/3/75 
(H3N2). Protection failed to correlate with either serum IgG antibody 
levels or numbers of virus-specific Tc cells, instead a good correlation 
was found with the level of IgA in the lungs. In contrast, if mice were 
inoculated with either live A/Rec31 intravenously (i/v) or UV-inactivated 
A/Kec31 s/c, then the mice were protected to a lesser extent against A/Vic 
challenge although higher serum antibody titres were produced. They 
suggested that secretory IgA was the most important factor in protection 
against a homotypic cross-reactive influenza virus infection. The 
importance of the local IgA response was studied by Sears et al. (1988).
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who also demonstrated that live and inactivated vaccines gave different 
responses. They found i/n vaccination using inactivated virus gave an 
increased serum antibody titre but a reduced the nasal antibody titre 
compared to a live attenuated vaccine. They also demonstrated that if IgA 
was present in nasal washes then the amount of virus shed upon challenge 
was greatly reduced. Coutelier et al. (1967) demonstrated that i/n 
infection of sice with a panel of viruses, including influenza, resulted in 
a serum response that was restricted to the IgG2a subclass; this fixes 
complement efficiently. Intraperitoneal (i/p) inoculation of protein 
antigens resulted in a predominance of IgGl antibodies which have poor
\
complement fixing activity. Hocart et al. (1966) confirmed the findings of 
Ccutelier et al. by investigating the IgG subclass response of mice after 
either i/n inoculation of live virus car i/m inoculation of purified HA.
Upon challenge, sice that received i/n live virus gave a predominantly 
IgG2a response in both the serum and to a lesser extent, in the lungs and 
saliva. In contrast, mice that received purified HA i/m gave a broad IgG 
response with no subclass predominating. Immunization by the i/m route did 
result in an IgA response in the mouse lungs but the size of this response 
was much reduced compared to that produced by i/n immunization.
To summarize, infection or immunization via the respiratory tract gives a 
local immune response which is durable, active at the site of infection and 
may be more cross-reactive between variants of the same HA subtype compared 
to the systemic response. The i/n immunization efficiently stimulates the 
systemic immune apparatus to produce virus-specific IgG that fixes 
complement.
3 .3 .  The s tr u ctu r e s  o f the d i f fe r e n t  antibody oil
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Antibodies belong to the immunoglobulin 'superfamily1 and share many 
structural features cannon to molecules such as the IMC antigens (Wiliams 
1984; 1985). They are multidomain glycoproteins that display very diverse 
range of binding specificities for epitopes on the surface of molecules 
that are recognised by the host s immune system as foreign or non-self. 
Genetically, antibodies achieve this diverse repertoire by a mechanism of 
somatic selection and expansion from a large but more limited germline 
(reviewed by Rajewsky et al.. 1987). The structure of all antibody classes 
(reviewed by Roitt et al.. 1985; Davies & Metzger. 1983) is based upon a 
four polypeptide chain building block composed of two light (L) chains and 
two heavy (H) chains. Each L chain is linked by disulphide bonds to a H 
chain, the H chains are also linked to each other by disulphide bonds and 
this results in a Y-shaped structure. Each chain has a variable (V) region 
and a constant (C) region. The binding of antibody to antigen is mediated 
by the V regions whereas the C regions mediate many of the biological 
activities of the antibody molecule e.g. complement activation, ADCC etc. 
There are two classes of L chain, kappa (k) and lambda (1). and five 
classes of H chain (pt.&.e, f .¿i) which define the five classes of antibody; 
IgA. IgD, IgE. IgG and IgM. The structures of IgG. IgM and IgA antibody 
classes are discussed briefly below as these are the major classes 
generated against influenza infection.
3J.1, W
IgG is the predominant class of circulating antibody and is produced in 
large quantities during anamnestic immune responses. It has the basic 
four-peptide structure previously described and is defined by the
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incorporation jfH chain into its structure. There are four major subclasses 
in man (designated IgGl. IgG2. IgG3 and lgG4) and in mice (designated IgGl. 
IgG2a, IgG2b and IgG3). These subclasses differ in sequence, carbohydrate 
content and disulphide bonds of the H chains and therefore mediate 
activities such as complement fixation to differing degrees (reviewed by 
Pumphrey. 1966a; 1906b; Oi et al.. 1904).
IgG can be cleaved by proteolytic enzymes into characteristic fragments. 
Papain cleavage of a single IgG molecule produces two Fab* ( fragment 
antigen binding') fragments and one Fc ('fragment crystal 1 izable') 
fragment. The Fab' fragments are soluble, they can still combine with 
antigen and each Fab' contains a complete L chain linked to two domains 
from the H chain by disulphide bonds. The Fc fragment has no antigen 
binding capacity and is composed of the remaining C region domains of the 
two H chains which are linked by disulphide bonds and can be crystalized. 
Another enzyme, pepsin, cleaves the Fc fragment from the rest of the IgG 
molecule, but the two Fab' fragments that were produced by papain remain 
linked together by disulphide bounds and do not separate; this is termed 
the (Fab'>2 fragment.
3J A  IflH
IgM (reviewed by Davies & Schulman, 1989) is a large molecule (Mr 900,000) 
and is the first antibody class to appear in the serum during a primary 
immune response. IgM molecules are polymers of five four-peptide units and 
have the^cH chain. The polymerization depends on the presence of a J-chain 
polypeptide whose function is to stabilize the IgM Fc regions during 
synthesis. In solution IgM molecules are observed to adopt a star-shaped'
conformation but upon binding to an antigen the IgM can dislocate into a 
'staple' conformation (Feinstein & Nunn, 1969). IgM is a powerful activator 
of complement and the dislocation of IgM molecules is thought to be an 
important step in complement fixation.
3,3,3, IgA
IgA (reviewed by Underdown & Schiff. 1966) appears in external secretions 
in elevated concentrations compared to other antibody classes and is also 
found in the serum. IgA can either be a monomer or polymer of four-peptide 
units with theatH chain. There are two subclasses of IgA in man, IgAl and 
IgA2. whereas the mouse has only one. Human serum IgA is 80» monomeric and 
80» of the IgAl subclass. The IgA in external secretions is 90» polymeric 
and 40» IgA2 subclass. Like IgM, polymeric IgA has a J-chain and is 
primarily dimeric composed of two four-peptide units, although trimeric. 
tetrameric and pentamer polymers are produced in decreasing amounts. The 
IgA found in external secretions also has a secretory component (9C). 
derived from the poly-Ig receptor which is a transmemtrane protein on the 
basolateral surface of the mucosal epithelial cells. The poly-Ig receptor 
binds IgA and transfers it across the mucosal epithelium into the external
secret ions.
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A. The in fe c t io u s  route o f influ enza v iru s .
The route of infection followed by viruses has been extensively studied, 
especially with viruses that utilise the host cells endocytotic apparatus 
(Reviewed by Helenius & Simons. I960; Harsh. 1964; Lenard & Miller. 1983; 
Patterson & Oxford. 1906) .^“’"Sirus infection can be divide into six 
chronological stages:
(1) attachment
(2) penetration
(3) uncoating
(4) replication and translation to produce viral proteins
(5) assembly of viral structural components
(6) release of progeny virus
I shall focus on the first three stages of infection.
4.1. Influenza virus attachment.
Viruses attach to cells via receptors on the host cell membrane (Reviewed 
by Meager & Hughes. 1977; Lonberg-Holm & Philipson. 1960; Lonberg-Holm, 
1981; Crowell. 1987; Rossman. 1900). The best understood and characterised 
cell receptors are those used by the non-enveloped picomaviruses. These 
receptors are present in limited numbers on cultured cell surfaces, they 
can be saturated by virus attachment and have in some cases been isolated 
e.g. a 90kD protein receptor for human rhi novirus isolated from He La cells 
(Tomassini & Colonno, 1986).
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Influenza viruses attach to cells via the binding of the haemagglutinin 
spike to N-^acetylneuraminic acid (sialic acid). The receptor binding site 
resides in a pocket at the distal end of the haemagglutinin spike 
(discussed previously) and shares morphological features that appear to be 
common to many viruses; the receptor binding site is highly conserved, 
surrounded by antigenic sites but in a depress ion/pocket/canyon which is 
inaccessible to antibody binding (Roesman & Palmenberg. 1988). The sialic 
acid moieties are found as oligosaccharide side chains to a wide range of 
cell membrane glycoproteins and glycolipids (gangliosides). This results in 
influenza virus having a very broad range of host cells to which the virus 
can attach. A degree of specificity is conferred by the sialic acid lirfeage 
as strains isolated from man bind to «(2.6) linked sialic acid while those 
isolated from avian or equine hosts bind *(2.3) linked sialic acid 
(Pritchett et al.. 1987). The influenza virus receptor on erythrocytes is 
the MN blood group antigen; glycophorin A (Jackson et al.. 1973) and in 
many ways this could be considered as a model cell receptor because the 
cross-linking of erythrocytes that results from virus attachment can be 
visualised and simply quantified by measuring haemagglutination. In fact 
the glycophorin A receptor is far from a perfect model for influenza virus 
attachment because it only projects 5nm from the erythrocyte cell surface 
and is buried deep in a web of other carbohydrate moieties (Viitala & 
Jamefelt, 1985). Attachment of influenza virus does not lead to a 
productive infection of nucleated avian erythrocytes (Dimmock et al.. 1981) 
and the haemagglutination inhibition effects of antibodies do not correlate 
with neutralization of the virus (Diamock. 1982).
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Using organ cultures of respiratory tissue (Dourmashkin & Tyrrell. 1970) 
and cultured epithelial cells (Matlin et al.. 1981; Yoehimura et al.. 1982) 
influenza viruses are observed to attach to prominent morphological 
features, such as cilia and microvilli. Virus attachment is rapid and can 
occur at low temperatures (Stephenson & Dimmock, 1975; Eisenlohr et al.. 
1987). The addition of DEAE dextran increases binding by electrostatic 
effect (Lenard & Miller, 1983) and binding is also dependent on the pH 
conditions (Huang et al.. 1974), but this is disputed by Yoshimura et al. 
(1982) who found no pH dependency. The presence of the neuraminidase spikes 
on the virus surface which cleave sialic acid, means that the binding is 
reversible but this is thought to be significant only under conditions of 
vast virus excess where released virus is unable to re-attach because the 
majority of receptor sites have been destroyed by neuraminidase action 
(Laver & Kilboume, 1966). Attached influenza virus can be released from 
the cell surface by addition ci -oluble neuraminidase (Clostridium 
perfnngens) and this technique has been used to assess virus penetration 
into cells (Matlin et al.. 1981; Richman et al. . 1986). Proteinase K has 
also been used to release attached virus (Taylor & Dimmock, 1985a, 1985b). 
but others have found this enzyme to be ineffective (Matlin et al.. 1981).
4.2. Influenza virus penetration.
Viruses that have attached to cells can penetrate by either viropexis or 
direct fusion with the plasma membrane (Reviewed by Marsh. 1984; Lenard & 
Miller. 1983; Patterson & Oxford. 1986).
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Paramyxoviruses e.g. Sendai virus and NEW. have been observed to fuse at 
the host cell surface whereas influenza viruses are internalised by 
viropexis (Dourmashkin & Tyrrell. 1970; Russell. 1966a). Viropexis utilises 
the normal cell processes of phagocytosis (the uptake of particles greater 
than 200m diameter) and plnocytosls (the uptake of particles less than 
150m diameter) (Harsh. 1964). Pinocytosis is further divided into either 
fluid phase or receptor-mediated (adsorptive endocytosis). fluid phase 
plnocytosis being relatively inefficient compared to adsorptive 
endocytosis.
Influenza virus has been found to penetrate cells by adsorptive endocytosis 
(Dourmashkin & Tyrrell. 1970; Hatlin et al.. 1961; Harsh. 1964). Coated 
pits form around attached virus particles, which are then internalized in 
the form of coated vesicles (Hatlin et al, ■ 1961). Adsorptive endocytosis 
is rapid with a half time of less than 10 minutes (Hatlin et al.. 1961; 
Yoshimura st ml.. 1962) and is dependent on both the virus strain and cell 
type (Russell. 1966). Influenza viruses with uncleaved haenagglutinln are 
not internalised (Scholtissek. 1966). Virus has also been seen in smooth 
vesicles, the functions and origins of which are uncertain (Dourmashkin & 
Tyrrell. 1970; Patterson et al.. 1979; Hatlin et al.. 1961).
There is considerable uncertainty as to whether influenza virus penetration 
is temperature dependent. Some workers report that internalization of virus 
is blocked at 4*C and that the majority of the virus remains external to 
the cells (Hatlin et al.. 1961; Richman et al.. 1966). Only when the 
temperature is increased towards 37'C does penetration occur. Similar 
findings have been made with other enveloped viruses e.g. VSV (Superti ei 
al.. 1967) and retrovirus (Anderson. 1967). In contrast others report
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efficient internalisation occurring at 4*C (Kato & Eggers, 1969; Stephenson 
& Dimmock, 1975; Stephenson et al.. 1978; Hudson et al.. 1978). The 
discrepancy is not due to the virus strain as both sets of workers used 
A/Fowl Plague Virus/Rostock/34 (H7N1) but may be due to the host cell. MDCK 
and LLC cells were used by those who found no entry at 4*C whereas CEF and 
EHK cells were used those who did find virus entry.
4.3. Influenza virus uncoatlno.
In less than 2 minutes after penetration, the coated vesicles lose their 
clatherin coats becoming prelysosomal or endoecmal vesicles (Anderson et 
al.. 1977; Marsh. 1984). These vesicles are devoid of lysosomal marker 
enzymes (e.g. acid phosphatase) and can be isolated from lysosomes by 
density gradient centrifugation (Marsh. 1984). Ehdosomes acidify to at 
least pH 5.5 via an ATP dependent proton pump (Davey et al.. 1985). which 
may be incorporated into the vesicle membrane at the plasma membrane before 
the endoeome matures. The acidification of the endcsooe is thought to be 
responsible for influenza virus uncoating by leading to fusion of the viral 
envelope and the endosomal membrane. The coming together of membranes is 
energetically highly unfavourable, therefore a mechanism must exist for 
overcoming this barrier. The uncoating stage has been investigated using 
two main approaches:
(i) Artificially reducing the pH of the medium to induce fusion of virus 
with the plasma membranes of cells.
(ii) Treating cells with weak bases and lysotropic agents to raise the 
endosomal pH and then examining the effects on virus uncoating, genome 
expression and infectivity. Also amantadine-resistant mutants have been 
examined to determine the site of mutation.
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4,3,1-__ AxJ Mediated »etrane fusion.
Lowering the pH of the medium results in the fusion of influenza virus 
particles to cells. Erythrocytes and 1 lpoecmes have been most studied. The 
lipid composition of the target bilayer is important (Dorns et al.. 1985; 
Stegman et al.. 1985). If liposomes have a high net charge (e.g. composed 
of brain ganglioeides) then fusion can occur at neutral pH (Haywood &
Boyer, 1985; 1906). Therefore an acid pH is not vital for membrane fusion. 
The low pH fusion event is temperature dependent (Huang et al.. 1981; Dorns 
et al.. 1985; Haywood & Boyer. 1985; 1986) and can be blocked by binding of 
antibody (Stegman et al.. 1985).
The low pH fusion event is a function of the influenza haemagglutinin 
protein and is dependent^ts cleavage into HA1/HA2 (Huang et al.. 1981; 
Yewdell et al.. 1983). Daniels et al. (1987) found that the receptor 
specificity also influenced the fusion activity. Lowering the pH leads to 
irreversible and major conformational changes in the haemagglutinin spike 
glycoprotein, as a result of which the haemagglutinin: (i) Becomes 
sensitive to proteinase K digestion and reduction of the inter-chain 
disulphide bond by reducing agents (Gething et al.. 1986) (ii) Acquires two 
tryptic digestion sites in the HA1 polypeptide (Skehel et al.. 1982;
Ge thing et al ■. 1986) (iii) Becomes more amphiphilic and binds to liposomes 
(Gething et al.. 1986) (iv) Acquires new antigenic sites and loses other 
antigenic sites on the native HA as discussed previously (v) Aggregates 
after brcmelain cleavage (Skehel et al.. 1982) (vi) Alters its optical 
properties determined by circular dichromism (Skehel et al.. 1982).
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Overall, the haemagglutinin is thought to partially dissociate at low pH. 
The HA1 globular heads lose their trimeric structure (Dons et al.. 1965;
Go thing et al.. 1906). The HA1/HA2 stess resain triseric, possibly adopting 
a sore stable conformation (Ruigrok et al.. 1968), and become* thinner 
(Ruigrok et al.. 1906a. 1906b). The N-tersinus of H*2 becomes exposed and 
moves out of its 'pocket* in the stes (Ruigrok et a1.. 1906a, 1906b) and 
increases in length (Ruigrok et al.. 1908). Oething et al. (1906) used site 
specific nut agones is of the N-terslnus of HA2 to produce variants with 
differing fusion characteristics. If glutasine residues were substituted 
for glycine residues in this region then the haeaagglutinin bound and 
underwent conformational change but fusion did not occur. Indicating that 
the haemagglutinin itself was not sufficient for fusion. If the length of 
the N-terminal HA2 region was increased then the size of the conformational 
change also increased but fusion activity was lessened. If in contrast the 
)+-terminal region was shortened then fusion occurred only with erythrocytes 
and not other cell types, again highlighting the l sport ant role played by 
the target bilayer composition. It was postulated by Gething et al. (1966) 
that the partial dissociation of the haesagglutinin brought the viral 
envelope closer to the target membrane. The N-terminus of HA2 Inserted into 
the target bilayer, thus making the haemagglutinin integral to both 
bi layers. In turn this destabilised the bi layer structure allowing fusion 
to occur. Dorns et al.. (1906) also demonstrated that the HA2 polypeptide 
was involved in fusion by producing a single mutation In the HX2 at 
position 132 which resulted in an increase in the pH at which fusion 
occurred compared to the parent virus strain.
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4,3.2. Weak bascg and lyacnoti-ocic aaenta.
Weak bases (e.g. ammonium chloride, methylamine) and lysomotropic agents 
(e.g. amantadine, rimantadine and chloroquine) all act in the same manner 
i.e. they raise the pH of endoscmal and lysosomal compartments and block 
influenza virus infection (reviewed by Lenard & Miller, 1983; Hay et al.. 
1905).
Amantadine does not affect attachment and penetration of influenza virus 
tut does block the endoscmal uncoating of the virus (Kato & Eggers, 1969; 
3cehel et al.. 1977). It is concentrated in both the cytosol and nucleus of 
cells and raises the pH of the lysosomal compartment from 4.7 to 5.5. The 
anti-viral effects of amantadine are transitory and although the 
concentration in the cytosol and nucleus remain high, the anti-viral 
activity is rapidly lost by changing the medium (Richman et al.. 1901). 
Yoshimura et al. (1962) found that if chloroquine-treated infected cells 
were briefly exposed to an acid environment then virus replication could be 
restored, demonstrating that the effects were reversible. If amantadine was 
not present at a time prior to or immediately after infection then no 
effect was fcxind (Kato & Eggers, 1969; Skehel et al.. 1977; Richman et al.. 
1981). Beyer et al. (1986) found that amantadine inhibited influenza 
viruses that possessed haemagglutmins with a low pH induced fusion 
threshold of less than 5.5, but failed to inhibit those with a threshold of 
more than 6.0. They concluded that amantadine resistance was determined by 
the haemagglutinin.
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4,3>-2- A gtre uncrating crggag:
Recently evidence has emerged indicating that unco^ting is a two stage
process. Bukrinskaya et al. (1900, 1982a, 1982b) found that rimantadine
treatment resulted in an accumulation of influenza subviral particles (SVP)
or virus cores in the nuclear-associated cytoplasm (NAC) whilst preventing
the entry of RNP into the nucleus itself. The infectious virus SVPs were
more heterogeneous compared to those from rimantadine treated cells. This \
resulted from differing amounts of associated matrix protein which
suggested a gradual release of matrix protein from the RNPs. The release of
the RNP was thought to occur at the perinuclear or nuclear membranes.
resulting in an accumulation of matrix protein in the perinuclear
membranes. They proposed thatA*coating was a two-stage mechanism; (1)
endosomal removal of the outer envelope together with the surface
glycoprotein spikes (ii) the removal of the matrix protein from the RNPs.
These workers also produced a rimantadine resistant variant, which could 
undergo secondary uncoating in the presence of rimantadine (Bukrinskaya et 
al.. 1982b).
Other groups have also found evidence of a two stage uncoating process.
Natl in et al. (1981) found low pH fusion at the plasma membrane of cells 
did not result in a productive infection, this suggests that fusion by 
itself was not sufficient for complete uncoating of the genome. Richman et 
al. (1981) found amantadine to non-specifically inhibit active cellular 
processes and suggested that the effects of the agent may not be directly 
related to its lyscmotrophic effects. Richman et al. (1986) found that both 
the haemagglutinin and matrix proteins of infecting influenza viruses were
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rapidly degraded whereas nucleoprotein was not. If the cells were treated 
with amantadine then the haemagglutinin continued to be degraded but matrix 
became resistant to degradation. They concluded that fusion of viral and 
cellular membranes had been inhibited, but an alternative explanation would 
be that fusion occurred and that secondary uncoating was blocked by 
amantadine. Bel she et al. (1988) examined rimantadine-resistant variants. 
The sole mutation was in the M2 matrix protein gene (position 30/31) which 
lay in the transmemtrane domain of this protein. This would again support a 
two stage uncoating mechanism. In contrast to the findings of Beyer et al. 
(1986) described above, other workers have found amantadine resistance to 
be conferred not by the haemagglutinin but instead by a protein coded for 
by RNA segment 7 (Hay et al.. 1979; Lubeck et al.. 1978; Scholtissek & 
Faulkner. 1979). This work was performed before M2 was discovered in the 
virion structure (Zebedee & Lamb. 1988) and lead to the conclusion that the 
sutation resided in Ml. The findings of Bel she et al. (1988) would indicate 
that the mutation affected M2 and not Ml. Hudson et al. (1978) found the 
matrix protein migrated to the nucleus together with the HNP segments 
whilst the virus envelope lipids and glycoprotein spikes remained 
cytoplasmic, indicating that the matrix protein remained associated with 
the RNPs following endosomal fusion.
4.4. Influenza virus replicaticn.
Following uncoating the virus cores migrate to the nucleus, the route to 
the nucleus is not known (Stephenson & Dimnock. 1975). Not all virus 
particles successfully uncoat, some nucleocapsid protein is degraded by 
lysosomes and this together with other degraded virus material appears in 
the medium roughly 30 minutes after infection (Matlin et al.. 1981).
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Influenza virus has negative (non-message) sense genomic RNA and the virus 
contains RNA-dependent enzymic activities (transcription and replication) 
which are carried out by PB1, PB2 and PA (reviewed by Krug. 1983; Lamb & 
Choppin, 1983; McCauley & Mahy, 1963). Replication is also dependent on an 
active host cell nucleus both far viral transcription and far the 
processing of viral mRNAs (Kelly et al.. 1974). In fact all virus-directed 
RNA synthesis is nuclear (Shapiro et al.. 1987). Primary transcription 
synthesizes viral mRNA species that are shorter than the template, capped 
at the 5' terminal and polyadenylated at the 3' terminal. Secondary 
transcription results in full-length non-po 1 yadeny 1 ated viral RNA 
transcripts which act as templates far the synthesis of vRNA species which 
are incorporated into progeny virus particles. Viral mRNA species are 
transcribed from the vRNA and are translated into virus proteins (Shapiro 
et al.. 1987).
4,4.1. Synthesis of viral mRNA.
Viral mRNAs are produced by primary and secondary transcription, and can be 
detected less than 30 minutes after infection and their rate of synthesis 
reaches a peak after approximately 2 hours (Stephenson & Dimmock. 1975;
Bean & Simpson, 1973; Hay et al.. 1977). Synthesis of mRNAs occurs in the 
nucleus (Shapiro et al.. 1987). a unique site for non-oncogenic RNA virus —  
transcription, and requires an intact DNA-dependent RNA polymerase II 
system (Lamb & Choppin. 1977; Jackson et al.. 1982). Transcription of the 
influenza virus genome to produce viral mRNA utilises newly synthesised 
host cell capped mRNA fragments which serve as primers far viral 
transcription (Plotch et al.. 1979; 1981; Krug et al.. 1979; 1980; Bouloy
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et al ■. 1978; I960; Strldh et al.. 1961). The PB2 viral protein generates 
the primers by recognising and cleaving methylated host mRNAs at a purine 
residue 10-13 bases downstream from the mRNA cap (Herz et al.. 1901:
Ulmanen et al,. 1963). The host oligonucleotide then forms the 5' end of 
the viral mRNA. Primers may also stimulate the virion polymerase by 
allosteric modulation of the complex (Penn & Mahy, 1984; Kawakami et al.. 
1985). Transcription is initiated by the PB1 protein which is also involved 
in chain elongation (Romanos & Hay. 1984; Krug. 1983).
Viral secondary mRNA is synthesized from de novo vRNA and its synthesis is 
regulated (McCauley & Mahy. 1983; Shapiro et al.. 1987; Barrett et al.. 
1979). Early in infection NP and NS1 predominate whereas later in infection 
the amounts of these species fall whilst the synthesis of HA, NA and Ml 
species increase. The P protein mRNAs are synthesised throughout the 
infection. Not all the influenza virus mRNAs are transcribed from col inear 
nucleotide sequences. The Ml and M2 proteins are derived from overlapping 
reading frames on RNA segment 7, NS1 and NS2 are derived from overlapping 
reading frames on RNA segment 8.
4A 2 .  gynthwi? <?t teaplat* RNA-
Ful 1 length copies of each segment of the virus genome are synthesized in 
equimolar amounts. The synthesis is not regulated and represents 5% of 
total viral RNA transcription (Hay et al. . 1977). Like mRNA synthesis, the 
synthesis of template RNA occurs in the cell nucleus (Herz et al.. 1961; 
Shapiro et al.. 1967) and uses the same viral enzyme complex as described 
above (Beaton & Krug. 1984) . Unlike mRNA synthesis there is no requirement 
for primer sequences and the transcripts are not po 1 yadeny 1 ated, suggesting
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that other proteins are involved which modify the activity of the 
transcriptase complex (Beaton & Krug, 1906). The inhibition of secondary 
transcription by cycloheximide confirms that other viral proteins are 
necessary (Taylor et al.. 1977; Barrett et al.. 1979).
4^4,3, Synthesis of progeny vRNA.
Progeny vRNA is synthesised from the full length template RNA transcripts. 
Polypeptide PA is involved and the event is nuclear (Shapiro et al.. 1907). 
The characteristics of influenza virus replication can vary depending on 
the host cell (Stanth & Hay, 1902) and virus strain (Lamb & Choppin, 1977; 
Hay et al.. 1977). Sub-genomic RNAs which interfere with subsequent virus 
replication are sometimes synthesised and are termed defective-interfering 
(DI) RNAs (reviewed by Nayak et al.. 1905). The generation of DI RNAs is 
favored by high multiplicities of infection and the host cell type (Choppin 
& Pons. 1970; Janda et al.. 1979).
4 4-4- Synthesis of influenza virus proteins and assembly of progeny virus.
Influenza virus utilises the normal host cell processes to synthesis viral 
proteins. Approximately 1 hour after infection NS1 and NP proteins are 
detected in the host cell and this is followed by a gradual reduction in 
host cell protein synthesis which is not completely inhibited (Skehel 1972; 
1973). Later in infection HA, NA and Ml proteins are produced, although the 
host cell type can influence viral protein synthesis (Minor et al.. 1979). 
Viral glycoproteins (HA and NA) are synthesised on membrane-bound 
polyribosomes and are contranslationally inserted into the rough 
endoplasmic reticulum (REJ?). The HA and NA proteins are glycosylated and
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modified as they progress from the RE2? through the Golgi apparatus to 
smooth vesicles. These vesicles migrate to and fuse with the apical plasma 
membrane of the infected cells. Other viral proteins are synthesised on 
free ribosomes in the cytoplasm and migrate to different sites of the cell 
by diffusion (Sfcith et al.. 1967). The P proteins become tightly associated 
with the cell nucleus, though PA is also found in the cytoplasm. The NP 
protein is initially found associated with the nucleus, later it is found 
in the cytoplasm before it migrates to the plasma membrane prior to progeny 
virus release.
Progeny virus particles are produced by budding from the infected cell 
membranes. The HA and NA glycoproteins concentrate in the apical plasma 
membrane and displace host cell proteins. The Ml (and M2) proteins migrate 
to the plasma membrane where they may interact with the viral 
glycoproteins, although this is not proven (see section 1.). The RNPs fora 
in the cytoplasm before also migrating to the plasma membrane. The 
mechanism of how the eight RNPs are incorporated into each virus particle, 
and how the progeny influenza viruses assemble is not known.
765. He O w n  gas of neutralization of viruses
The binding of antibodies, both neutralizing and non-neutralizing, can 
inactivate virus infectivity in conjunction with accessory factors e.g. 
complement (reviewed by Lachmann, 1965; Davies & Metzger. 1963; Beebe et 
al.. 1963; Math lessen et al.. 1968; Vasantha et al. ■ 1968). rheumatoid 
factor (Coutelier & van Shick. 1968) or antibody-dependent cytotoxic cells 
(section 3.1.1.). In this section I will focus on neutralization resulting 
from the binding of antibody alone. This type of neutralization depends on 
the interaction of three components; the virus, the antibody and the cell 
(reviewed by Dismock. 1967).
Neutralization (reviewed by D inmock. 1964; 1967; Mandel, 1965) results from 
the binding of one or more antibody molecules to a particular protein on 
the virus particle leading to a loss of infectivity. For influenza virus, 
antibodies directed against the HA glycoprotein are neutralizing whereas 
those directed against the NA glycoprotein are non-neutralizing, although 
they do limit infection (Seto & Rott. 1966; Webster & Laver. 1967). In 
order to neutralize influenza virus, antibodies have to bind not only to 
the HA but to specific epitopes (critical sites) on the molecule (section
1.5.). Antibodies that bind to the HA at epitopes outside these antigen 
regions (non-critical sites) fail to neutralize the virus (Breschkin si 
al.. 1961).
Neutralization can be mediated by all three major immunoglobulin classes. 
IgG. IgM and IgA (Ogra et al.. 1975; reviewed by Mandel, 1964). The class of 
antibody is a major factor in determining the mechanism of influenza virus 
neutralization and this will be discussed below. Most of the work on the
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neutralization process for other viruses has involved the use of the IgG 
and unless stated otherwise, it is this class of antibody to which I am 
referring. The virus occupies a central position when considering 
neutralization. The diversity of virus structures means that the findings 
pertaining to one type of virus (e.g. the non-enveloped picomavirus, 
polio) cannot be automatically interpreted as applying to others (e.g. the 
enveloped orthomyxovirus, influenza). Considering the diversity of 
different virus structures it is not surprising there is no single 
mechanism of neutralization for all viruses. The target cell type has 
received comparatively little attention, although some studies, using 
influenza and other virus systems, have demonstrated a clear and important 
role for the target cell in the neutralization process and will be 
discussed below.
The mechanisms by which the binding of antibody can result in a loss of 
virus infectivity can divided into four categories:
(i) Aggregation
(ii) Inhibition of virus attachment to cells
(iii) Inhibition of virus penetration into cells
(iv) Inhibition of subsequent intracellular stages of infection 
Neutralization may not necessarily result from the inhibition of just one 
of these but be due to a combination of these events.
5,1, tagraaticn ae a .ieaw uw  9l ngutralizaUon.
An infectious unit can comprise either a single virus particle or a virus 
aggregate. Therefore aggregation by antibody will reduce the total number 
of infectious units within a virus population and result in neutralization.
Neutralization by aggregation does not necessarily involve an intrinsic 
loss of virus infectivity. each virus particle nay retain full infectivity 
but the infectivity of the population will be reduced.
Aggregation appears to be a major mechanism of neutralization for 
poliovirus. Using a panel of polyclonal and monoclonal antibodies, Thomas 
et al. (1965; 1966) found that the neutralization of poliovirus correlated 
with the loss of single virus particles and an increase in aggregation. The 
poliovirus aggregates were separated using sedimentation velocity gradients 
and occurred even when low virus concentrations «1000 pfu/ml) were used.
These workers failed to demonstrate the shift in isoelectric point (pi) 
that Mandel (1976) had previously found and which will be discussed later. 
Thomas et al. (1985) treated poliovirus aggregates with papain which 
disaggregated the virus and restored the infectivity. demonstrating that 
aggregation had not intrinsically damaged virus infectivity. Addition of an 
anti-Ig antibody to the resulting poliovirus-Fab‘ complexes caused a return 
of both aggregation and neutralization. Interestingly. Thomas et al ■ (1986) 
found that the amount of aggregation fell when the concentration of 
antibody was in excess of that required for saturation of the virus but 
there was no return of infectivity. indicating that aggregation was not the 
sole mechanism of poliovirus neutralization. Aggregated poliovirus was 
stable and could be separated using sedimentation velocity gradients 
(Icenogle et al.. 1963). Wetz et al. (1986) also observed a rise in 
aggregation as the concentration of neutralizing anti-VPl antibody was 
increased. However single virions, separated frcm the aggregated 
neutralized virus preparations, had lost 22% infectivity. These had an 
average of one antibody molecule bound per five virus particles, indicating 
that a single antibody molecule could mediate neutralization in the
78
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absence of aggregation. Wetz et al. suggested that two mechanisms of 
neutralization operated (i) an antibody-mediated conformational change in 
the viral capsid proteins, similar to that described by Mandel (1976), and 
(ii) aggregation as described by Thomas et al. (1985; 1966). Neutralization 
of adenovirus type 2 by polyclonal anti-fibre antibodies correlated with 
the amount of aggregation (Wohlfart et al.. 1985; Wohlfart. 1968). 
Neutralizing anti-hexon and anti-pent on antibodies did not aggregate 
adenovirus, except when used in high concentrations, suggesting that the 
protein to which the antibody bound was an important determinant of 
aggregation.
The relevance of aggregation to influenza virus neutralization has not been 
extensively studied. Taylor (1986) found aggregation of influenza virus. 
A/Fowl Plague Virus/Host ock/34 (H7N1). was negligible when saturating 
amounts of antibody were used for neutralization. When sub-saturating 
amounts of antibody (either IgG, IgM or slgA) were used, aggregation did 
occur but the effects of aggregation were not investigated. Taylor et al ■ 
(1987) used the same influenza virus strain and quantified the amount of 
aggregation at various monoclonal IgG concentrations. At high IgG 
concentrations they found no aggregation but as the antibody was diluted 
the majority of virus became aggregated. Surprisingly aggregation of virus 
was observed when the antibody was diluted to sub-neutralizing 
concentrations, and they proposed that aggregation was occurring on the EX 
grid. The rise and fall of influenza virus aggregation dependent on 
antibody concentration is very similar to that discussed above for 
poliovirus, which would suggest that it is a common phenomenon.
so
3,2- Inhib itio n  of virus attachment to c e lls .
The steric inhibition of virus attachment to cells resulting from the 
binding of antibody is conceptually the simplest mechanism of 
neutralization.
Lee et al ■ (1961) demonstrated that antibodies against the sigma 1 capsid 
protein of reovirus inhibited virus attachment to L cells by up to 99*. For 
Epstein Barr virus (EEV). monoclonal neutralizing antibodies against the 
gp220 and gp350 glycoproteins inhibited virus attachment to lymphoblastoid 
cell lines by more than 96* (Miller & Hutt-Fletcher. 1968). In contrast, 
they found neutralizing antibodies against the gp85 glycoprotein failed to 
reduce EBV attachment. The inhibition of attachment to cells for other 
viruses appears to be a less important as a mechanism of neutralization. 
Anti-gD antibodies only partially inhibited (by up to 30*) the attachment 
of herpes simplex virus type 1 (HSV-1) to Vfero cells (Highlander et al.. 
1967) and HE*>-2 cells (Fuller & Spear. 1965). The small reduction in HSV-1 
attachment did not account for the amount of neutralization observed, which 
implied that other neutralization mechanisms were also operating. Similar 
findings were obtained using rabies virus neutralized by two different 
anti-G monoclonal antibodies (Dietzschold et al.. 1987). They found the 
attachment of rabies virus to EH< cells was reduced by 33* and 60* whilst 
infectivity was "completely neutralized". Roehrig et al. (1988) studied the 
neutralization of Venezuelan equine encephalomyelitis (VEE) virus by 
monoclonal antibodies against the E2 glycoprotein. They showed that the 
inhibition of VEE attachment to either Vero or IMF—90 cells was influenced 
by the epitope-specificity of the anti-£2 antibodies. Antibodies against
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E2c and E2h epitopes inhibited attachment by 80-90%. antibodies against 
other E2 epitopes reduced attachment only by 10-30% whilst those against 
the E2f epitope actually enhanced attachment by 50-100%. The reduction in 
VEX attachment was not due to aggregation because Fab' fragments also 
neutralized the virus (although less efficiently) and inhibited virus 
attachment, and the addition of an anti-ismunoglobulin failed to increase 
either effect. Joklik (1964) found that polyclonal serum reduced the amount 
of rabbit pox virus attaching to HeLa cells by 40% but again this did not 
account for 92-97% loss of infectivity.
The relevance of inhibition of attachment of poliovirus by antibody to 
neutralization is less clear. Handel (1967) found poliovirus neutralized by 
polyclonal hyperimmune serum attached to HeLa cells in similar amounts as 
infectious virus. In contrast, Efcini et al, (1963a) found that monoclonal 
anti-VP 1 antibodies did reduce poliovirus attachment to HeLa cells by 
30-00% but this was not sufficient to account for neutralization (99%). 
Inhibition of attachment increased in proportion to antibody concentration 
up to saturating amounts. One monoclonal antibody and a polyclonal 
hyperimmune serum enhanced attachment to HeLa and L cells by more than 
three-fold, which is surprising, because L cells lack poliovirus receptors. 
It was not known if the binding of antibody had altered the virus-receptor 
specificity as had been found for vesicular stomatitis virus (VSV)
(Schlegel & Wade, 1983), or whether the increased attachment was mediated 
by the antibodies themselves. All the neutralizing antibodies induced a pi 
shift from pH 7 to pH 3.6-4.1 which had previously been implicated as a 
mechanism of neutralization (Handel. 1976). Etoini et al. (1983a) also used 
a neutralizing polyclonal anti-VP4 serum which inhibited virus attachment
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by more than 50» depending on the antibody concentration used. This 
antibody did not induce a pi shift and the inhibition of virus attachment 
by this antibody may be its predominant mechanism of neutralization.
Neutralization of transmissible gastroenteritis virus (TGEV) by polyclonal 
IgG or secretary IgA (slgA) antibodies failed to inhibit virus attachment 
to swine testis or pig kidney cells although the virus was neutralized by 
99.99% (Nguyen et al ■ ■ 1986). Interestingly, increasing the concentration 
of slgA resulted in a three-fold enhancement of virus attachment. The 
attachment of TGEV to cells did not appear to be mediated by Fc receptors 
and they suggested that the enhanced attachment of slgA neutralized virus 
was due to an aggregation effect. Skinner et al. (1988) examined the 
effects of neutralizing antibodies against human immunodeficiency virus 
(HIV) type 1 on the binding of purified gpl20 to CD4 positive MOLT-4 cells. 
Polyclonal antibodies raised against recombinant HIV envelope components 
were primarily directed towards a hypervariable region of the gpl20 
glycoprotein and failed to inhibit gpl20-CD4 binding. Two monoclonal 
antibodies against the same hypervariable region gave similar results. In 
contrast, human serum from infected patients did inhibit gpl20-CD4 binding 
and reasonable corrrelation (0.92) was found between the titres required 
for neutralization and for inhibited gpl20-CD4 binding. These data support 
the suggestion that two different mechanisms of HIV neutralization can 
operate dependent on the epitope to which the antibody molecules bind.
For influenza virus, some groups have claimed that neutralization results 
mainly from the inhibition of virus attachment to cells (Weis et al..
1988). This suggestion is based solely on the fact that the antigenic sites 
on HA glycoprotein are in close proximity to the receptor binding pocket.
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No data were presented to demonstrate a reduced attachment of influenza 
virus to cells. Contrary to the suggestion of Weis et al.. others have 
found the ability of antibody to inhibit attachment to cells depends on 
class of antibody and the cell type used. Poesee et al. (1962) demonstrated 
that polyclonal anti-HA antibodies from hyperimmune rabbit serum against 
A/Fowl Plague Virus/Rostock/34 (H7N1) (A/FPV/R) did not prevent virus 
attachment to CEF cells although the virus was neutralized by 99.999%. This 
finding was confirmed using B-K cells and A/FPV/R neutralized by saturating 
amounts of monoclonal IgG antibodies directed against different antigenic 
sites on the H7 haemagglutinin (Taylor, 1986; Taylor & Diamock, 1985a).
When polyclonal IgM anti-HA antibodies were used to neutralize A/FPV/R then 
a reduction in virus attachment to EH< cells was found (Taylor & Dimmock. 
1985b). The reduction in attachment was temperature dependent; at 4*C the 
amount of virus attaching was negligible, but as the temperature was raised 
more virus attached and at 37*C the amount of IgM-neutra 1 ized virus 
attaching had increased to approximately 50% of non-neutral ized virus 
levels. These workers suggested that the larger molecular size of IgM 
antibodies sterically hindered virus attachment and that thermal agitation 
was responsible for bringing the cell receptor and haemagglutinin into the 
correct juxtaposition. Taylor & Dimmock (1985a) found that neutralizing 
polyclonal slgA antibody also inhibited 4/FPV/R attachment to EHK cells in 
a manner very similar to that found using IgM. Monomeric IgA. produced by 
differential reduction of the slgA, did not prevent A/FPV/R attachment but 
continued to neutralize the virus. Therefore the molecular size of the 
antibody influences its ability to inhibit the attachment of influenza 
virus to cells; large polymeric antibodies (IgM and slgA) reduce 
attachment, whilst smaller monomeric antibodies (IgG and monomeric IgA) do
not.
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Although neutralizing anti-HA IgG antibodies at saturating concentrations 
do not reduce the attachment of A/ITV/R to CEF or EH< cells (as discussed 
above), they can inhibit virus attachment to chicken erythrocytes (Poesee. 
1961). Dinmock (1967) proposed that the difference was due to the length of 
the cell receptors. The erythrocyte receptor for influenza virus is 
probably glycophorin (Jackson et al.. 1973) which only extends 5nm from the 
erythrocyte surface (Viitala & Jamefelt, 1965). Dimmock argues that the 
bound IgG molecule is sufficiently large enough to prevent the virus 
haemagglutinin making contact with the glycophorin. Although the receptor 
for influenza virus on cultured cells has not been identified, Dimmock 
suggests that the receptor is long enough to penetrate the fringe of IgG 
molecules bound to the virus allowing the haemagglutinin to make contact.
It is possible that glycophorin (or a similar size of molecule) is the 
influenza virus cell receptor on all haemopoietic cells, because Eisenlohr 
et al. (1967) found that a neutralizing monoclonal IgG2a anti-HA antibody 
inhibited the attachment of A/PR/8/34 (H1N1) to A20 murine B-lymphoma cells 
by more than 90* and (Fab' )2 fragments were equally effective.
The attachment of influenza virus to chicken erythrocytes does not result 
in a productive infection (Cook et al.. 1979). The attachment of virus 
particles cross-links erythrocytes and is visualized as haemagglutination. 
The inhibiton of attachment of influenza virus to erythrocytes probably 
accounts for the inhibition of haemaggluti nation (HI) but this does not 
necessarily reflect neutralization. Polyclonal (Yoden et al.. 1962) and 
monoclonal (Kida et al.. 1962) anti-HA antibodies can exert a neutralizing 
effect on influenza virus in the absence of HI activity. These workers 
suggested that position of the antigenic site on the HA molecule may
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determine whether antibodies had HI activity or not. Gitelman et al. (1966) 
produced monoclonal antibody escape mutants which were not neutralized by 
the generating antibody but the antibody still had HI activity against the 
variant. They suggested that this may result from altered specificity 
and/or avidity of the virus variant for cell receptors because the pattern 
of haemaggluti nation titres using erythrocytes from different animal 
species was also altered. Casino et al ■ (1906) reported that a monoclonal 
IgM antibody had HI activity but did not neutralize. They suggested that 
"either the epitope for neutralization overlaps with, but is smaller than, 
the epitope for hemagglutination, or that it only partially overlaps with 
the latter epitope" but this interpretation is open to question (section
10.3.5.). The fact that neutralization and haemagglutlnatlon-inhibitlon are 
not closely linked suggests that the erythrocyte is a poor model on which 
to study neutralization of influenza virus by antibody. Escape mutants of 
poliovirus have been produced to which the generating antibody continues to 
bind (Thomas et al.. 1966).
5 .3 , fc  anUbody-dranflont gnhancwnt 1ACEJ aiirrftcu v itr .
The enhanced attachment of neutralized poliovirus and TCEV to cells 
described above did not appear to be mediated by Fc receptors (FcR). The 
binding of sub-neutralizing amounts of IgGl car IgG2a monoclonal antibody to 
the flavivirus. West Nile virus (WNV). resulted in almost a 200-fold 
enhancement of infectivity using the macrophage cell line, P308D1 (Peiris 
et a 1.. 1981; 1962). ADE could be abolished by pre-treating the cells with 
antl-FcR antibody. If WNV was treated with (Fab')2 fragments prepared from 
the neutralizing antibodies then ADE did not occur but the (Fab')2
fragments could neutralize infectivity if their concentration was 
increased. The WNV. with sub-neutralizing amounts of antibody bound, 
attached to and entered P388D1 cells using the same endosomal pathway as 
virus with no antibody bound (Gollins & Porterfield. 1904; 1966). Similar 
ACE have been found using macrophage cell lines and other viruses including 
alphaviruses (Peiris & Porterfield. 1962). respiratory syncytial (RS) virus 
(Gimenez et al.. 1969) and Sindbis virus (Chanas et al.. 1962).
Ochiai et al. (1966) demonstrated ACE for influenza virus A/NWS (H1N1) 
treated sub-neutralizing amounts of IgG antibody and grown on P368D1 
macrophage cells. The virus attached to and multiplied in 
neuraminidase-treated cells; ACE was not mediated by Fab' fragments. 
Treatment of cells with ammonium chloride abolished multiplication of both 
the normal and ACE virus which demonstrated that they were internalized and 
uncoated by a similar endoeomal pathway. If the antibody concentration was 
increased to that required for neutralization (determined by plaque assay 
using M X X  cells) then ACE also decreased, demonstrating that 
neutralization could occur in P308D1 cells.
5 .4 . In h ib itio n  of v iru s  p e n e tratio n  i n - t o  « H a * .
Joklik (1964) demonstrated that the neutral ized-rabbitpax virus that had 
attached to He La cells was not internalised and the majority eluted from 
the cell surface. Similarly IgG and slgA neutralized TCEV which had 
attached normally to swine testis and pig kidney cells was not internalized 
(Nguyen et al.. 1906). Internalization was determined by treating the cells
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with proteinase K at various tines after the virus attached. After 45 sin. 
p.i. 90* of infectious virus was resistant to renova 1 by proteinase K but 
there was no increase in resistance of neutralized virus.
Highlander et al. (1967) found anti-gD antibodies slewed, rather than 
blocked. HSV entry into V/ero cells. Anti-gB antibodies did block HSV entry, 
again suggesting that the mechanism of neutralization is dependent on the 
protein to which the antibody is directed. Ekini et al ■ (1963a) used a 
panel of polyclonal and monoclonal antibodies against poliovirus and found 
they all inhibited penetration by approximately 50*. Hypernamune sera 
completely abolished poliovirus entry but complete inhibition of entry 
could not be achieved using a cocktail of monoclonal antibodies against 5 
different poliovirus epitopes. Surprisingly a non-neutralizing polyclonal 
antibody preparation inhibited virus penetration to similar extent as found 
using neutralizing monoclonal antibodies, suggesting that the inhibition of 
virus entry was not an important mechanism of neutralization for 
poliovirus.
Influenza virus (A/FPV/R) neutralized by either IgG or monomeric IgA 
antibodies was internalized by CET and BH< cells with kinetics 
indistinguishable from those of infectious virus (Possee et al.. 1962; 
Taylor, 1966; Taylor & Dimmock, 1965a). The IgM or slgA neutralized virus 
that attached to EH< cells was not internalized and remained sensitive to 
removal by proteinase K (Taylor & Dimmock. 1965b) .
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5.1. I n h ib it io n  ot in tr a c e llu la r  rteaea o f  v iru s  in f e c t iv i t y .
Gol 1 ins & Porterfield (1966) demonstrated that polyclonal IgG antibodies 
neutralized WNV on P388D1 macrophage cells when used in concentrations 
greater than required for ACE. They found that neutralization correlated 
with a block in uncoating, defined as increased resistance of the virion 
RNA to degradation by RNase. Also the antibody dilution required for 
neutralization correlated with that required to inhibit fusion of WNV with 
liposomes at pH6.6. They concluded that neutralizing antibody inhibited 
WNV-endosome fusion and neutralization resulted from the degradation of 
virus in lysosomal vesicles. Miller & Hutt-Fletcher (1968) measured the 
membrane fusion activity of EBV by using a self-quenching fluorescent 
rhodamine probe. Monoclonal anti-gp65 antibodies inhibited fusion whereas 
antibodies against gp220 and gp350 (previously shewn to inhibit virus 
attachment) did not. Neutralization of adenovirus type 2 by polyclonal 
anti-hexon and anti-pent on antibodies did not inhibit virus attachment to 
or internalization by HeLa cells (Wohlfart et al.. 1965; Wohlfart. 1988). 
The majority of neutralized virus appeared to be trapped in intracellular 
vesicles suggesting that virus-endoeomal fusion had been inhibited.
The binding of neutralizing antibody to poliovirus has been shewn to shift 
the pi of the virus from pH 7 to roughly pH 4 (Mandel, 1976; Bnini et al.. 
1983a). These workers found a good correlation between the pi shift and 
virus neutralization and suggested that the binding of antibody induced an 
irreversible conformational change in the viral capsid protein, manifested 
as the pi shift, which blocked the successful uncoating of the virus 
particles. Mandel (1976) found Fab' fragments caused a pi shift and
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neutralization similar to intact antibody. Ekini et al. (1963b) found 
cleavage of attached anti-VP 1 antibodies using papain restored both 
poliovirus infectivity and reversed the pi shift. Addition of 
anti-immunoglobulin to Fab -virus complexes resulted in a return of 
neutralization and pi shift. In contrast to Handel, these workers concluded 
that bivalent antibody binding was necessary for neutralization. Eteini gt 
al. (1963b) also found the neutralized virus was not aggregated by the 
neutralizing antibody. Others dispute the pi shift hypothesis (El-ioen et 
&L_. 1985b) and claim that neutralization of poliovirus occurs in the 
absence of a pi shift. Neutralization instead correlated with aggregation 
(Thomas et al ■. 1965; 1986). Others suggest that both mechanisms may 
operate depending either on the antibody concentration (Wetz et al.. 1966) 
or specificity (Icenogle et al.. 1963). ETioen et al. (1965a) demonstrated 
yet another mechanism of poliovirus neutralization. They found that using 
low ionic strength conditions the binding of neutralizing monoclonal 
antibody 35-IÎ4 resulted in disruption of the virions leaving empty viral 
capsids which were no longer recognised by the antibody. The bound antibody 
was released and could neutralize other virions, therefore they termed this 
a "hit and run" mechanism. If isotonic conditions were used 35-If4 
neutralized poliovirus by aggregation.
Similar findings to those for poliovirus have been made using a different 
picomavirus, human r+nnovirus type 14 (HRV14) (Colonno et al.. 1989) .
Eight IgG2a monoclonal antibodies against four different antigenic sites on 
VP1. VP2 and VP3 were tested. All the antibodies caused a pi shift and 
papain treatment of intact antibody already bound to virions reversed this 
shift. Interestingly Fab' fragments prepared before their addition to HRV14 
did neutralize, although a 13- to 61-fold increase in Fab' concentration
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was required compared to intact antibody. Antibodies to three of the four 
sites aggregated the virus but because Fab' fragments could neutralize in 
the absence of aggregation the importance of this is not clear. Fab’ 
fragments prepared from each antibody group inhibited WV14 attachment to 
membranes prepared from He La cells. The inhibition by intact antibody was 
confused by the effects of aggregation and were difficult to assess. These 
data suggest that the mechanism of neutralization of HRV14 is complex and 
involved aggregation, pi shift and inhibition of attachment to cells.
For influenza virus the inhibition of virus uncoating can be sub-divided 
into inhibition of membrane fusion and inhibition of secondary uncoating.
Four non-overlapping antigenic sites (I. II. Ill, IV) on the H7 
haemagglutinin of A/Seal/Mass/1/00 (H7N7) were defined by mapping of 
monoclonal antibody escape mutants (Kida et al.. 1965; Yoden et al.. 1966). 
Antibodies against each site neutralized the virus and inhibited low pH 
haemolysis. At pH 7. antibodies against sites I and II had HI activity 
whilst those against sites III and IV did not. At this pH antibodies 
against each site were capable of inhibiting the haemagglutination by HA 
rosettes (HIR). At pH 5.9 neither of these activities were apparent for 
antibodies against any site. If the antibody reacted with the virus HA at 
pH 7 before being shifted to pH 5.9. then the HI and HIR activities were 
unaffected. These findings indicated that the binding of antibody was 
interfering with the conformational change that occurs in the HA molecule 
at low pH (section 1.5.3.). This was further examined by spin-labelling the 
HA molecule and detecting changes (L and S components) in the electron spin 
resonance (esr). The binding of one antibody. 06/1 (site IV), suppressed 
both the L and S components while another antibody, 58/6 (site I).
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suppressed only the S component. These workers suggested that the fact that 
86/1 had no HI activity but did neutralize was due to interference with the 
low pH endosomal fusion event. Also Fab’ fragments from antibodies against 
sites I and II neutralized the virus, although only poorly. Fab' fragments 
from antibodies against sites III and IV failed to neutralize the virus 
unless ant 1 -Fab’ was added. This indicated that bivalency was important in 
the neutralization by site III and site IV antibodies but no mechanism was 
proposed.
In contrast to the findings reported above. Possee et al. (1982) 
demonstrated that radiolabel led virion RNA of A/FFV/R neutralized by 99.8% 
by anti-HA polyclonal IgG antibody accumulated in the nucleus of CEF cells 
with the same Kinetics as infectious virus but there wasjprimary 
transcription of the virus gencme. This implied that viral and endoeomal 
memtrane fusion had occurred and that the antibody block occurred at a 
later stage. Examination of the in vitro neutralized virion transcriptase 
activity revealed a 7-fold reduction compared to infectious virus. Using 
the X49 (H3N2) strain neutralized by 99.999% by monoclonal IgG antibodies a 
reduction of 9-fold was found in the virion transcriptase activity. In vivo 
a good correlation was found between the increase in virion RNA resistance 
to RNase digestion and neutralizing antibody concentration. It was 
suggested that the binding of neutralizing antibody to the influenza virus 
HA directly or indirectly inhibited transcription of virion mRNA. The 
binding of antibody changed the conformation of the HA molecule and this 
was communicated to the underlying proteins via the C-terminus of HA2 
(Diamock. 1964). Later Rigg et al. (1989) found that the RNA of neutralized 
virus recovered from cell extracts was resistant to RNase whereas that of 
infectious virus became sensitive. This was interpreted as showing that
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neutralization caused a block in secondary uncoating of the virus core. The 
failure of transcription is thus considered to be an incidental effect and 
it is predicted that if secondary uncoating was achieved artificially the 
transcriptase would be functional. Antibody is known to induce 
conformational changes in viral proteins, including the HA (Lubeck & 
Gerhard. 1962) and NA (Colman et al. . 1987). and non-viral proteins 
(reviewed by Celada et al.. 1963). Taylor et al. (1967) developed this 
model of influenza virus neutralization by studying the kinetics and 
stoi chôme try of the reaction, and this will be discussed later. Shimizu et 
al. (1985) found a 50-63% reduction in virion transcriptase activity 
following neutralization of A/Udcm/72 (H3N2) with polyclonal IgG. One 
neutralizing monoclonal anti-HA antibody. 22/1 (site B), reduced the 
transcriptase activity by 76% but seven other monoclonal antibodies had no 
effect. They confirmed that for some antibodies the inhibition of 
transcriptase activity was a mechanism of neutralization. The fact that 
most monoclonal antibodies failed to inhibit the in vitro transcriptase 
activity implied that it was not a common or the sole mechanism of 
neutralization and was dependent on the antigenic site against which 
antibody was directed.
flw ftiW içn of ihs n vA n linU çn  rwrtisn,
The question of how many bound antibody molecules are required for 
neutralization is a contentious subject (reviewed by Mande 1. 1985) and will 
only be briefly discussed here. Two models have been proposed; single-hit 
and multi-hit. The single-hit model argues that the binding of one antibody 
molecule to a virus particle results in neutralization. The multi-hit model
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argues that more than one antibody molecule has to bind to result in 
neutralization. The kinetics of the neutralization reaction can be defined 
by the equation:
(1) &  -kt/D n
Vo - 1- <1-0 ) (Handel. 1905)
where Vt and Vo are the infectivity titres at time t and 0. k is the 
reaction rate constant. D is the dilution factor of the serum and n is the 
number of 'hits' required for neutralization.
If n-1 (the single-hit model) then a plot of log^ remaining infectivity 
with respect to time (using a constant antibody dilution) will give a 
straight line. Infectivity will fall immediately with no lag period.
If n is greater than 1 (the multi-hit model) a plot of log* of remaining 
infectivity against time results in a curve. During the early stages of the 
reaction, relatively little or no loss of infectivity occurs and this is 
termed the lag period.
For poliovirus. Handel (1976) found single-hit kinetics of neutralization 
but this model has been challenged and the arguments for a multi-hit model 
are reviewed by Della-Porta & Westaway (1977). The ability of monoclonal 
antibodies to enhance virus infectivity at sub-neutralizing concentrations 
(as described above) is clear evidence of a multi-hit mechanism because 
molecules must have bound before the neutralization effect was observed. 
Synergistic neutralization between monoclonal antibodies against different 
epitopes also demonstrates a multi-hit mechanism of neutralization (e.g.
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rubella virus. Gena et al.. 1907). No neutralization was detected using 
monoclonal antibodies against the El envelope protein, but when two 
different antibodies were pooled neutralization was detected. The pooling 
of antibodies also increased the HI activity by 2- to 8-fold. Individually 
most of the monoclonal antibodies neutralized rubella virus if 
anti-immunoglobulin was also added, suggesting that cross-linking of
antibodies on a single virion or aggregation of virus was important, 
to*Synergistic neutralization^also been demonstrated for RS virus (Anderson 
al.. I960). Newcastle disease virus (Russell. 1906; Iorio & &-att, 1904) 
and La Crosse virus (Kingsford et al.. 1983). Synergistic binding of 
antibodies has been shown for Sindbis virus (Clegg et al.. 1983), 
tick-borne encephalitis virus (Heinz et al■. 1904). VSV (LeFrancois &
Lyles, 1982) and influenza virus (Lubeck & Gerhard. 1902). The problem of 
quantifying neutralization can be approached in another way. The 
stoichometry of the neutralization reaction can be examined by comparing 
the amount of neutralization observed with the number of antibody molecules
bound per virion. Icenogle et al. (1903) demonstrated that although
mt
poliovirus had single-hit kinetics, the binding^ four antibody molecules 
were required for neutralization. They proposed cross-linking of capsid 
pentamers by the bivalent antibody molecule was important for 
neutralization. They suggested two hypotheses to explain the both kinetic 
and stoichooetric data; 'stepwise' neutralization and 'critical site’ 
neutralization. The first hypothesis proposes that the binding of each 
successive antibody reduces the virus infectivity by a factor of 3/4. The 
second hypothesis proposes that only antibody binding to 'critical1 
antigenic sites (in this case about 1 out of 4) results in neutralization, 
the binding of antibody to 'non-critical1 sites does not affect 
infectivity. The 'critical* and 'non-critical‘ sites are equivalent in
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terns of antibody binding but are not e<^iivalent in terns of function. They 
suggested that possibly the 'critical' sites were internally associated 
with crucial regions of the virion RNA and that the binding of antibody 
prevented the successful uncoating of the viral genome. The data reported 
were not precise enough to distinguish between the two models.
Taylor et al. (1967) quantified the neutralization reaction for a 
monoclonal antibody to influenza virus using kinetic and stoichometnc 
analysis. At three temperatures, the neutralization of influenza virus by 
O.lug of IgG followed single-hit kinetics i.e. there was no lag period. 
Lowering the IgG concentration 10-fold did produce a lag period and linear 
regression analysis and extrapolation of the slope indicated that 2- or 
3-hits were required for neutralization. Lafferty (1963) had previously 
demonstrated that the neutralization of influenza virus was multihit when 
lew antibody concentrations were used at low temperatures (4*0 but 
interpretation is difficult because he was using a polyclonal, polyspecific 
antiserum. Taylor et al. (1987) then determined the stoichcmetry of 
neutralization using two methods; the attachment of radiolabel led IgG of 
known specific activity, and the detection of attached IgG by anti-IgG 
labelled with colloidal gold. Comparison of the number of radiolabel led IgG 
molecules bound with the amount of neutralization demonstrated that at 50% 
neutralization there was approximately 50 IgG molecules bound per virion. A 
similar result was obtained using colloidal gold detection of IgG bound to 
virions. The presence of bound IgG molecules was detected using an antibody 
dilution 100-fold less than that required for neutralization of the virus. 
Therefore, the kinetic data which suggested a single (or limited number) of 
'hits' failed to agree with the stoichometric data which demonstrated that 
many antibody 'hits' were necessary to achieve neutralization. These
workers reconciled the difference between the kinetic and the stoichcmetric 
data by suggesting the existence of neutralization 'relevant' and 
'irrelevant' HA spikes. This hypothesis proposes that antibody binding to 
'irrelevant' HA spikes, which are in the majority (49/50). fails to 
neutralize the virus and that only antibody binding to 'relevant' (1/50) HA 
spikes causes neutralization. This proposal satisfies both the kinetic 
and stoichometric data, neutralization would result fro* a single antibody 
'hit' but an average of 50 antibodies would have to bind before the 'hit1 
could be made. The mechanism of how the binding of antibody to 'relevant' 
spikes might mediate neutralization has been discussed previously.
5 .7 . The TO lt o f  the ta r g e t  c e l l  in  th «  n e u tr a liz a t io n process.
As previously mentioned, the effects of antibody binding to influenza virus 
can be influenced by whether cultured or haemopoietic cells are used. The 
potential role of the target cell in the neutralization process has also 
been demonstrated using other viruses.
Grady & Kinch (1965) found that one monoclonal anti-Gl antibody. 3G8. 
neutralized La Crosse (LAC) virus when assayed using EhK cells but not on 
mosquito cells. A second monoclonal anti-Gl antibody. ZB9, had the converse 
effect, showing neutralization on mosquito cells but having no effect using 
BH< cells. They suggested the difference may have a significance in the 
life-cycle of LAC which interacts with mosquitos and small mammals. Kjellen 
& von Zeipel (1964) demonstrated that echovirus type 4 was more effectively 
neutralized on RD cells compared to GM< cells. Aggregation was not 
responsible for the difference between the two cell types, or for the 
non-neutralizable fraction. Kjellen (1965) found that the kinetics and
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amount of neutralization by polyclonal hyperimmune serum of enterovirus 71 
differed according to whether the assay was performed using RD cells, which 
resulted in greater neutralization, or GM< cells. The differences in 
kinetics were not due to aggregation and were not due to variation in rates 
of virus attachment or entry into the two cell types. The antibody 
population that neutralized on RD cells appeared to bind to the virus only 
after the virus had attached to the RD cells, indicating that "new" 
antigenic sites were revealed during interaction of the virus with the cell 
receptor. Unfortunately these workers did not attempt to remove the free 
antibody before inoculating the cells which would had proven the 
poet-attachment neutralization. Kennedy-Stoskopf & Narayan (1986) 
demonstrated the mechanism of neutralization of visna virus by polyclonal 
hyperimmune serum differed according to whether fibroblast or macrophage 
cell lines were used. On both cell types the antibody prevented 
transcription of the viral RNA and resulted in 99% neutralization by plaque 
assay using monolayers of fibroblasts. Using fibroblasts, the antibody 
inhibited the binding of virus to cells by more than 80%. The virus that 
had attached was not internalized by the cells. Using macrophages, virus 
attachment was enhanced by 50%, and the attached virus was internalized and 
uncoated. They suggested that the mechanism of neutralization using 
macrophages involved a block between the uncoating and transcription of the 
virion RNA. The kinetics of neutralization was slow compared to the rate of 
virus attachment and entry into cells. They suggested that this may be an 
explanation for the persistence of visna virus infection of macrophages in
vivo.

9 9$ 1 -  a p pi i f f ?  9f r« ran tg
(Amersham) Amersham International pic. Amersham. U.K.
(Ami con) Ami con Ltd. Storehouse. U.K.
(BEH) BDH Chemicals Ltd., Poole. U.K.
(Difco) Difco Ltd., London. U.K.
(Fisons) Fison Scientific Apparatus. Loughborough, U.K.
(Flow) Flow Laboratories. Irvine. U.K.
(Gibco) Gibco-BRL Ltd.. Paisley. U.K.
(Hylyne) Hylyne Rabbits Ltd., Northwich. U.K.
(Nordic) Nordic Immunology, Tilburg. Netherlands.
(Searle) G D Searle Ltd.. High Wycombe. U.K.
(Sigma) Sigma London Chemical Co.. Poole, U.K.
(Steri 1 in) Sterilin Ltd. Peltham. U.K.
6.2. Celle.
Iigyt culture rellg,
Primary chick embryo fibroblast (OF) cells were prepared as described by 
Morser et al.. (1973). Plastic Petri dishes. 5cm diameter (Gibco). were 
seeded with either 9 x 10* or 3 x 10* cells per dish in 3ml of medium and 
incubated at 37*C in an atmosphere of 5% CCy until confluent. Roller 
bottles were seeded with 2 x 10* cells in 200ml of medium and grown to 
confluence. The medium used was 199 medium (Flow) containing lOOU/ml 
penicillin. lOOug/ml streptomycin. ImM glutamine and 5% v/v newborn calf 
serum (NCS) (Gibco).
Baby hamster kidney (EH<-21) cells were propagated In Glasgow Modified 
Cagles Medium (GMEM) (Gibco) containing lOOU/ml penicillin. lOOug/ml 
streptomycin. 4mM glutamine and 5% v/v NCS.
C3H10T1/2 mouse fifcroblast cells were grown in GMEM supplemented with 
non-essential amino acids (GMEJ4-NEAA) (Gibco). lOOU/ml penicillin. lOOug/ml 
streptomycin, 4mM glutamine and 5% v/v NCS.
Madin-Darby canine kidney (MDCX) cells were propagated in Du1beccoiModified 
Eagles Medium (LMEM) (Gibco) containing lOOU/ml penicillin, 10(X»g/al 
streptomycin. 4mM glutamine and 5% v/v NCS.
6,2.2: Preparation o f trach ea l organ c u ltu r e s .
5-10 week old C3H He Mg mice of both sexes were killed by cervical 
dislocation and the trachea removed as rapidly and aseptically as possible 
and placed in a vial of 199 medium. The tracheas were then taken back to 
the laboratory where extraneous tissue was removed using a sharp scalpel 
blade and organ cultures prepared. Tracheal organ cultures can be prepared 
either using longitudinal or transverse sectioning (Figure 6.1.).
Early organ culture work (reviewed by Hoorn. 1966) used the longitudinal 
method of sectioning and the cultures were observed microscopically using 
reflected light. I initially attempted this method but found the sectioning 
difficult due to the very small diameter of the mouse trachea and the 
highly elastic nature of the tissue. I also found the reflected light 
examination technique unsatisfactory and time-consuming.
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Longitudinalsectioning
Fig.6.1. Different techniques used to prepare trachealorgan cultures; longitudinal and transverse sectioning.
Hoot organ culture work after 1970 has used the transverse method of 
sectioning and produces trachea ‘ring ■" cultures which can be observed 
using transmitted light microscopy. It is important that each section 
contains at least one cartilage ring, otherwise the culture rapidly sheds 
the epithelial lining and dies (Hoorn. 1966; Husseini et al.. 1963). I have 
found the transverse method of sectioning relatively fast, reliable and 
reproducible, and is the method I have used throughout ay work.
\
Transverse organ culture sections were cut using a sterile scalpel blade 
and placed in 199 medium supplemented with 0.1% bovine serum albumin (BSA)
(Sigma), and maintained at 37*C (5% 00a atmosphere) overnight before use.
This medium containing dead cells and debris. was removed and replaced with 
fresh medium before the cultures were used.
The choice of medium in which to maintain the cultures presented a problem 
because each research group has tended to use a different medium 
supplemented with various buffers and additives. I used 199 medium buffered 
with bicarbonate which has been used throughout organ culture work, from 
the early days of research (e.g. Hoorn & Tyrrell, 1965a) to more recent 
times (e.g. Heath et al.. 1963). Others have used either LI5 medium (e.g. 
Boudreault. 1979) or Eagles HEX (e.g. Derbyshire et al ■. 1979). Attempts 
have been made to assess the effects of different media and buffers on the 
performance of chick embryo tracheal and human fallopian tube organ 
cultures (Blaskovic et al.. 1973; McGee et al.. 1976). The results were 
inconclusive but HEFES or TRIS buffers were preferred to the use of 
bicarbonate buffer. This has not prevented the successful use of 
bicarbonate by other workers and I found bicarbonate buffering 
satisfactory.
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When studying virus growth, batches of organ cultures were inoculated and 
then seeded into 96 well, flat bottoaed. tissue culture trays (Sterilin) 
with one culture and 50ul medium per well. The medium was harvested daily 
and replaced with fresh medium, the cultures were then examined 
microscopically. The samples of harvested media were centrifuged to remove 
cell debris before storing at -70*C.
When studying virus attachment, organ cultures were grouped into batches of 
20-30 cultures and maintained at 37*C in 1ml of medium.
D titn im U m  oi ciliary activity,
The condition of the tracheal organ cultures can be determined by assessing 
the level of activity of the ciliated cells making up the luminal lining of 
the cultures. The "ring“ organ cultures were observed by transmitted light 
using an inverted microscope (Olympus) with the X40 objective and X10 
eyepiece. The cilia were clearly seen and the whole of the trachea ring was 
visible in a single field of view.
A system of scoring ciliary activity was developed; various workers have 
used different methods of determining the condition of organ cultures e.g. 
percentage surface area beating (e.g. Moetow et al.. 1979), vigour of 
beating (Cherry & Taylor-Robinson. 1970). mapping of individual sections 
(e.g. Edwards et al.. 1986) or histologically using the tetrazolium trypan 
blue (TT) test (Herbst-Laier, 1970). The scoring technique I developed is 
shown in Table 6.1.. Such a scheme is subjective but this is a inherent
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Table 6 .1 . Method used to determine the am ount of ciliary activity o f mouse tracheal organ  cultures.
SCORE0123
4
DESCRIPTION No observable activity Patchy,but definite activity Activity covering <50% area Activity covering >50% area Strong activity covering 100% area
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problem of all such schemes. In practice, it is fast and easy to use; with 
experience intermediate scores can be given as well as those listed and. to 
reduce any bias, each section is scored "blind".
S2- 4-  RW?v?i Qt W ith e rs ! c?li?,
The method used was kindly supplied by ET.C.a#eet (University of 
Birmingham, personal ccomumcation) as is described below.—
\
The organ cultures are digested with 1ml of Hank£ balanced salt solution 
(HBSS) (Flow) containing 7mM Mg*\ 0.02% w/v EX3TA (Sigma). lOU/ml protease 
XIV (Sigma). lOU/ml protease XXI (Sigma) . The digest was carried out at 37*
C for 20 min., with occasional gentle shaking at approximately 5 min. 
intervals. At the end of the digestion the cultures were vigorously 
agitated to free the cells, this was done by tapping the vial containing 
the cultures firmly on a hard surface. The supernatant was removed and kept 
on ice. This procedure was repeated four times, the organ cultures were 
then washed with 1ml of 199 media to ensure all the available cells were 
collected. At the end of the procedure the four digests and the wash were 
pooled and the cells pelleted tty centrifuging for 10 min. at 650g. The 
pelleted cells were resuspended in 1ml 199 medium containing 0.1% BSA by 
gently sucking up and down with a Pasteur pipette.
kJ, Vinitw.6, 3, 1,  Influenza strains and their propagation.
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The avian strain of influenza A/Fowl Plague/Rostock/34 (H7N1) (A/FPV/R) was 
grown up from #533 stock preparation (University of Warwick) in the 
allantoic cavity of 10 day old embryonated hen eggs and incubated for 20 
hours at 37*C. The allantoic fluid was collected after chilling the eggs at 
4#C overnight, clarified by low speed centrifugation, allquoted, snap 
frozen and stored at -70#C.
A mouse-adapted derivative of the above strain, designated adpFPV/R (H7N1). 
was prepared by serial passaging in C3H10T1/2 cells, followed by plaque 
purification (further details given in section 7.2.4.). The virus was grown 
up in eggs in an identical manner described above.
The avian strain A/Fowl PI ague/Dutch/27 (H7N7) (A/FPV/D) was grown up from 
#336 stock preparation (University of Warwick) and was propagated In a 
manner identical to A/FPV/R.
The infectivlties of A/FPV/R. adpFPV/R and A/FPV/D were determined by 
plaque assay on CEF cell monolayers under 0.9» agar (Difco) in 199 medium 
containing lOOU/ml penicillin. lOOjg/ml streptomycin and 5» v/v NCS. Ttye 
cell monolayers were incubated at 37*C (5% CQ| in air) for 3 days before 
staining with 0.02» neutral red (Flow) in PBS. The infectivity was 
expressed as plaque forming units (pfu) per al (Diamock & Watson. 1969).
The human Influenza strain A/Wilson Smith Neurotropic/40 (H1N1) (A/WSN) was 
grown up from #320 stock preparation (University of Warwick) in the 
allantoic cavity of 10 day old emtryonated hen eggs and incubated for 36 
hours at 33*C. The allantoic fluid was collected and treated as before. The 
infectivity was determined as previously described except 0.15* w/v BSA 
replaced the NCS. and 0.02* w/v DEAE/dextran (Sigma) was added to the 
overlay medium.
The human strains A/Puerto Rico/8/34 (H1N1) (A/PR/8) and A/Japan/305/57 
(H2N2) (A/Jap) were derived respectively from #593 and #572 stock 
preparations (University of Warwick). The human strain A/Colorado/231/83 
(H3N2) (A/Clr) was kindly donated by Er.P.D.Minor (N.I.B.S.C.. South Minas. 
U.K.). The avian strains A/Chicken/Scotland (H5N1) and 
A/TUrkey/0ntario/6118/68 (H8N4) were derived respectively from #251 and 
#260 stock preparations (University of Warwick). The type B influenza virus 
B/Lee/40 was kindly donated by L.McLain (University of Warwick).
These strains were grown up in the allantoic cavities of 10 day old eggs 
and incubated for 36 hours at 33*C before being harvested and stored at -70* C.
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The infectivities of these strains were determined by plaquing on MDCX cell 
monolayers rather than CEF cells. The overlay contained 0.15* w/v BSA.
0.02* w/v DEAE/dextran and 1.25ug/ml trypsin TPCX (Sigma). The monolayers 
were then incubated at 33*C (5* CCfc in air) for 3 days before staining. 
Trypsin was required in the overlay to ensure the cleavage of the 
haemagglutinin necessary for infectivity.
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The haemagglutination titre of all the influenza strains was determined by 
making doubling dilutions in PE6 and adding chicken erythrocytes to 0.5% 
v/v. This is equivalent to 7.3 x 10* cells per well. The titre was taken as 
the 50% end-point between full agglutination and zero agglutination after 
30 min. incubation at room temperature. The titres were expressed as 
haemagglutination units (HAU) per ml.
6.3i2: Purification vi influenza yiiubl
The procedure described by Kelly & Dimmock (1974) was followed and all 
steps were carried out at 4*C. Allantoic fluid containing the virus was 
clarified by spinning at 1.500g for 30 sin. The supernatant centrifuged at 
75,000g for 90 min. The pellets were soaked overnight in 0.5ml PBS. then 
resuspended, vigorously vortexed and clarified at low speed. The 
supernatant was loaded onto a 50ml 15-45% w/v linear sucrose gradient in 
150mM NaCl containing lOmM TVis/HCl pH 7.4 (TN) and spun at 60,000g for 90 
min. The visible band was harvested and diluted to 25ml with PBS and loaded 
onto a 30-70% w/v linear sucrose gradient in TN and centrifuged at 60,000g 
for 16 hours. The virus band was collected and diluted to 12ml with PBS and 
spun at HO.OOOg for 90 min. The resulting pellets were soaked overnight in 
200ul PBS. then resuspended and stored as aliquots at -70*C.
6.3.3. Radiolabel 1ing of influenza virus.A/TPV/R mfluengfl strain-
Confluent CEF monolayers in roller bottles were incubated for 24 hours with 
phosphate free GMEM (GMEX-P) containing 4mM glutamine. lOOU/ml penicillin. 
lOOug/ml streptomycin and 1% v/v NCS. The monolayers were then washed with
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phosphate free saline and 10ml of GMEX-P containing 1 pfu/cell of virus was 
added to each bottle. The cells were incubated for 60 min to allow the 
virus to attach before adding a further 35ml of medium plus 2.5mCi 
“ P-orthophoephate (Amersham) to each bottle, incubation was continued for 
a further 20 hours. The cells were then examined for evidence of cytopathic 
effect (CPE) and the tissue culture fluid was harvested and clarified by 
centrifuging at 1.000g for 10 min. at 4*C. All the following procedures 
were carried out at 4*C. The virus in the supernatant was precipitated by 
adding (NH*)x 9C^to give 60% saturation whilst stirring on ice. and purified 
by sucrose velocity centrifugation (Diamock et al.. 1977) except that no 
unlabelled carrier was added. The precipitate was pelleted by centrifuging 
at 20.OOOg for 20 min, resuspended in 5m 1 PBS and loaded onto a 55ml 15-45% 
linear sucrose gradient in TN containing 0.1% w/v BSA. Following 
centrifugation at 90.000g for 90 min. the gradient was fractionated into 
2m 1 aliquots and assayed for radioactivity and HAU activity. Where the 
peaks of activity coincided the fractions were pooled. The virus in this 
pooled peak was diluted with PBS to 30ml and precipitated with 60% 
saturating SQ, on ice with fetuin (gift from A.Carver. University of
Warwick) added as a carrier. The virus was again pelleted by centrifuging 
at 20.000g for 20 min., resuspended in 0.5ml PBS and dialysed overnight 
against PBS. The resulting preparation was tested for radioactivity, 
infectivity and HAU titre before being aliquoted and stored at -70*C.
£,3.3-2. A/PR/e influenza strain.
Confluent MOCK cell monolayers in roller bottles were incubated for 24 
hours at 33*C with phosphate free GMEM (GMEM-P) (Gibco) containing 4mM 
glutamine, 100U/ml penicillin. 100ug/ml streptomycin and 0.1% w/v BSA. The
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monolayers were then washed with phosphate free saline and 10ml of GMEM-P 
containing 1 pfu/cell of virus was added to each bottle. The cells were 
incubated for 60 min. to allow the virus to attach before adding a further 
35ml of medium plus 2.5mCi *P-orthophosphate (Amersham) and 125ug trypsin 
TPCX (Sigma) to each bottle. The incubation was continued for a further 40 
hours. The cells were then examined for evidence of cytopathic effect (CPE) 
and the tissue culture fluid was harvested and clarified by centrifuging at 
l.OOOg for 10 min at 4#C. All the following procedures were carried out at 
4*C. The virus in the supernatant was precipitated by adding (hU*^ SC^to 
give 60% saturation whilst stirring on ice, and pelleted by centrifuging at 
20,OOOg for 20 min. The pellet was resuspended in 5m 1 PBS and loaded onto a 
30-70% w/v sucrose gradient in TN plus 0.1 % BSA and spun at 60.OOOg for 16 
hours. The visible virus band was collected and diluted to 12ml with PBS 
and spun at 110,OOOg for 90 min. The resulting pellet was soaked overnight 
in 200ul PBS, then resuspended, assayed for radioactivity, infectivity and 
HAU titre. then stored as aliquots at -70*C.
flgtg-a-ppt9i»rt«?ng irecUvaUsn s i influenza virua^
Beta-propiolactone (EPL) (Sigma) was added to the purified virus to give a 
final concentration of 1/1000 (v/v). The mixture was incubated for 60 min 
at room temperature and then overnight at 4*C. The inactivated virus was 
dialysed against PBS to remove any remaining EPL and the residual 
infectivity determined by plaque assay.
6.4. Antibodi— .
6.4.1. Scurc«».Mgnwlgwl 6Ptit44>i46
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Ascitic fluid containing neutralizing murine monoclonal IgG antibodies 
against the haemagglutimn of A/FPV/R (H7N1) were kindly provided by 
A.R.Douglas and J.J.Skehel (N.I.N.R.. London. U.K.). These are designated 
HC2; HC10; HC50; HC61. These monoclonal antibodies have been extensively 
studied by Taylor (1966) and have been shown to bind to different antigenic 
sites on the H7 haemagglutinin (P.Gamer & N . J . Dimmock, University of 
Warwick, personal communication). Recently Dr.A.Hay (N.I.M.R., London.
U.K.) has confirmed that the antibodies map to different antigenic sites by 
sequencing escape mutants produced by each of the monoclonal antibodies 
(personal communication).
Ascitic fluid containing monoclonal IgG antibody against the haemagglutinin
of A/Texas/1/77 (H3N2). designated 185/1. was kindly provided by
Dr.R .G .Webster (St. Jude Childrens' Research Hospital. Memphis, U.S.A.).
Murine hybridcma cells producing neutralizing IgA antibodies against the 
haemagglutinin of A/PR/8 (H1N1) were kindly provided by Er.W.Gerhard. 
(Wistar Institute. Philadelphia, U.S.A.). These cells were grown up by 
E.Green (University of Warwick) to provide tissue culture fluid 
(tcff37-66-1). The hybridcma cells were also seeded into Balb-c mice to 
provide ascitic fluid (WR131).
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$■4.1.2. Polyclonal antibodies.
Polyclonal IgG hyperimmune sera to the H7 haemagglutinin was prepared in 
2kg half-lop rabbits (Hylyne). This was done by inoculation via the ear 
vein of 10* HAU of EPL-inactivated, purified A/FPV/D (H7N7) boosted at day 
22 with a similar inoculum. Blood was collected at days 5. 6 or 7 
post-boost and serum prepared. The sera from 2 rabbits were produced, 
designated WR120 and WR121.
Polyclonal IgM sera to the H7 haemagglutinin was produced by tail vein 
inoculation of 7-12 week old C3H-He aica. Each aouaa received 10**HWJ of 
BPL-inactivated, purified A/FPV/D (H7N7) and the blood collected on day 6 
post-inoculation from the heart. Serum from each mouse was prepared 
individually before being pooled into batches of between 100-150 samples. 
Each mouse yielded on average 0.25ml of serum.
$.4.2. Purification.
Purified preparations of the IgG monoclonal antibodies were kindly donated 
by H.P.Taylor (University of Warwick). They had been purified by affinity 
chromatography using a protein A-Sepharose CL-4B column (Sigma).
The IgM was purified from the day 6 post-inoculation mouse serum by gel 
filtration using a Sephacryl S-300 (Sigma) column. A polyethylene glycol 
6000 (PBS) (BDH) precipitation step was carried out as a preliminary 
concentration step. 5m 1 of serum was dialysed overnight at 4*C against 2mM 
phosphate buffer pH 6. The pH of the serum was raised to pH 8 with 2M TVis 
and PBS added to give 6% w/v whilst stirring on ice. After 60 min. the
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sample was centrifuged at 2.000g for 10 sin. at 4#C. The precipitate was 
resuspended in 2b 1 TN and applied to the S-300 column (length 60cm, 
diameter 1cm) and eluted with TN containing 0.06* Naty at 4*C. Fractions 
were collected at 15 min. intervals (volume approximately 1ml) over a 
period of 12 hours. The fractions were assayed for haemagglutlnation 
inhibition (HI) (section 6.4.3.) and protein concentration using the Biorad 
method (section 6.4.6.). The peaks containing the highest HI activity were 
pooled and concentrated using Centricoo-10 (Amicon) tubes.
The IgA monoclonal antibody was purified using a technique similar to that 
used for the IgM except the PEG precipitation step was not used because 
this failed to precipitate a significant amount of the antibody. Again the 
peak containing the HI activity was pooled and concentrated.
Monomeric IgA was prepared from purified IgA using the method of Taylor & 
Dimmock (1965) which involved differential reduction using 0.01* w/v 
beta-mercaptoethanol (EME) (Sigma) in 0.3M Tris/HCl pH 6 plus 0.12M 
lodoacetamine for 60 min. at 25*C. After dialysis overnight at 4 C against 
TN the antibody was loaded onto a S-300 column and eluted with TN 
containing 0.08* NaNj and fractions collected. These were assayed for HI 
activity and run on a non-reducing SD6-PAGE gel to determine if reduction 
had occurred.
The IgG antibodies were stored at -70*C , whilst the IgM and IgA were stored 
at 4 #C because freezing and thawing was found to be deleterious to 
polymeric antibodies.
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6.4.3. a Mav
The titres of anti-HA antibodies were determined by making doubling 
dilutions in lOOul PBS using round bottomed microtitre trays (Sterilin). To 
these dilutions 4 HAU/well of virus was added, mixed and incubated for 60 
sin. at room temperature. 25ul of 2% chick erythrocytes was added to each 
well, mixed and left for 30 min. The 50% end-point was estimated in a 
manner siailar to the HA assay. The titre is expressed as 
haemagglutination-inhibition units (HIU) per ml.
6.4.4. Anti-nem-»ipi<aw aggfiyt
In a capped boiling tube, 50ul of virus with a known neuraminidase activity 
was mixed with 50ul of serial dilution of the serum under study, plus 
appropriate controls. These were incubated for 60 min. at 25*C before the 
addition of lOOul of 12.5mg/ml fetuin (Gibco) in 0.2M phosphate buffer pH 
6. The tubes were incubated for 90 min. at 37*0 and then cooled to room 
temperature before adding lOOul 4.28% w/v sodium periodate (BOH) in 62% v/v 
arthophosphoric acid (BEH) . The tubes were left for 20 min. at rocm 
temperature. 1ml filtered arsenite solution (10% w/v sodium arsenite (BCH); 
7.1% w/v sodium sulphate (BCH); 0.28% v/v sulphuric acid (Fisons)) was 
added and vigorously mixed until all evolved iodine had redissolved. 2.5ml 
of 0.6% w/v thiobarbituric acid (BCH) in 7.1% w/v sodium sulphate was added 
and the tubes were boiled for 15 min., a red colour developed which faded 
as the solution was cooled to room temperature. 4m 1 of M-tutanol (Fisons) 
was added, mixed and the tubes were centrifuged for 10 min. at 1500g to
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separate the two phases. The butanol phase was removed and read on a 
spectrophotometer at 549nm. The anti-neuraminidase titre was that which 
caused a 50% reduction in neuraminidase activity of the standard virus.
£.4^. affifiwlcny onatms.
2.5ml molten 1% w/v "Noble” agar (Difco) containing 0.08% NaNj was poured 
into 5cm diameter plastic petri dishes. The agar was allowed to set at room 
temperature before wells were cut into the agar using a sterile size 1 cork 
borer. Six wells surrounding a central well were cut using a template to 
ensure all the surrounding wells were ec^iidistant from the centre. Each 
wel 1 held 15ul. Into the central well was placed the test serum and the 
surrounding wells were charged with a panel of specific goat anti-mcuse 
immunoglobulin subtype (GAM) sera (Nordic). The agar plates were then 
placed into a humidified container and left at room temperature until 
precipitation bands appeared. In practice it took approximately 1 week 
before the bands were visible using dark-ground illumination. The agar 
plates were then fixed and stained using 0.025% w/v Coomassie Ek-i 11 lant 
Blue R (Searle) in 50% v/v methanol :7% v/v acetic acid, followed tty 
repeated destaining with solvent alone. The Ouchterlony plates were then 
washed extensively with distilled water before being dried in a 37*C
incubator.
6.1.6. Sel clgctrocfioregis 
6-4.6.1, general.
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Proteins from purified immunoglobulins were analysed by
(i) Polyacrylamide (PAA) gel electrophoresis.
(ii) Sodium dodecylsulphate-polyacrylamide gel electrophoresis (SDS-PAGE).
The protein bands were located using 0.025% w/v Coomassie Brilliant Blue R 
(Searle) in 50% v/v methanol .-7% v/v acetic acid, followed by repeated 
destaining with solvent alone. The gels were then washed extensively with 
water before being dried.
6»4-$,2- PM Stiff,
Non-denaturing gels were prepared using a method supplied by S. van de 
Vries (University of Warwick). 4-30% gels were prepared using the solutions 
described below;
4% acrylamide solution
4% w/v acrylamide (ECH). 0.2% w/v bisacrylamide (ECH). 0.4M Tris/HCl pH 8.8 
(BDH). Immediately prior to use 0.05% w/v ammonium persulphate (APS) (BCH) 
and 0.6ul/ml TEWED (Biorad) was added.
30% acrylamide solution.-
30% w/v acrylamide. 0.14% w/v bisacrylamide. 0.4M TVis/HCl pH 8.8. 11% v/v 
glycerol (BCH). Immediately prior to use 0.025% w/v APS and 0.3ul/ml TEWED
was added.
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Sample buffer:-
The sample buffer (50% sucrose plus tromophenol blue (Searle)) was added to 
the samples in a ratio of 1 to 4; the sample was then vartexed before 
application to the gel.
Running buffer
28.8g/l glycine (ECH) containing 6g/l TVis.
\
6.4.6.3. SC6-PAGE dels.
Reducing and non-reducing, denaturing gels were prepared as either 10-30% 
gradients or 20% single strength gels (combining the 10% and 30% acrylamide 
solutions before pouring the gel) (Laemmli. 1970). The ingredients used are 
listed below;
10% acrylamide solution:-
10% w/v acrylamide (BOH). 0.05% w/v bisacrylamide (ECH). 0.1% w/v SDS 
(BDH), 0.375M Tris/HCl pH 8.6 (BCH). Immediately prior to use 0.015% w/v 
APS (BCH) and 1.3ul/»l TEHEE (Biorad) was added.
30% acrylamide solution.--
30% w/v acrylamide, 0.138% w/v bisacrylamide. 0.1% w/v SDS. 7.8% v/v 
glycerol (BCH), 0.375M Tris/HCl pH 8.6. Immediately prior to use 0.007% w/v 
APS and 1.3ul/al TEHEE was added.
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Stacker gel
4.5% w/v acrylamide, 0.12% w/v bisacrylamide, 0.1% w/v SD6, 0.125M Tris/HCl 
pH 6.8. Immediately prior to use 0.03% w/v APS and 3.0ul/ml TEKED was 
added.
Sample buffers:-
Either (i) Reducing buffer; lOmM Tris/HCl pH 7.4 containing 2% w/v SDB, 5% 
w/v EME (Sigma), 5% w/v glycerol and 0.01% w/v tromophenol blue (Searle), 
or (11) Non-reducing buffer; as previous except the EME was omitted.
The sample buffers were added to the samples in a ratio of 1 to 4, then the 
samples were vortexed and boiled for 5 min. before application to the gels.
Running buffer.—
13.95g/l glycine (BCH) containing 3g/l Ti-is and lg/1 SDS.
6 .4 .7 .  Io d in a tio n  o f a n tib o d ie s .
15ul lOOmM and 13ul 1.5mM chloramine T (BCH) were mixed with 15ul ImM
KI and 250uCi sodium |**I) iodide (Amersham). and incubated for 30 seconds 
at room temperature. After this time 15ul 1H phosphate (KH*) buffer pH 7.9 
was added to neutralize the mixture. 15(Xil of antibody preparation was 
added and left for 2 min. before being applied to a G-25 sephadex 
(Pharmacia) column. The antibody was eluted with PBS and fractions 
collected. The fractions were assayed for radioactivity and HI activity, 
the peak in which these activities coincided was pooled and the protein 
concentration. HI and radioactivity determined. BSA was then added to the 
fraction to a concentration of 1% w/v to stabilise the antibody, and the 
fraction stored at 4*C.
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6 .4  8. P rotein  « g « y .
The concentrât lone of proteins were determined using a commercial kit 
manufactured by Biorad. Absorbances were taken at 595no and the protein 
concentrations read off a standard curve prepared using a range of BSA 
concentrations up to 2mg/ml.
$•?: Neytrd iim ie n  Qt inHumm virus fry anUfeodi«,
Plaqua retortion
Virus ( 10* pfu/ml) was incubated with an equal volume of purified 
immunoglobulin (IgG. IgM or IgA) for 1 hour at 25*C for 60 min. The 
residual infectivity was determined by plaque assay on CEF or MDCK cell 
monolayers (section 6.3.1.).
A second form of neutralization assay was performed using virus diluted to 
10* HAU/ml before addition of antibody, this was the inoculum used in virus 
attachment experiments. The neutralized virus needed to be diluted in PBS 
before being assayed for residual infectivity.
6.5.2. Assay of remaining haemaqqlutination activity.
Considering the number of virus attachment assays performed it was 
impractical to measure the degree of neutralization by plaque reduction in 
every experiment; this was usually done in the first of a series of
experiments. In all experiments, neutralization was determined by measuring 
the residual haemagglutination activity (HA) of the fractions as previously 
described (section 6.3.1.).
6 .3 .3 . 3tudy o f the aaar»g«tion o f in flu e n za v iru a  t v  e le c tro n  n c ro e c o c v .
The procedure used was described by Taylor et al. (1987). Virus 
preparations were mixed with an equal volume of 3% sodium silicotungstate 
(Agar Aids, Stanstead. U.K.). pH 6.5. Sul samples were placed on Formar 
coated copper grids. After 5 min. the liquid was removed using filter paper 
and the grids were examined using a JEX3L JEM-1005 transmission electron 
microscope. Areas of the grid were scanned sequentially, noting each single 
virus particle and the number of virion in each cluster. The total number 
of virions counted was divided by the number of single virions plus the 
number of clusters. The resulting figure was termed the average clump size.
6 .3 .4 , Attachment o t in flu e n za  viru s to  c e l l s .
The procedure followed is outlined diagrammatically (Figure 6.2.) and 
general details are given below. More specific experimental details are 
supplied where relevant it the text of the thesis.
*P labelled virus and dilutions of the antibody under study, were incubated 
for 60 min at 25*C before being inoculated onto PBS washed preparations of 
cells. Cells were washed once with PBS to remove dead cells and defcris. 
Aliquots of neutralized virus were also tested for the degree of 
neutralization by plaque reduction (section 6.5.1.), remaining 
haemaggluti nation activity (section 6.5.2.) and aggregation (section
120
Fig.6.2. Method used to determine the amount of 
radiolabelled virus attached to various cell 
types. Details of the method are given in 
the text (section 6.5 .4.).
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6.5.3.). The inoculated cells were Incubated at 37*C for various times 
before being extensively washed with chilled PBS. The number of washes 
required to free the excess, unattached virus from the cells varied 
according to the cell type under study; chicken erythrocytes required 3 
washes, BH< cells 4 washes and organ cultures 5 washes.
When organ cultures were used, epithelial cells were released by protease 
digestion (section 6.2.4.) and the number of isolated cells was determined 
using a Neubauer counting chamber. The epithelial cell preparations were 
then vortexed, sonicated and the levels of cell-associated radioactivity 
assayed.
EH< cells were removed from the plastic ^ -etri dishes by scraping into 1ml 
PBS using rubber “policemen" and the cells vortexed and sonicated. The 
cells obtained by scraping were too clumped to enable efficient cell counts 
to be performed, therefore cells were removed from a parallel set of plates 
with trypein and counted as described above; this enabled the average 
number of cells per plate to be determined. The protein content of the 
sonicated cell preparations were then assayed (section 6.6.1.), and an 
average value determined. Using these figures, the average protein 
concentration per cell could be calculated. Assuming this figure to be 
constant within an experiment then the cell number for each individual 
sonicated cell preparation could be calculated from the known protein 
concentration value. This procedure was important to check the efficiency 
of cell scraping because this could be variable. Finally the sonicated 
preparations were assayed for cel 1-associated radioactivity.
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Adult chicken erythrocytes (1 X 10* cells) were inoculated. No appreciable 
haemolysis was seen and it was assumed that 1 X 10* cells remained at the 
end of procedure. The cells were sonicated as before and the level of 
radioactivity determined.
InternaliraUon gf influenza virus iu  cgllg,
The method is essentially the same as that described for the study of virus 
attachment (section 6.5.4.) with the following additions. After allowing 
the infectious or neutralized virus to attach, the cells were washed and 
treated with either PBS or 0.5U of neuraminidase, Clostridium perfringens 
(NAase) (Sigma) in PBS at 37*C for 60 sin. The cells were washed 3 times 
with PBS to remove any virus released, before further treatment.
In other experiments, the effects of NAase pre-treatment of cells on virus 
attachment was studied. The method used was similar to that previously 
described (section 6.5.4.) except that before inoculation with the virus 
preparations, the cells were treated with either PBS or 0.5U NAase for 60 
min. at 37*C. The cells were washed twice with PBS to remove the NAase 
before addition of the inoculum.
Pngg.Uon Qt influera mtiaeng usina nvxywggnt anUfrrty-
Confluent EH< cells on covers 1 ips were washed with PBS before 20il of an 
appropriate dilution of A/WSN was applied. The covers 1 ipe were gently 
rocked to ensure all the cells were infected and incubated for 60 min at 
rocm temperature. Then the covers 1 ips were extensively washed with PBS to 
remove unattached virus. The cells were incubated for various periods of
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time at 37*C in a Petri dish containing the 4m 1 GMEM medium. The covers 11pe 
were again washed and allowed to dry before fixing with acetone at -20*C 
for 15 min. The cells were stored at -20*0 until required.
Crgan cultures were infected with the A/WSN before the epithelial cells 
were removed by protease digestion. These cells, resuspended in 199 medium 
containing 20% v/v NCS. were then dried onto covers 1 ipe. The cells were
\then fixed using acetone as described above.
Infected and non-infected cells fixed on coverslipe were air dried before 
adding 20ul of 1/10 WR16 anti-WSN HA rabbit antiserum (kindly donated by 
L.McLain, University of Warwick). The covers 1 ips were gently rocked to 
ensure an even exposure to the antibody and incubated at 37#C for 25 min. 
in a humidified container. The cells were washed extensively with PBS and 
allowed to dry. 2(Xil of 1/40 fluorescein isothiocyanate (FITC)-labelled 
goat anti-rabbit (GAR) serum (Nordic) was then added to the coverslipe and 
incubated for 25 min. at 37*C in the humidified container. The cells were 
again washed extensively in PBS, then washed with distilled water before 
being air dried. The coverslipe were mounted onto microscope slides with 
85% glycerol v/v in PBS and examined using a Nikon UFX II microscope with 
illumination provided by a Nikon Hg 100W lamp.
It proved difficult to fix isolated organ culture cells to the coverslipe 
and a large number of the cells detached during the staining procedure.
Increasing the NCS concentration to 40% or substituting 5% w/v BSA for the 
NCS in medium in which the cells were resuspended before fixation proved 
unsuccessful.
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7:1 ■. Intreflugucn.
This chapter describes: (1) The preparation and maintenance of tracheal 
organ cultures fro* the mouse. Earlier workers found that organ cultures 
derived from the mouse trachea were difficult to maintain (e.g. Cherry & 
Taylor-Robinson. 1970) and for this reason they have been largely ignored 
as a model system. Despite these earlier difficulties, the mouse was chosen 
for my work since a primary aim was to create a homogeneous experimental 
system where the target cells, antibody and virus were all derived from the 
same host species. (2) An investigation as to whether or not mouse tracheal 
organ cultures could support the multiplication of the influenza strain, 
A/FPV/R. This avian strain of influenza virus was chosen because there was 
a set of well characterised neutralizing monoclonal IgG antibodies to this 
strain in the laboratory (i.e. HC2. HC10, HC56 and HC61). Also, previous 
work on the mechanisms of neutralization of influenza virus had been done 
using this strain (Poesee et al.. 1982; Taylor & Dimmock. 1985a & 1985b; 
Taylor. 1986; Taylor et al.. 1967). (3) An attempt to specifically remove 
the epithelial cells lining the lumen of the trachea from the organ 
cultures. This would allow later investigation at the cellular level of the 
mechanisms of neutralization of influenza virus. (4) An investigation as to 
whether or not cells infected and isolated from to tracheal organ cultures 
are those which are infected by intranasal inoculation in vivo.
7 ,2 - ftegultg,7-2-1, Prspflmian <?t tratfwal «ran suliM m
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"Ring" organ cultures were prepared by transverse sectioning of trachea# 
removed from 5-10 week old C3 I lie Mg mice (section 6.2.2.). Each trachea 
yielded on average 6-7 cultures which compared well with numbers produced 
by other workers using mice (Cherry & Taylcr-Robinson. 1970). Tracheae from 
larger animals yield a greater number of cultures e.g. hamster. 8-12 (Heath 
et al.. 1983; Hu et al.. 1975). human foetus. 8-15 (Hara et al. .1974; Moetow 
& Tyrrell. 1973). chick embryo. 17 (Cherry & Taylcr-Robinson. 1970) and \
ferret. 40-50 (Hara et al.. 1974).
No attempt was made to separate the organ cultures prepared from the upper 
and lower trachea. Others have found no difference in the ability of 
different parts of the trachea to sustain an infection of influenza virus 
(Hara et al. .1974. Kingsman et al.. 1977a).
At approximately 24 hour intervals the medium was changed and the 'ciliary 
score' noted for each culture (section 6.2.3.). The 24 hours 
post-dissect ion value is assumed to represent maximal (100%) activity 
(Blaskovic et al.. 1972c; Moetow & Tyrrell. 1973; Heath et al,. 1983) and 
all subsequent scores are related to this initial value. Figure 7.1. shows 
that cultures could be maintained for approximately 150 hours 
poet-dissect ion before an appreciable reduction in activity was observed.
No out-growth of dedifferentiated cells was seen similar to observations of 
others (Hoorn. 1966). although Moetow & Tyrrell (1973) observed fibroblast 
outgrowth from human embryo organ cultures at 12-14 days poet-dissect ion.
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Fig.7.1. Ciliary activity of non-infected 
mouse tracheal organ cultures. 
Results from 3 experiments;
O — O  Average score from 13 organ cultures
Q - - - Q  Average score from 18 organ cultures
... -A  Average score from 18 organ cultures
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Organ cultures were prepared and infected with A/FPV/R (H7N1) for 60 min. 
at 37*C. The organ cultures were extensively washed with PE6 (5 washes, 
each 2.5ml PBS) and then placed individually into 96 well flat bottomed, 
tissue culture trays. These were incubated at 37*C and the medium harvested 
daily and replaced. The harvested medium was centrifuged to remove cell 
detrio before being frozen and stored at -70*C. The cultures were also 
observed daily and the ciliary activity score measured (section 6.2.3.). At 
the end of the experiment the infectivity of each sample of harvested 
medium was determined (section 6.3.1.).
A range of inocula. from 10* to 10* pfu/ml. was used (results not shown) 
but A/FPV/R failed to multiply on the organ cultures. Some residual virus 
remained associated with the organ cultures and most of this eluted during 
the first 24 hours of incubation. A/FPV/R caused no appreciable reduction 
in the ciliary activity of the cultures when compared to the non-infected 
controls. This would be expected if no infection had been established. To 
overcome the fact that A/FPV/R failed to multiply I attempted (a) to 
propagate a panel of different influenza virus strains on mcuse tracheal 
organ cultures and (b) to adapt A/FPV/R to mouse cells by repeated serial 
passaging in a mouse tissue culture cell line (i.e. C3H10T1/2 fitroblasts).
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7.;.3. Propagation of a panel of influenza strains on tracheal organ 
culturea.
A panel of influenza virus strains available within the laboratory h»  
tested for their ability to Multiply on mouse tracheal organ cultures and 
the effects on the ciliary activity of the cultures were also investigated
\
(Figures 7.2. to 7.8.). Results are summarised in Table 7.1.. The 
infectivity (pfu/ml) at 96 hours p.i. has been used as a criterion of 
infection (Kingsman et al. . 1977b). The pathogenic effect of the virus is 
determined by taking the time at which 50% ciliary activity inhibition 
(CAIj* ) occurred (Diaz-Rodriguez & Boudreau 11, 1962).
The human influenza strains (A/PR/8; A/WSN; A/Jap; A/Clr) all multiplied on 
mouse tracheal organ cultures. Virus titres of between 10** -10*'* pfu/ml 
were obtained at 96 hours p.i. (Table 7.1.). although there were higher 
titres at approximately 48 hours p.i.. It would appear that repeated 
passages of these viruses in fertile eggs of hens had not prevented them 
from infecting respiratory tissue from a mammalian source. The 
pathogenicity differed between strains: A/Clr caused a rapid loss of 
ciliary activity. A/WSN and A/Jap also caused a loss of activity but at a 
slower rate and A/PR/8 caused no reduction in the ciliary activity.
The influenza strains isolated from chickens (A/Ch/Scot; A/FPV/D) failed to 
multiply on mouse tracheal organ cultures. The influenza strain isolated 
from turkeys (A/Tky/Ont) did multiply but growth was delayed and there was 
a no appreciable multiplication before 72 hours p.i.. 9uch a delay in
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Fig.7.2. Multiplication and effect of A /P R /8  on 
mouse tracheal organ cultures.
Cultures were inoculated with 10 ^ ^ f u / m l  (  A — A  ); 
11 o.c. were used in this experiment and the 
supernatants pooled. Non-infected controls ( 0 — 0  ).
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Fig.7.3. Multiplication and effect of A/WSN on 
mouse tracheal organ cultures.
Cultures were inoculated with 10 ^-^pfu/m l ( A — A  ).
35 o.c. were used in this experiment and the
supernatants pooled. Non-infected controls ( 0  -0  ).
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Fig.7.4. Multiplication and effect of A/Jap on
mouse trocheal organ cultures.
Cultures were inoculated with 10 ^ ^pfu/m l (A — A ) .
18 o.c. were used in this experiment and the
supernatants pooled. Non-infected controls ( 0 — 0  ).
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Fig.7.5. Multiplication and effect of A/Clr
on mouse tracheal organ cultures.
Cultures were inoculated with 10 ^ pfu/ml ( A — A  ).
20 o.c. were used in this experiment and the
supernatants pooled. Non-infected controls ( O - O  ).
Ciliary 
Activity
 Score
 (%) 
Log,„pf
u/ml
1 3 5
Fig.7.6. Multiplication and effect of A/FPV/D
on mouse tracheal organ cultures.
Cultures were inoculated with 10 8 '5pfu/ml ( A — A  ).
14 o.c. were used in this experiment and the
supernatants pooled. Non-infected controls (O ------O  )•
1 3 6
Fig.7.7. Multiplication and effect of A/Ch/Scot
on mouse tracheal organ cultures.
Cultures were inoculated with 10 5 1 pfu/ml ( A — A ) .
14 o.c. were used in this experiment and the
supernatants pooled. Non-infected controls ( 0 " 0 ) .
Ciliory 
Activity
 Score
 (X) 
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/ml
1 3 7
Fig.7.8. Multiplication and effect of A/Tky/Ont
on mouse tracheal organ cultures.
Cultures were inoculated with 10 7-2pfu/m l ( A — A  ).
14 o.c. were used in this experiment and the
supernatants pooled. Non— infected controls ( 0 - - - 0  ).
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Table 7.1.
Sum mary of the multiplication characteristics of a panel 
of influenza viruses on mouse tracheal organ cultures.
Infectivity ot Time at which a 
96 hours p.i. 50X reduction in ciliary 
Influenza strain (Log»pfu/ml) octivity score (hours p.i.)
Control (no n-in  fee ted) 
A/FPV/R (H7N1) 
A/PR/8 (M IN I) 
A/WSN (H1N1)
A/Jop (H2N2)
A/Clr (H3N2) 
A/Ch/Scot (H5N1) 
A /Tky/O nt(H 8N4) 
A/fPV/D (H7N7)
N/A 240
< 2.0 170
5.3 >200
4.7 120
5.2 130
4.6 90
< 2.0 190
3.7 190
2.5 220
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growth was not seen for any of the influenza strains isolated from man No 
reduction in ciliary activity was seen in the organ cultures infected with 
these avian influenza strains.
? .3-4- MartaUen <?f A/FTV/R,
An attempt to adapt the avian influenza strain A/FPV/R to mouse e*lU
was made by serially passaging in a mouse fibroblast cell line. 
C3H10T1/2.
The C3H10T1/2 monolayers (approximately 10* cells) were inoculated with a 
known amount of infectious virus in 20ml medium and incubated for 60 min. 
at 37 *C. The cells were then washed twice with 20ml PBS and 20ml fresh 
mediub added. The monolayers were incubated at 37*C for 46 hours or until a 
cytopathic effect (CPE) was observed. At the end of this period the medium 
was harvested and the inf activity measured.
Initially A/FTV/R multiplied poorly, or failed to multiply, on C3H10T1/2 
cells (Figure 7.9.). Less virus was recovered than was applied and some of 
the recovered virus may be due, in part, to elution of residual inoculum 
from the monolayer. The multiplication was so poor, on occasions, that the 
harvested virus had to be boosted by growing in fertile hens eggs (section 
6.3.1.) before continuing to passage in C3H10T1/2 cells. The recovered 
virus was diluted and used to infect more C3H10T1/2 monolayers in a similar 
manner. The multiplicity of infection (MOI) was always adjusted by dilution 
to 0.1 or less in order to reduce the incidence of defective interfering 
(DI) influenza particles (Nayak et al. . 1965; Janda et al ■. 1979).
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Passage number in C3H cells
Fig.7.9. Adaptation of A/FPV/R by serial 
passaging in C3H10T1/2 cells
pfu applied pfu recovered
1 4 1
A/FPV/R began to show signs of adaptation on the 5th passage when more 
virus was recovered than was used to inoculate the cells. Good growth was 
seen in the 6th passage and this pattern of growth was repeated in 
subsequent passages. The virus produced by the 7th passage was plaque 
purified and grow up in fertile hens eggs (section 6.3.1.). This was used 
as a working stock preparation and designated adpFPV/R.
7.2.5. Propagation of adcFFV/R on tracheal «non culture».
Mouse tracheal organ cultures were prepared and infected with the mouse 
adapted A/FPV/R influenza virus (adpFPV/R). Virus multiplication was 
determined and the effect on the ciliary activity observed (Figure 7.10.).
The adpFPV/R strain multiplied to high titres, with 10* pfu/ml at 48 hours 
p.i. . The 96 hours p.i. titre of 10** pfu/ml was the highest found for any 
influenza strain (Table 7.1.). The adpFPV/R was also highly pathogenic to 
the organ cultures, the CAI^b occurred at 65 hours p.i.. This was more rapid 
than that found for the human A/Clr strain, and the adpFPV/R strain could 
be designated as being virulent on this basis. The virus was treated with 
caution because of its potential virulence for mammalian hosts.
?■•?■$* Aptiqpnic EY jdapWlon 9t h/TTV/R is awtx rellgj
It was of interest to see if the process of adaptation of A/FPV/R had 
altered the antigenic nature of the H7 haemagglutinin. This was done by 
examining the haemagglutination-inhibition (HI) and neutralization caused 
by a panel of monoclonal IgG antibodies available to A/FPV/R (i.e. HC2; 
HC10; HC58; HC61).
Ciliary 
Activity
 Score 
(%) 
Log,pfu
/ml
1 4 2
Fig.7.10. Multiplication and effect of adpFPV/R 
on mouse tracheal organ cultures.
Cultures were inoculated with 10 ^ pfu/m l (A — A  ).
20 o.c. were used in this experiment and the
supernatants pooled. Non-infected controls ( O - O ).
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The HI profile of the adpFPV/R (Table 7.2a.) had changed with an increased 
titre against HC2 and HC58; the HI titres were largely unchanged against 
HC10 and HC61. The adpFPV/R strain was also more sensitive than the 
unadapted A/FPV/R to neutralization irrespective of the monoclonal antibody 
used (Table 7.2b.).
These results suggest that antigenic alteration(s) of the A/FPV/R had been 
forced by its adaptation to the mouse host. It was of interest to determine 
if the change resided in the H7 haemagglutinin. and if so. where it was 
located. A sample of adpFPV/R was sent to Dr.J.W.McCauley (Pirbright. U.K.) 
who sequenced the haemagglutinin gene of adpFPV/R and compared it to the 
original A/FPV/R. The sole change was a single residue at position 37 of 
HA2 from Lysine to Glutamine (personal communication). No change occurred 
at or close too the antigenic sites or the virus attachment site previously 
mapped on the HA1 of other haemagglutinins (sections 1.4. and 1.3.).
7 .2 .7 . R f o v a l  ol c il ia t e d  e p it h e l ia l  « 11 1  Iro «  trach eal organ c u ltu r M .
Attempts to remove the epithelial cells from organ cultures have been made 
using a loose-fitting glass hooogemser (Almeida & Tyrrell. 1967). trypsin 
(Cavanagh et al ■. 1979) and ETTA (Kingsman et al.. 1977b). The latter two 
groups employed a degree of mechanical force as well. I removed the 
epithelial cells from the organ cultures using an enzymatic treatment 
method supplied by a-.C.Sweet (University of Birmingham), which he had 
developed to remove epithelial cells from organ cultures of ferret nasal 
turbinates (methods 2.4). Dr.C.Sweet reported that the technique yielded 
approximately 1-1.5 X 10* cells f* U*U. . Between 10-20% of the
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Table 7.2. Antigenic changes of adpFPV/R following adaptation to mouse cells.
a) determined by HI activity*
IqG mcAb A/FPV/R odpFPV/R increase
HC2 10,600 35,500 X 3.4
HC58 12,600 25,100 X 2.0
HC10 10,750 14,950 X 1.4
HC61 4.950 4,900 X 1.0
values expressed as HIU/ml
)4c
b) determined by plaque reduction
IqG mcAb A/FPV/R odpFPV/R increase
HC2 6,900 12. 150 X 1.76
HC58 3,150 4,250 X 1.35
HC10 12,900 21,900 X 1.70
HC61 17,000 26,300 X 1.55
reciprocal of the dilution required to cause 
50% neutralization of 1,000 pfu/ml virus 
when plaqued on CEF monolayers
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isolated cells were obviously ciliated and 60k of these possessed beating 
cilia. The renaming cells were morphologically similar except that they 
lacked cilia (personal communication).
Using mouse tracheal organ cultures. I found this technique yielded 1.6 X 
10* («•/- 0.4) cells per trachea, or 2.4 X 10* (♦/- 0.6) cells per organ 
culture ring. 30-40% possessed actively beating cilia, a value higher than 
that reported by Er.C.a#eet.
Cavanagh et al. (1979) reported a yield of 7.3 X 10* cells from ferret 
nasal turbinate organ cultures, while Kingsman et al. (1977b) found a yield 
of 1.7 X 10* cel Is from similar tissue. My results therefore compare 
favourably with previous findings.
Examples of the cells obtained by this technique are shown in Figure 7.11. 
The majority of the ciliated cells (Figure 7.11a/b) had actively beating 
cilia, making the cells highly motile and difficult to study under the 
microscope. The motility could be reduced by chilling the cells to 4*C. 
Ciliated cells were often seen in pairs or small groups as their cilia 
became entwined. Cells with very similar morphology and behaviour were 
found by Hoorn & Tyrrell (1965). The non-ciliated cells (Figure 7.11c/d) 
appear to be morphologically similar by light microscopy and they are often 
seen in small clusters, frequently attached to cells bearing cilia. They 
may have physically lost their cilia or are possibly immature epithelial 
cells. The epithelial cell preparations had very little contamination with 
erythrocytes or cell debris, but some contamination can be seen in Figure 
7.lid. The quality of a preparation was highly dependant on the degree of 
care taken when dissecting the trachea from the mouse.
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Fig.7.11. Cells isolated from mouse tracheal organ cultures 
visualized by phase contrast (x720).
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The ciliary activity of the isolated epithelial cells could be maintained 
for short periods of time (up to 6 hours) at roco temperature or 4*C. 
Attempts to maintain these cells overnight, either at 4#C and 37*C, proved 
unsuccessful. The cell number dropped, the level of cell debris became 
marked and the cells that survived lacked actively beating cilia.
Epithelial cells were examined using the trans^Hw* electron microscope by 
Dr.S.J.Armstrong (University of Warwick) . She found approximately 50% of 
the cells displayed evidence of cilia; either actual cilia or cilia base 
plates (Figure 7.12.) (personal communication). The cilia display the 2 
singlet: 9 doublet microtubule structure that has also been observed by 
others using tracheal organ cultures (Blaskovic et al.. 1972a).
Dr.S.J.Armstrong also confirmed that the non-ciliated cells were 
morphologically similar to those displaying cilia and presumably were also 
originally from the same epithelial layer or were the same cells. Most of 
the cells were vacuolated suggesting a degree of trauma had been introduced 
by the isolation technique. Vacuo 1 at ion has been found by others in 
epithelial cells removed from organ cultures by making an 'impression' on a 
glass slide (Hoorn & Tyrrell. 1965; Blaskovic et al.. 1972a).
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7.2.8. In vivo infection of the trachea with l/VSN.
It was important to investigate whether or not the ciliated epithelium of 
the trachea was infected in vivo. Therefore I infected mice before 
subsequently preparing the tracheal organ cultures. The influenza strain 
A/VSN was used in preference to adpFPV/R because our laboratory A/VSN 
strain is pathogenic for mice (Dimmock et al.. 1906) and tracheal organ 
cultures (section 7.2.3.). and because A/FPV/R is restricted to the 
controlled laboratory area.
When ether-anaesthetised mice are inoculated, A/VSN may primarily infect 
the lower respiratory tract rather than the trachea. I therefore dissected 
A/VSN-infected mice at various times post-infection so that if the 
infection proceeds in an upward direction, the samples prepared immediately 
post-infection would show less infection, than those prepared later (Figure 
7.13.).
Organ cultures prepared from mice at 2 hours p.i. (Figure 7.13a.) initially 
showed low levels of multiplication at 96 hours p.i. with a maximum titre 
of 10** pfu/ml. No reduction in ciliary activity was seen.
Organ cultures prepared from mice dissected at 24 hours p.i. (Figure 
7.13b.) shed virus at 48 hours p.i. and gave a maximum titre of nearly 10* 
pfu/ml. There appeared to be some impairment of ciliary activity initially 
but by 120 hours p.i. the infected and non-infected organ cultures were 
indistinguishable.
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a )  dissected 2 hours post— infection (p .i.)
Fig.7.13. Growth and effect of A/WSN on m ouse 
tracheal organ cultures taken from 
mice infected in vivo.
-e - A/WSN infected tracheas 
—  Non-infected tracheas
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Organ cultures prepared iron mice dissected at 48 hours p.i. (Figure 
7.13c.) showed virus Multiplication at the first time interval (72 hours 
p.i.). with maximum virus titres of lC?*pfu/ml. At first the organ cultures 
had very little ciliary activity and the respiratory surface of the organ 
cultures was covered with cell debris and rounded cells which lacked cilia. 
There were bare patches on the organ cultures where all the epithelial 
cells had been shed. The ciliary activity score gradually increased as 
overlying debris and cells were removed by harvesting and replacing of the 
medium. By 144 hours p.i. the score obtained was the same as that of the 
non-infected control organ cultures.
7-Î-9- Pwcrgtraticn ot y wgp an t in g  in i m UmIm I relis of 9raap
cultures infected in vivo.
Mice were infected with A/WSN by intranasal inoculation as previously 
described. At 24 hours p.i. the tracheas were removed and organ cultures 
prepared; from these the epithelial cells were immediately removed. The 
cells produced were fixed to covers 1 ipe and stained for A/WSN antigens 
using a fluorescent antibody technique (section 6.5.6.).
BH< cells were also infected with A/WSN and used as controls. The results 
(Figure 7.14.) demonstrate that good specific staining was achieved with 
little non-specific background.
Fig.7.1 4. Immunofluorescent staining of A/WSN antigens in
(a ) non-infected, and (b ) A/WSN infected BHK cells. 
Method described in section 6.5.6.. (x700 )
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The majority of epithelial cells show positive staining for A/WSN antigens 
(Figure 7.15.) but the intensity of staining was weaker than that found 
using EH< cells (Figure 7.14.). It is also of interest to note that all 
evidence of cilia was lost during this procedure, indicating their fragile 
nature.
The results confirm that the majority of the cells removed from organ 
cultures taken from mice infected in vivo are infected and are presumably 
epithelial cells.
7 .3 :  P ire v g g iq n ,
The data show that the maximum time organ cultures from mouse trachea can 
be maintained in good condition is 150 hours post-dissect ion, as judged by 
ciliary activity. This is a shorter period than found by others and may be 
due to the small size of the mouse trachea which makes it more susceptible 
to damage incurred during sectioning which leads to a reduced lifespan 
(Herbst-Laier. 1970). Westerberg et al. (1972). using mouse tracheal organ 
cultures, found no decline in ciliary activity over a 15 day period. 
Histologically the epithelium appeared healthy except* the nuclei seemed to 
move towards the apical surface instead of remaining at the base of the 
cells. Westerberg sectioned the trachea longitudinally (section 6.2.2.) and 
this may account for the differences in the maintenance results.
O y a n  cultures from larger animals have been successfully maintained for 
longer periods, again indicating that the size of the trachea may influence 
the longevity of the organ cultures produced. Ferrets, the most common 
source of tracheal organ cultures, yield cultures which can be maintained
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Fig .7 .1 £  Immunofluorescent stoining og A/WSN antigens in 
cells isolated from trochees of (a ) non— infected 
mice, or (b ) mice infected in vivo with A/WSN 
24 hours prior to dissection. (x700).
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for 10 days post dissection (Hara et al.. 1974). A sisilar period of 
maintenance was found for hamster tracheal organ cultures (Heath et al.. 
1983; 1986). Chick embryo tracheal organ cultures can be maintained for 
approximately 14 days poet dissection (Blaskovic et al.. 1972b). but some 
spontaneous degeneration of the ciliated epithelium was occasionally 
observed, resulting possibly from secondary infection (Blaskovic et al.. 
1972a). Organ cultures that are kept in motion remain in better condition 
than those kept stationary (Cherry & Taylor-Robinson, 1970). Organ cultures 
from monkeys can be maintained for 24 days with full activity (Hoorn & 
Tyrrell. 1965b). hkiman foetus appears the best source of tracheal organ 
cultures and these have been successfully maintained for up to 6 weeks post 
dissection (Hoorn, 1966; Mostow & Tyrrell. 1973). Very little decline in 
ciliary activity occurred during this period though the epithelial layer 
becomes progressively more thin and flat, and some loss of ciliated cells 
was also noted, Homan nasal turbinate organ cultures could be maintained 
for at least 22 days (Hoorn & Tyrrell, 1965b).
The first ciliary activity score was made at 24 hours post dissection 
rather than immediately after dissection (section 7.2.1.). because the 
organ cultures appear to enter a period of 'post-operative' shock where 
little or no ciliary activity is observable (Hoorn. 1966; Mostow & Tyrrell. 
1973). All workers agree that organ cultures are best maintained for at 
least 24 hours or overnight after sectioning before use (e.g. Mostow & 
Tyrrell. 1973). but some workers do maintain them for longer periods (e.g. 
Boudreault, 1979; Harnett & Hooper. 1968). Maintained ferret tracheal organ 
cultures gave a more reliable growth pattern for influenza virus (Kingsman 
et al. . 1977a; Cavanagh et al. .1979). Kingsman et al. (1977a) found no major 
histological changes between fresh and maintained ferret tracheal organ
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cultures and that further maintenance (48 hours post dissection) did not 
improve the performance of such cultures. No mucus covering of the 
epithelial lining was observed but the goblet cells appeared to empty on 
maintenance (Herbst-Laier, 1970). The presence of a mucus covering has been 
reported by others (Blaskovic et al. .1972a) using chick embryo tracheal 
organ cultures. Considering my findings, and those reported by others, I 
decided to maintain the tracheal organ cultures overnight before use.
Comparison of the ability of different influenza strains to multiply on 
tracheal organ cultures (section 7.2.3.), with that found by others, is 
complicated. The passage history of the influenza strains and the donor 
animal used to provide the cultures may influence the results obtained. I 
found A/PR/8 multiplied well (Figure 7.2.) on mouse tracheal organ 
cultures. This agrees with data from others who have used tracheal organ 
cultures from mouse, hamster, rat. dog. ferret and man (Westerberg et al.. 
1972; Schiff. 1974; Herbst-Laier. 1970). Hara et al. (1974) reported better 
growth on human rather than ferret tissues, with maximal titres occurring 
1-2 days p. i.. Schiff (1974), used hamster tracheal organ cultures and 
found the older the donor animal then the slower the multiplication of 
virus. Cogliano & Small (1978) also found the sercetatus of the ferrets 
affected the susceptibility of the organ cultures to infection.
Seropositive animal donors required 130-fold more inoculum to infect the 
cultures. The ability of A/PR/8 to reduce the ciliary activity of organ 
cultures from different species is less clear. My results show that A/PR/8 
causeW no appreciable reduction in ciliary activity (Figure 7.2.), but 
Westerberg et al. (1972) found A/PR/8 destroyed the ciliary activity of 
mouse tracheal organ cultures by 7 days p.i.. The A/PR/8 virus I used had 
been repeatedly passaged in hens eggs, but the virus used by Westerberg et
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al. had been passaged a total of 593 times in mice and this may have 
increased its pathogenicity to this animal host. Herbet-Laier (1970) found 
that A/PR/8 reduced the ciliary activity of ferret and dog tracheal organ 
cultures but not those of vervet monkey or pig. Mostow & Tyrrell (1973) 
found damage occurring in ferret but not human tracheal organ cultures.
Hara et al. (1974) described A/PR/8 as avirulent on the basis of its low 
pathogenicity on both human and ferret tracheal organ cultures.
A/WSN (Figure 7.3.) has not. to my knowledge, been propagated on organ 
cultures before. A/WSN causes a lower respiratory tract (LRT) infection 
with considerable pathology in the lungs (Dimmock et al.. 1986).
A/Jap (Figure 7.4.) has also not been grown on organ cultures although 
other H2N2 influenza strains have been successfully propagated (Kingsman et 
al.. 1977a; Herbet-Laier. 1970). Heath et al. (1983) found the A/Ann 
Arbor/6/60 influenza strain grew on hamster tracheal organ cultures and 
gave a CAI$# by day 6 p.i.. Moetow & Tyrrell (1973) used tissue from human 
sources and found that attenuated variants of the A/Qrgland/501/68 strain 
caused a variable amount of damage and that this correlated with the in 
vivo virulence in man.
The A/Clr influenza strain multiplied well on the mouse tracheal organ 
cultures and rapidly caused a considerable reduction in ciliary activity 
(Figure 7.5.). This may be due to the fact that the virus has been grown 
only in MDCK cells and never passaged in eggs. Many other H3N2 influenza 
strains have been successfully grown on tracheal organ cultures derived 
from various animal sources. All show good growth with maximal titres by 
day 3 p.i.. The wild-type and virulent recombinants all rapidly destroy the
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ciliated epithelium with the CAIjb occurring within 7 days p.i. (Blaskovic 
et al.. 1972c; Herbet-Laier. 1970; Sweet et al.. 1961; Heath et al.. 1986; 
Moetow & Tyrrell, 1973). The A/Ehgland/939/69 strain was unusual since it 
rapidly destroyed the ciliary activity on human tracheal organ cultures but 
caused little (Hara et al.. 1974) or no damage to ferret tissue (Moetow & 
Tyrrell. 1973). Moetow & Tyrrell (1973) also found that low levels of virus 
continued to be produced human organ cultures even when they were denuded 
of visible ciliated cells. Tracheal organ cultures have frequently been 
used to measure the degree of attenuation of temperature-sensitive and 
cold-adapted H3N2 strains. The successfully attenuated strains multiplied 
but failed to produce significant damage to the ciliated epithelium (Moetow 
et al.. 1979; Heath et al.. 1966). Some workers have chosen the A/Hong 
Kong/l/68-ts-(E] influenza virus as a reference strain against which 
attenuation can be measured (Boudreau11. 1978).
To my knowledge no other workers have attempted to grow avian influenza 
strains on either mammalian or avian tracheal organ cultures. My results 
suggest that the initial source of the influenza strain may play a crucial 
role in its ability to grow on mouse tracheal organ cultures. Three 
isolates from chickens did not grow, whilst a strain isolated from turkeys 
did grow. The reasons for this difference are not clear. The turkey 
influenza virus caused no loss of ciliary activity and was non-pathogenic 
on mouse tracheal organ cultures. By repeated serial passaging in a mouse 
tissue culture cell line A/FPV/F can be adapted to multiply on mouse 
tracheal organ cultures (Figure 7.9.). The virus produced. adpFPV/R, caused 
a very rapid reduction in ciliary activity and was handled with care 
because of its potential virulence to other mammals, including man.
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The antigenic changes in the H7 haemagglutinin caused by the adaptation 
were small (section 7.2.6.). Surprisingly, no change was seen at residue 
226. the key residue associated with the attachment of influenza to 
different sialic acid receptors (section 1.4.).
The intranasal inoculation of mice with A/VSN before preparation of 
tracheal organ cultures (section 7.2.8.) demonstrated that the epithelial 
cells of the trachea were infected in vivo. The trachea was not the major 
initial site of infection since there was little virus multiplication at 24 
hours p.i. but multiplication occurred later. By 48 hours p.i. considerable 
damage to the respiratory surface of the trachea had occurred which may 
have resulted from virus multiplication or from an lmmune-mediated response 
to the infection by the host. Toms et al. (1976) carried out similar 
experiments in ferrets using H3N2 reassortants. There was little damage to 
the ciliated epithelium. Virulent reassortants multiplied in organ cultures 
prepared days 2-6 p.i.. whilst attenuated reassortants only multiplied in 
cultures prepared on day 4 p.i.. and to lower titres. An apparent recovery 
of ciliary activity was also found when cell debris was removed during 
maintenance. Husseini et al. (1983) demonstrated that the trachea was an 
initial site of influenza virus infection in vivo in ferrets. Sweet et al. 
(1983) confirmed that virus replication was occurring in this tissue and 
that the virus found did not result from residual inoculum. Kingsman et al. 
(1977b) estimated that less than 1% of the original inoculum remained 24 
hours p.i.
The distribution of viral antigens detected by fluorescent antibody 
labelling (section 7.2.9.) in cells removed from organ cultures of 
intranasally infected mice confirmed that tracheal epithelial cells were
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infected in vivo. Blaskovic et el. (1972c) demonstrated a similar degree of 
fluorescent antibody staining in cells obtained from smears of influenza 
infected ferret tracheal organ cultures with maximal staining at 2-3 days 
p.i. Husseini et al. (1963) also showed that fluorescence was maximal 2-3 
days p.i.. Husseini found between 10-50* of the cells showed positive 
staining and stated that ciliated cells were predominantly infected. 
Kingsman et al. (1977b) detected influenza virus antigens by fluorescent 
antibody staining using cells obtained from an organ culture impression on 
a slide. They found that only 26* of the cells from ferret tracheal organ 
cultures were infected. If a low inoculum was used the number of cells 
infected fell to 2-5* but the viral antigen was apparent by 0-10 hours, 
again indicating that the trachea was an initial site of in vivo infection.
To conclude, my data demonstrate that mouse tracheal organ cultures are a 
viable experimental model system on which to study influenza virus 
infection.

1 6 2
8,1- ImjTQ0Mgt»9n,
The attachment of influenza virus to ciliated cells of crgan cultures from 
various species has been observed by electron microscopy. Influenza virus 
attaches strongly to the cilia (Blaskovic et a l . . 1972a). but this does not 
mean that the virus enters the cells via the cilia (Douraashkin & Tyrrell, 
1970). The attachment of the virus to cilia may play an important role in 
vivo by clumping the cilia, inhibiting the ciliary action and preventing 
elimination of virus in the mucous blanket (Wester berg et al.. 1972). Few 
quantitative data relating to the attachment of virus to ciliated cells of 
organ cultures in situ are available due to the lack of a suitable method 
for isolating such cells. The previous chapter described the use of 
protease digestion to isolate epithelial cells from mouse tracheal organ 
cultures. This technique enables a quantitative study of the attachment of 
radiolabel led influenza virus to differentiated epithelial cells to be 
attempted.
The attachment of radiolabel led influenza virus to dedifferentiated tissue 
culture cells and erythrocytes has been studied previously (Possee. 1981; 
Poesee et al.. 1982; Taylor. 1986; Taylor & Dimaock. 1985a 1985b; Taylor 
al.. 1987). These studies were performed at 4*C. I chose to investigate 
attachment at 37#C in preference to 4*C because;
(i) The effects of low temperatures (i.e. (f-4*C) on the early events of 
influenza virus infection are not clear. Influenza virus does attach to 
cells at this temperature (Dourmashkin & Tyrrell. 1970) and it has also 
been shown that temperature does not affect the rate of influenza virus 
attachment (Taylor & Dimoock. 1985a). Some workers found that the virus was 
internalised and uncoated but that no viral macromolecular synthesis
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occurred (Stephenson & Dimmock. 1975). whereas others found that virus 
entry was blocked and virtually no internalization took place (Matlin et 
al.. 1981; Richman et al.. 1986). At physiological temperatures all agree 
that Influenza virus does attach and Is internalized.
(ii) One of my primary aims is to study the attachment of influenza virus 
to the ciliated epithelium of tracheal organ cultures prepared from mice. 
These epithelial cells have actively beating cilia, the vigour of which is 
greatly diminished by chilling (section 7 .2 .7 . ) .  Blaskovic et al. (1972a) 
studied the attachment of influenza virus to chick embryo organ cultures 
and stated that when organ cultures were held at 4#C "the migration of 
virions through the mucous blanket was very slow ... ciliary activity 
diminished to a standstill resulting in slower movement of the muccus 
blanket, which, in addition became more viscous. These conditions, it is 
assumed, also interfered with the normal activity of neuraminidase, which 
further contributed to the retardation of virion migration ... inoculated 
cultures should be held during the adsorption period at 36*C rather than 
4*C for at least 30 minutes."
This chapter describes the inoculation of tracheal organ cultures with 
infectious W P adpFPV/R and determination of the amount of radioactive 
virus attaching to epithelial cells subsequently isolated from such 
cultures. The amount of attachment is compared with the attachment of virus 
to other types of cell.
Also described in this chapter are preliminary findings regarding the 
effect of IgG neutralization on the ability of the virus to attach to 
cells. Neutralization by polyclonal IgG antibodies directed against the 
haemagglutinin had previously been shown to cause a reduction in attachment
of A/FPV/R to chicken erythrocytes (Possee. 1961; Dimmock. 1984) but did 
not reduce the levels or rates of A/FFV/R attachment to CEF cells 
(Possee et al.. 1962) and BhK cells (Diamock, 1964; Taylor. 1986). I will 
describe the effects of IgG neutralization on attachment of adpFPV/R to 
tracheal organ culture cells and compare this with the attachment to other 
cell types.
§:2.- Beauty
8-2.1. Effect of the proteases on the attachment of adpFTV/R to cells.
Attachment of adpFPV/R to epithelial cells isolated from mouse tracheal 
organ cultures was studied by the application of radiolabel led virus to the 
whole organ cultures, followed by the detachment of the epithelial cells by 
protease digestion (section 6.5.4.) and the measurement of attached 
radioactivity. These proteases may release virus from the cell surface and 
give a falsely lew level of virus attachment. Proteinase K released 
attached A/FFV/R from the surface of EH< cells (TayLor & Dimmock, 1985a. 
1985b). however others found proteinase K. trypsin and chymotrypsin failed 
to release A/FFV/R from the surface of MDCX cells (Matlin et al.. 1981).
It was not possible to directly test the effects of the protease XIV and 
XXI on virus attached to organ cultures since their use is essential to the 
process of isolating cells from organ cultures. Instead, two mammalian 
tissue culture cell lines, BFK and C3H10T1/2, were used. * P adpFFV/R was 
inoculated onto confluent monolayers and after incubation at 37*C for 
various times, the cells were washed to remove the excess unattached virus. 
The monolayers were then treated with either medium alone or medium plus 
proteases. The proteases freed considerable numbers of cells from the
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plastic Petri dishes; these cells were harvested between each digestion and 
held at 37"c to ensure continued protease action for the full tine course 
of digestion. The results (Figures 8.1. and 8.2.) demonstrate that the 
level of adpFFV/R attachment was identical irrespective of whether the 
cells were treated with proteases or not. Therefore, the proteases do not 
appear to release attached virus from either of these tissue culture cell 
lines. I have assumed on the basis of these results that the proteases XIV 
and XXI do not release attached adpFFV/R from tracheal organ culture cells 
and that any release of attached adpFPV/R from such cells will represent a 
minimal value.
8,2-2= Attachment of infectious adbFPV/R to various cell types.
Different amounts of ^P-label led adpFPV/R were inoculated onto a range of 
cell types. These were incubated at 37*C for 60 min. before determining how 
much virus had attached (section 6.5.4.).
A good correlation (X).95) by linear regression analysis was found, within 
each cell type, between the amount of virus inoculated and the amount of 
virus attached per cell (Figures 8.3. to 8.7.). The correlation remained 
constant within different assays on the same cell type. The relationship 
between the inoculum and the amount of adpFPV/R attached was approximately 
proportional for all cell types. Linear regression analysis gave a slope of 
between 0.86 and 1.13. Total proportionality would give a slope with a 
value of 1.
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Fig .8 .1. Protease treatment does not release virus 
that is attached to BHK cells.
Confluent monolayers of BHK cells (3 .8  X 106 cells) 
were inoculated with 50 HAU adpFPV/R and incubated for 
various times at 37° C. The cells were the washed with 
PBS (5  X 2m l) before treatment with either medium alone 
( O  ). or medium plus 10U/m l proteases (  A  ). The 
conditions used were the same as for removing epithelial 
cells from tracheal organ cultures. The cells were then 
harvested and the associated radioactivity determined.
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F ig .8.2. Protease treatment does not release virus 
that is attached to C3H10T1/2 cells.
Confluent monolayers of C3H10T1/2 cells (3  X 10® cells) 
were inoculated with 50 HAU adpFPV/R and incubated for 
various times at 3 ^ C .  The cells were the washed with 
P B S  (5  X 2ml) before treatment with either medium alone 
(—O - - - ) ,  or medium plus 10U/ml proteases ( A  ). The 
conditions used were the same as for removing epithelial 
cells from tracheal organ cultures. The cells were then 
harvested and the associated radioactivity determined.
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Fig.8.3. Attachment of non-neutralized adpFPV/R to
epithelial cells isolated from  organ cultures.
Various amounts of adpFPV/R were inoculated onto 
tracheal organ culture preparations. After incubation at 
37°C for 60 min. the organ cultures were washed 5 times 
with PBS to remove unattached virus. The epithelial cells 
were removed from the organ cultures by protease digestion, 
resuspended in 1ml PBS, sonicated and the amount of 
radioactivity determined. The number of counts associated 
with the cells were converted to give the amount of virus 
attached by dividing by the CPM.HAU ratio (see text).
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Fig.8.4. Attachment of non-neutralized adpFPV/R to
baby hamster kidney (BH K ) cells.
Various amounts of adpFPV/R were inoculated onto 
confluent monolayers of BHK cells (5  X 1(^ cells). After 
incubation at Z>~P C for 60 min. the cells were washed 
4 times with PBS and the cells were scraped from the Petri 
dish, resuspended in 1ml PBS, sonicated and the amount of 
radioactivity determined. The number of counts associated 
with the cells were converted to give the amount of virus 
attached by dividing by the CPM:HAU ratio (see text).
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Fig.8.5. Attachment of non-neutralized adpFPV/R to
chicken erythrocytes.
Various amounts of ^2p  adpFPV/R were inoculated into 
suspensions of chicken erythrocytes ( 1 X 1 0 ®  cells). After 
incubation at 3 ^ C  for 60 min. the cells were washed 
3 times with PBS to remove unattached virus. The cells 
were resuspended in 1ml PBS, sonicated and the amount 
of radioactivity determined. The number of counts associated 
with the cells were converted to give the am ount of 
virus attached by dividing by the CPM.HAU ratio (see text).
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Fig.8.6. Attachment of non-neutralized adpFPV/R to
chick embryo fibroblast (C E F ) cells.
Various amounts o f ^ P  adpFPV/R were inoculated onto 
confluent monolayers of CEF cells (2 .3  X 10^ cells).
After incubation at 37°C for 60 min. the cells were 
washed 4 times with PBS and scraped from the petri dish. 
The cells were resuspended in 1ml PBS. sonicated and 
the amount of radioactivity determined. The number of 
counts associated with the cells were converted to give 
the amount of virus attached by dividing by the CPM:HAU 
ratio (see text).
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Fig.8.7. Attachment of non-neutralized adpFPV/R to
mouse fibroblasts (C 3H 10T1/2) cells.
Various amounts of ^ P  adpFPV/R were inoculated onto 
confluent monolayers of C3H10T1/2 cells (2 .6  X 10^ cells). 
After incubation at 37°C for 60 min. the cells were washed 
4 times with PBS and scroped from the Petri dish. The 
cells were resuspended in 1ml PBS, sonicated and the 
amount of radioactivity determined. The number of counts 
associated with the cells were converted to give the 
am ount of virus attached by dividing by the CPM:HAU 
ratio (see text).
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Saturation of the cells with adpFPV/R was not observed. If saturation was 
occurring then a levelling off in the amount of virus attaching would be 
observed as the amount of virus in the inoculua increased towards 
saturating amounts.
I have chosen to express the attachment of virus to cells in terms of HAU 
per cell because:
(i) The number of cells used in the assay is accounted for, so that 
attachment to different cell types can be compared e.g. less than 10* organ 
culture cells were used compared to 10* chicken erythrocytes. Also the 
number of tissue culture cells per confluent monolayer was variable between 
experiments e.g. 4.71 +/-1.90 X 10* BhK cells per 5cm Petri dish.
(ii) The CPM.-HAU ratio was determined within each assay, dividing the 
number of counts attached to each cell (CFM/cel1) by the CFM.-HAU ratio 
converted the measurement of attachment to HAU/cell. This correction was 
used to account for quality of the preparation of radiolabel led virus being 
used. The amount of *P-radiolabel incorporated into each adpFPV/R 
preparation varied considerably (891 ♦/- 1593 CFM:HAU). The ratio for each 
preparation also declined with time as the radiolabel decayed.
(iii) Previous studies on the attachment of radiolabel led virus to cells 
have expressed attachment as a proportion (percentage) of the inoculum 
applied (Taylor & Dinmock, 1985a, 1985b). I found that the cell type 
greatly affected the proportion of inoculated virus that did attach. Also 
there was considerable variation between experiments within each cell type 
(Table 8.1.).
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Table 8.1. Proportion of adpFPV/R attaching to 
different cell types.
Cell type;
Proportion of 
inoculum attaching (%)
Number of 
experiments
Range of 
inocula (HAU)
chicken erythrocytes 45.3 ( + / -  20.3) 19 1 -  400
organ culture cells 1.7 ( + / -  1.3) 21 4 -  4000
BHK cells 23.6 ( + / -  10.6) 31 3 - 8 0 0
CEF cells 17.0 ( + / -  5.5) 6 5 - 4 5 0
C3H10T1/2 cells 11.3 ( + / -  2.8) 4 7 - 2 0 0
Different amounts of MP adpFPV/R were inoculated onto 
the various cell types. After incubation at 37*t for 
60 minutes the amount of radioactivity attached to the 
cells was determined and expressed as a 
percentage of the inoculum applied.
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8.2.3. The rate of adofTV/R attachment.
As well as determining the amount of virus attaching to cells. 1 compared 
the rates of attachment of adpFPV/R to tracheal organ culture epithelial 
cells and to other cell types. The amount of virus attaching following a 60 
min. incubation was taken as the 100% value. Figure 8.0. shows that 
attachment is rapid, irrespective of the cell type studied, the majority 
(>80%) of the labelled adpFFV/R attaching within 5 min. The amount of virus 
inoculated (420 HAU) was not sufficient to saturate the cells (section 
8 . 2 . 2 . ) .
8.2.4. Effect of the proteases on adpFTPV/R neutralizaticti.
Before examining the effects of neutralization on the attachment of 
adpFPV/R to organ culture cells, it was necessary to show that the 
proteases did not effect this process. For example, protease treatment 
could affect virus infectivity, or attack the virus/antibody complex, 
perhaps by altering the ability of antibody to neutralize.
To test the effect of proteases on virus infectivity. adpFPV/R was 
incubated with either medium alone or medium plus proteases in a manner 
similar to that used to isolate epithelial cells from tracheal organ 
cultures. The incubations were carried out at three temperatures. If a 
reduction in infectivity was caused by enzymatic digestion, such a change 
might be expected to be temperature dependant. Following incubation the 
samples were assayed far infectivity (Table 8.2.). Proteases reduced the
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Fig.8.8. Attachment of non— neutralized adpFPV/R to
various cell types as a function of time.
adpFPV/R (420 HAU) was inoculated onto (i) tracheal 
organ cultures ( O ' ) .  BHK cells ( —Q -  )  and chicken 
erythrocytes (  -£x-). After incubation at 37°C for various 
times, the unattached virus was removed by washing with 
PBS. The cells were then isolated (m ethods section), 
resuspended in 1ml PBS, sonicated and the amount of 
radioactivity determined. The amount of virus attached 
to the cells at each time interval has been related as 
a percentage to the value at 60 min. post— inoculation.
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Table 8.2.
Effect of protease treatment 
on adpFPV/R infectivity.
Temperature 
of incubation
odpFPV/R * 
■+ proteases
odpFPV/R* 
+ medium
protease value^lOO 
medium value 1
4°C 6.20 X 107 6.90 X 107 89.9%
2<fC 6.50 X 107 7.40 X 107 87.8%
3*>C 7.45 X tO7 8.45 X 107 88.2%
infectivities expressed as pfu/ml.
infectivity of the virus by a small amount (10-13%). No temperature 
dependence was seen indicating that this reduction was not due to an 
enzymatic protease digestion.
The effect of the proteases on the neutralization process was then 
examined. Samples of adpFPV/R (1000 HAU/ml) were incubated with an equal 
volume of either PBS. or the monoclonal antibodies HC2 (1/300) or HC61 
(1/1000) for 60 min. at 25#C. To these virus/antibody mixtures was added an 
equal volume of either (i) PBS. (ii) medium alone, or (iii) medium plus 
proteases. The samples were incubated for a further 00 min. at 37*C and 
then assayed for residual infectivity. The results (Table 8.3.) demonstrate 
that protease treatment did not reduce the neutralizing capacity of the 
antibodies investigated.
8^ 2 ,5 , N e u tra liza tio n  o f  adpFPV/R by HC2 and th e e ffe c t  on v iru s
aUachacPt. *
**P adpFPV/R (1000 HAU/ml) was neutralized with an equal volume of HC2 
(1/300) for 60 min. at 25#C. sufficient to cause a 99.2% reduction in 
infectivity by plaque assay. The amount of neutralized adpFPV/R attaching 
to different cell types was determined and compared to the respective 
non-neutralized controls (Figure 8.9.). A significant reduction in virus 
attachment compared to the controls (100%) was observed on all cell types 
studied. The lowest level of attachment of neutralized virus was seen on 
chicken erythrocytes (10.9%). the highest was found on C3H10T1/2 tissue 
culture cells (68.9%). An intermediate level of attachment by neutralized 
adpFW/R was found on cells isolated from mouse tracheal organ cultures 
(31.0%). However the reduction in attachment caused by neutralization was
178
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Table 8.3.
Effect of protease treatment on the ability of 
antibodies to neutralize adpFPV/R infectivity.
Post­
neutralization
treatment
Control
Neutralization 
by HC2 
(1/300)
Neutralization 
by HC61 
(1/1000)
PBS 7.38 (100%)* 5.62 (1.75%) 6.11 (5.42%)
Medium 7.38 (100%) 5 68 (2.00%) 6.15 (5.94%)
Proteases 7.32 (100%) 5.61 (1.95%) 6.08 (5.71%)
Log.oPfu/ml (% control value)
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Fig.8.9. Neutralization of adpFPV/R by HC2 and
attachment to various cell types.
32 P adpFPV/R (1 X 1 0 ^ H A U / m l) was incubated at 2 f? C  for 
60 min. with 1/300 dilutions of either HC2 or the a n ti-H 3  
monoclonal antibody, 185/1, which is the control. The 
virus/antibody mixtures were inoculated onto various cell 
types and incubated at 37°C for 60 min. The excess unattached 
virus was removed by washing with PBS, before the cells 
were isolated, sonicated and the amount of cell associated 
radioactivity determined.
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always less than the reduction in infectivity. indicating that failure of 
attachment was not necessarily the reason why virus had become 
non-infectious. The differences between my findings and those in previously 
published works (Poesee et al.. 1982; Dismock. 1904; Taylor. 1906) will be 
discussed at the end of this chapter.
0-2.6. Nwtr.ali»u<?n <?f »tofTV/R to HC6 1  and ttw sffret on viruaauachaent,
The finding that IgG (HC2) neutralization of adpFPV/R reduced attachment to 
all cell types, including one of those previously studied by others 
(section 8.1.). was surprising. To confirm this finding, a similar set of 
experiments was done using a different monoclonal IgG i.e. HC61.
* P  labelled adpFPV/R (4100 HAU/ml) was incubated with a 1/20 dilution of 
HC61. sufficient to cause greater than a 99.9% reduction in infectivity. A 
significant reduction in virus attachment was observed on each of the three 
cell types studied (Figure 8.10.). similar to the situation found using
HC2.
fLZJ: S ite d  Qt Iqg rttutralisouon <m the m e  <2t adpfPV/R aUflchagrrt-
It is possible that the reduction in attachment of HC2- and 
HC61-neutral lzed adpFPV/R resulted from a slower rate of attachment 
compared to the non-neutrallzed control. This was studied using BH< cells 
and chicken erythrocytes. Figures 8.11. and 8.12. show that the
1S 2
Fig.8.10. Neutralization o f ^ P  adpFPV/R by HC61 and 
attachment to three types of cells.
32 P adpFPV/R (4.1 X 103 HAU/ml) was incubated at 2S>C for 
60 min with 1/20 dilutions of either HC61 or 185/1. The 
virus/antibody mixtures were then inoculated onto 
the different cell types and incubated at 37^C for 60 min.
The cells were then washed with PBS to remove the excess 
unattached virus, before the cells were isolated and the 
amount of cell associated radioactivity determined.
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Fig.8.11. Rates of attachment of HC61-neutralized and 
non-neutralized 32 P adpFPV/R to BHK cells.
52P adpFPV/R (4.1 X 10^ HAU/ml) was incubated at 2iP C for 
60 min with 1/20 dilutions of either 185/1 (— )  or HC61 
( — ). The virus/antibody mixtures were inoculated onto 
confluent BHK monolayers (1 .62 X 10® cells) and incubated at 
37°C for different times. The cells were then washed with 
PBS to remove the excess unattached virus. The cells were 
then scraped from the Petri dish, resuspended in 1ml PBS, 
sonicated and the amount of cell associated radioactivity 
determined.
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Fig.8.12. Rates of attachment of HC61-neutralized and
non-neutralized 33 P adpFPV/R to chicken erythrocytes.
” p adpFPV/R (4.1 X 105 HAU/m l) was incubated at 2 ^ C  for 
60 m in with 1/20 dilutions of either 185/1 (— ) or HC61
( ..... ). The virus/antibody mixtures were inoculated onto
chicken erythrocytes (1 X 10 °cells) and incubated at 
37°C for different times. The cells were then washed with 
PBS to remove unattached virus, resuspended in 1ml PBS, 
sonicated and the am ount of cell associated radioactivity 
determined.
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HC61-neutralized adpFPV/R attached at a similar rate to the non-neutral 1 zed 
virus (but again to a reduced level) i.e. the majority of the neutralized 
virus that is able to attach did so within 5 min. post-inoculation.
Plgfliffgjgn.
My results demonstrate that tracheal organ cultures can be used to study 
the attachment of influenza virus to differentiated cells of the 
respiratory tract. The proportion of the inoculum attaching to the ciliated 
epithelial cells of organ cultures (Table 8.1.) is low (1.7%). possibly 
reflecting a restricted access for the inoculum to the ciliated epithelium 
on the lumenal organ culture surface.
An alternative method of assessing virus attachment to whole organ cultures 
is to determine the infectivity of the inoculum before and after 
inoculation, the difference representing the amount of virus attached.
Using this technique Kingsman et al. (1977b) reported that roughly 10* of 
A/Moscow/1019/65 (H2N2) attached to ferret nasal turbinate organ cultures 
after 5, 60 or 240 min. poet-infection at 4*C. Schiff (1974) reported that 
over 90* of the A/PR/8 (H1N1) attached to 2-day old hamster tracheal organ 
cultures at 120 minutes post-infection (in fact, there was no residual 
infectivity in the supernatant culture fluid!). A difference in attachment 
was found using organ cultures from 4-week old hamsters, where only 50% of 
the inoculum attached. Schiff concluded that influenza virus showed 1st 
order kinetics of binding and that possibly the older animals had less 
receptors on the cells. It was noted that the surface area of the organ 
cultures from animals of different ages could vary and that caution needed 
to be taken in interpreting the results.
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Probably the reason for the difference between my findings and those 
described above, is the method of assay. I studied attachment of virus to 
cells which were subsequently removed from organ cultures whereas others 
studied attachment to whole organ cultures. I found, using radiolabel led 
virus, that tracheal organ cultures retained a large population of loosely 
or non-attached virions, which could be recovered by extensive washing. The 
ciliated nature of the cells, or the ring-shaped structure of the cultures, 
may be responsible for the retention of the virus. The age and species of 
the animal used, together with variations in the virus strain may also 
affect the results, as indicated above.
The proportion of virus attaching to cells did not appear to depend on the 
amount of virus in the inoculum, but was dependant on the cell type being 
studied. I found a larger proportion of the inoculum attached to tissue 
culture cells than attached to epithelial cells of organ cultures. The 
greatest amount attached to chicken erythrocytes. This may reflect an 
increase in access for the virus to the target cells. Saturation of the 
cells with virus did not occur at the highest inocula tested. Taylor & 
Dimmock (1985a, 1985b) using A/FTV/R. found that 20-30% of the inoculum 
attached to BHK cells, this agrees well with my findings. If the levels of 
attachment found by Taylor & Dimoock (1985a; 1985b) are converted to HAU 
per cell, using additional data provided, again good agreement is found 
with my results. Interestingly their data also reveal great variation in 
the quantity of radiolabel incorporated per virus particle, ranging from 
213 CPU:HAU (Taylor & Dismock. 1965b) to 619 and 4255 CPU:HAU (Taylor & 
Dimmock, 1985a). Mat 1 in et al. (1981) found that a maximum of between 35% 
to 55% A/FPV/R attached to MDCK cells. The virus bound to the microvilli
and penetrated the cells at the base of these structures, a situation 
similar to that seen using tracheal organ cultures (Dourmashkin & Tyrrell. 
1970). Richman et al. (1906) found only 1 «  of A/HC/68 (H3N2) attached to 
MDCK or LUC cells. The observation that only a small proportion of inoculum 
is able to attach to cells appears to be common to many virus systems e.g. 
Venezuelan equine encephalomyelitus (VEE) (Roehrig et al.. 1988). avian 
infectious bronchitis virus (IBV) (Cavanagh & Davis. 1986), rabies virus 
(Dietzschold et al.. 1987). It seems that both the virus strain and the 
cell type under study can affect the amount of virus attaching to cells.
At a constant inoculum (100 HAU), the extent of attachment of adpFPV/R to 
different cell types can be compared (Table 8.4.). The values calculated in 
this table should only be considered as approximate. On a per cell basis 
the greatest number of adpFPV/R virions attach to C3H10T1/2 cells, and the 
least to chicken erythrocytes. This finding does not account for the 
relative size and surface areas of different cells. On a unit area basis a 
different picture emerges, nearly 4-fold more virions attach to EH< cells 
than to C3H10T1/2 cells. The relatively low number of virions attaching per 
chicken erythrocyte now falls into line with CEF and C3H10T1/2 cells and 
does reflect the small surface area of these cells compared to the others 
studied. The ciliated nature of the organ culture cells greatly complicates 
any surface area estimations. Edwards et al. (1986). working on ciliated 
human adenoidal organ cultures, estimated that 2 X 10* cel Is occupied 3mm*-.
If the cells were not ciliated and this value was applied to my data, there 
would be 6.67 virions per l(Xjm* of organ culture cell surface. This is 
certain to be an over-estimate as no account is taken of the increased 
surface area due to the cilia. The differences in the amounts of adpFPV/R 
attaching to different cell types may reflect either (a) the numbers of
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Table 8.4.
Comparison of the levels of attachment o f^ P  labelled 
adpFPV/R to different cell types.
Cell
Type
a
L o g .  HAU 
attoched per 
106 cells
b
virions 
per cell
cell
number
c
m ean cell 
surfoce area
virions 
per 10 /um2
O.C. cell« ♦0.4 100 varies not nown
BHK cells ♦0.9 316 5.0 X 106 392.7  yum2 8.05
cRBC's -0 .6 10 1.0 * !0 8 8 8  9 "  <1 1.12
CEF cells ♦0.7 199 2.3 X 106 85 3.7  " 2.33
C 3H 10 T1/2  cells +  1.6 1584 2.6 X I0 5 7 5 51 .9  " 2.10
N O TE S :-
o. The results are taken from figures 1-3 -*•*■ , where the 
inoculum size is 100 HAU.
b. For A/FPV/R 1 HAU represents 3.98 X 107 virus 
particles (Taylor et ol.. 1987). This is assumed 
to apply also to adpFPV/R.
c. Calculated by dividing the orea of a 5cm  diameter petri 
dish by the cell number. Assumes that the cells lie 
uniformly flat.
d. Chicken erythrocytes hove an average volum e of 79 ,urri 
(Cook et al.. 1979). The surface area has been calculated 
assuming the cells are spherical.
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cell receptors for the virus, or (b) the affinity of the virus for the 
particular cell receptors. If the diameter of adpFPV/R is assumed to be 
similar to that of A/FPV/R i.e. 119.5nm (Taylor et al.. 1967). then over 
100 virions could pack into a lOum* area. Therefore less than 8% of the BhK 
cell surface area is covered by attached virions.
The rate of attachment of adpFPV/R was rapid irrespective of cell type 
(Figure 8.8.). the majority of virus attached within 5 min. 
post-inoculation. As the incubation time was increased the rate of virus 
attachment slowed considerably, with little additional virus able to 
attach. Others have found that A/FPV/R attaches more gradually to cultured 
cells and that the rate slews after 60 to 90 min. poet-inoculation 
(Hatlin et al.. 1981; Taylor & Dimmock. 1985a. 1985b). Schiff (1974) 
demonstrated that 70* of the A/HC/68 inoculum attached to whole hamster 
tracheal organ cultures within 30 min. poet-inoculation. These findings are 
surprising and may reflect a slow rate of diffusion rather than attachment. 
Attachment of influenza virus to cells is temperature-independent (Taylor & 
Dimmock, 1985a). probably because the abundance of cell receptors gives a 
high probability of virus/cell collision (Lonberg-Holm & Philipson. 1980).
An abundance of cell receptors would predict a rapid rate of attachment, as 
I have found. My data do not allow the rate constant to be accurately 
calculated, considerably shorter time intervals would be required. The use^  
cell suspensions rather than monolayers would also be advantageous and 
would increase the "encounter efficiency" of virus-cell collisons 
(Lonberg-Holm, 1981).
I found that neutralization of adpFPV/R by monoclonal IgG antibodies 
directed against the haemagglutinin did cause a significant reduction in 
attachment, the size of which depended on the cell type studied. However, 
the reduction in attachment never equalled the reduction in infectivity 
caused by neutralization. My observation that neutralizing monoclonal IgG 
reduces attachment of influenza virus to chicken erythrocytes confirms the 
findings of Poesee (1961) who used polyclonal IgG to neutralize A/FPV/R. A 
difference with published data (Poesee et al.. 1962; Dimmock. 1964; Taylor. 
1986) is my finding that there is a reduction in attachment of IgG 
neutralized virus to CEF and EH< cells. This was not attributable to a 
slower rate of attachment. The discrepancy between my observations and 
those of Taylor (1966) was especially worrying because we both used the 
same H-K cell line, identical monoclonal antibodies (HC2 and HC61), a 
similar inoculum size and virus strain (A/FPV/R). The major difference 
between protocols was that Taylor used saturating concentrations of 
neutralizing antibody whereas I used lower, sub-saturating amounts. At 
sub-saturating IgG concentrations substantial aggregation of A/FPV/R occurs 
(Taylor et al.. 1967) and this may affect the levels of attachment of 
neutralized adpFPV/R. It therefore appears that the antibody to virus ratio 
may be important in interpreting and understanding IgG neutralization of 
influenza virus. Although my findings clearly show that the reduction in 
attachment of virus does not fully account for the reduction in infectivity 
caused by IgG neutralization, they do indicate that the mechanism(s) of 
neutralization of influenza virus are more complex than previously proposed 
(Dimmock. 1964; Diamock. 1967).
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1 0 29,1. Introduction.
My initial findings (section 8.) shewed that contrary to the data of others 
(Reviewed by Dimmock 1964. 1967) IgG neutralization did cause a significant 
reduction in the ability of the virus to attach to cells, which may depend 
on the target cell type, the antibody .-virus ratio and the ability of 
antibody to aggregate virus at sub-saturating antibody concentrations.
The aim of this chapter is to investigate the sechanisss of IgG 
neutralization of influenza virus. Three neutralizing IgG sonoclonal 
antibodies (HC2. HC10 and HC61) directed against the H7 haemagglutinin were 
selected. All were of the IgG2a sub-class and each was directed against a 
different non-overlapping antigenic site (personal or—  ini cat ion P. Gamer, 
and ET.A.Hay) . I used three cell types. TYecheal organ culture cells were 
used because these are the natural target for influenza virus and thus the 
best model with which to study the natural influenza virus infection. The 
use of such differentiated cells might possibly reveal differences between 
the in vitro and in vivo mechanisms of neutralization. EH< cells were 
included as a model of in vitro neutralization. This cell type has been 
previously used to study the neutralization of influenza virus (Taylor & 
Di— ock. 1965a. 1965b; Taylor. 1966). An alternative would have been to use 
CEF cells as these too had been used in earlier studies (Posse« et al.. 
1962). but CEF cells are a primary cell culture and hence are 
heterogeneous. The third choice of cell type was the chicken erythrocyte. 
Influenza virus attachment to these cells can be visualised with the naked 
eye (i.e. haemagglutination assay), as can the one of the effects of
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antibody binding (i.a. haemagglutination inhibition). Also, attachment of 
influenza virus to these cells does not lead to appreciable internalization 
of the virus or to productive infection (Cook et al.. 1979).
In order to define the components of the neutralization Mixture I have used 
a constant amount of virus throughout in terse of haesagglutination units 
(HAL)) since overall it is the reaction of antibody with all virus particles 
having surface haemagglutinin protein which is important as well as the 
reaction with infectious virus. The choice of the virus concentration was 
influenced by amount of radioactive virus thich attached to the cells, 
especially to tracheal organ culture cells, and the number of virus 
particles which were needed for electron microscopy. I used 1000 HAU/ml 
mixed with an equal volume of neutralizing antibody, only occasionally did 
the incorporation of radiolabel into the virus prove too low for assays to 
be performed with tracheal organ cultures.
The concentration of antibody used is presented in terms of one of its 
biological activities i.e. haemagglutination-inhibition units (HIU). The 
relative amounts of antibody and virus present in the mixture is defined by 
the ratio, log^HIU:HAU. This method of expressing the antibody 
concentration was subsequently adopted by others in our laboratory (Taylor 
et al.. 1907). Previously antibody concentrations were reported as 
dilutions or a total protein concentration which made it impossible to 
compare one antibody preparation with another. Use of the log.HIU:HAU ratio 
allows such comparisons to be made.
9,2, BowUtg.9 ,2 .1 .  I¿3  n e u tr a liz a tio n  nl wlnfFV/li ln f » c t iv lt y  on organ c u ltu r w
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Since ay aim was to investigate the role of the target cell in 
neutralization, plaque reduction on tissue culture cell lines could not be 
taken as proof that neutralization was also occurring on the epithelial 
surface of tracheal organ cultures. As plaque reduction could not be 
performed using organ cultures, neutralization was examined by comparing 
the ability of neutralized and non-neutralized adpFPV/R to multiply on 
tracheal organ cultures.
The reailts for the HC2 are shown in Figure 9.1.. Two different antibody 
concentrations were used, the higher concentration neutralized and coated 
the virus but caused no virus aggregation whilst the lower antibody 
concentration neutralized the virus and caused considerable aggregation 
(personal ccaaunicaticn, Efc-.S. J. Armstrong). The inf activity of the virus 
was neutralized by more than 99.3* in both cases.
Multiplication was retarded by neutralizing antibody, the neutralized 
adpFFV/R showed negligible Multiplication in the organ cultures during the 
first 12 hours post-infection and was reduced over the Initial 24 to 36 
hours post-infection ooapared to the non-neutralized controls. Infectlvity 
of the virus was not totally abolished as maximum yields of adpFPV/R were 
seen with further incubation resulting from secondary cycles of 
multiplication. The virus produced could still be neutralized by HC2 and 
did not result from antibody-escape mutations. Limitations in the amounts
105
Fig.9.1. Neutralization of adpFPV/R by HC2 and the 
effect on virus multiplication on tracheal 
organ cultures.
adpFPV/R was diluted to 1000 HAU/ml before adding 
an equal volume of non— neutralizing 185/1 -(-O'*) or 
HC2 diluted to a LoqQHIU:HAU ratio of + 1 .0  - f B — ) or 
—0 . 5 - f A — ). The virus plus IgG mixtures were incubated at 
25^C for 60 min.. 20Qul of each virus/antibody mixture 
were added to batches of 18 tracheal organ cultures.
After 60 min. at 3/>C, the cultures were washed with 
PBS and seeded as individual cultures into wells of 
a microtitre tray and 50pl of media added. The cultures 
were incuboted at 37°C, and the media was regularly 
harvested and replace with fresh media. The infectivity 
of the pooled media was determined by plaque assay.
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of monoclonal antibody available precluded its continued presence in the 
culture medium. Experiments using HC10 and HC61 (not shown) gave similar 
results to those for HC2.
9 .2 .2 , A b ility  of the IoG monoclonal antibodies to  neutralize adpFPV/p
In an earlier part of this thesis neutralization of adpFFV/R by HC2, HC10 
and HC61 had been determined using a final virus concentration of 1000 
pfu/ml (section 7.2.6.). Here a final concentration, after the addition of 
antibody, of 500 HMJ/ml is used, which represents an increase of 
approximately 10*fold in the amount of virus to be neutralized. Therefore 
the amount of antibody required would also be expected to increase, and 
this was examined.
The neutralization profiles of each of the monoclones versus the higher 
adpffPV/R concentration are shown in Figure 9.2.. The amount of antibody 
used has been expressed os a ratio of antibody to virus, i.e. log„HIU:HAU. 
rather than as dilutions, as discussed earlier. The dilutions of antibody 
required for 50ft neutralization are shewn in Table 9.1.. These amounts are 
compared to the amounts required for 50ft neutralization of 1000 pfu/ml 
adpFFV/R (section 7.2.6.). More antibody was required to neutralize 1000 
HAU/ml adpFFV/R but the increase in antibody was many orders of magnitude 
less than the increase in the amount of virus. The efficiency of 
neutralization was dependant on the amount of virus to be neutralized.
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Fig.9.2. Neutralization of adpFPV/R by IgG monoclones.
Dilutions of antibody were added to equal volumes of adpFPV/R 
(1000 HAU/m l). mixed and incubated for 60 min. at 25°C. The 
remaining infectivity was determined by plaque assay on CEF cells.
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Table 9.1.
The dilutions of IgG required to cause 50% neutralization 
of two different concentrations of adpFPV/R.
*
Antibody
versus 1000 H AU/m l 
Log* HIU:HAU Dilution 
(A )
versus 1000 pfu/m l 
Dilution 
(B ) % >
HC2 - 1 . 5 1 /1122 1/12162 10.8
HC10 - 2 . 0 1 /14 9 6 1/21 6 78 14.6
HC61 -2 . 1 1 / 615 1/26 3 03 42.8
Values previously reported (section 7 .2 .6 .).
1 G 99 .2 .3 . Neutralization o f «dpFTV/R ty HC2.
The «e c h a m n  of neutralization of adpFPV/R by HC2 was investigated 
(section 6.5.4.) using a range of HC2 concentrations. The effects of HC2 on 
virus aggregation and attachsent to the different cell types were examined. 
The neutralization profile of HC2 has also been included in all the figures 
to allow a clear comparison of data.
tag raa tio n  <?( aflrfTV/B revert tv  HSx
Cr.S .J .Armstrong kindly performed all the EX procedures on the samples I 
supplied. The number of virus particles in each of the aggregates was 
counted and the results are shown in Figure 9.3.
Aggregation of adpFPV/R did occur and reached a maximum average aggregate 
size of 6.3 virus particles at a log^HIU:HAU ratio of -1.0. The rise in 
aggregation coincided with the HC2 concentration that caused 
neutralization. The amount of aggregation fell as the HC2 concentration 
increased. There was no aggregation (compared to the non-neutralized 
controls) above a log„HIU:HAU ratio of +0.5, the virus being monodisperse 
at this concentration.
9 .2 .3 .2 . Reduction in attachment of sdPFPV/R to  organ culture CffU?  CWMfl by HC2.
There was a significant reduction in attachsent of adpFFV/R to organ 
culture cells at the same concentration of HC2 required to initiate 
neutralization (Figure 9.4a). However the size of the reduction in
2 0 0
Log* HIU/HAU ratio
Fig.9.3. Aggregation of adpFPV/R due to HC2.
Dilutions of HC2 were odded to equal volumes 
of adpFPV/R (1000 HAU/ml), mixed and incubated 
for 60 min. at 25PC. The samples were then 
examined by EM and the amount of aggregation 
determined (■ ■ A — ) and compared to the non — neutralized
adpFPV/R controls ( ---------). Also shown is the
Hc2 neutralization profile ( ---------)  from Fig.9.2.
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Tracheal organ culture cells
Chicken erythrocytes
Fig.9.4. Neutralization of adpFPV/R by HC2 and the
effect on attachment to various cells.
Dilutions of HC2 were added to equal volumes of 
52 P adpFPV/R, mixed and incubated for 60 min. at 
25°C. The amounts of virus attaching were 
determined as previously described (section 6.5 .4.). 
Also shown is the HC2 neutralization profile £....... ).
The line is drawn through the average value of two 
duplicate samples which ore shown by the bars. 
Other attachment data reported in thesis are 
presented in a similar manner.
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attachment was always less than the reduction in infectivity. The maximum 
reduction in attachment was 60% whereas infect ivity was reduced to 99.9% 
and this occurred at log^HIU:HAU ratio of -0.4. As the HC2 concentration 
was increased the amount of attachment to the organ culture cells also 
increased so that at a log^HIU:HAU ratio of ♦1.0, attachment of adpFPV/R 
was 100%.
9.2-3,3, tedueUm in aU»tf»gm, <?( «IrtTV/R to ifrft ctIIg gauged fey H£2,
Reduction in attachment of HC2-neutrallzed adpFFV/R to EH< cells was 
similar to that observed using tracheal organ culture cells, except the 
magnitude of the reduction was smaller (Figure 9.4b). The maximum reduction 
in attachment was 45% and occurred at a logfc.HIU.HAU ratio of -0.3. 
Attachment returned to a higher level (82%) at a log*HIU:HAU ratio of 
greater than +1.0.
9,Z:3,4, Rpfluguon in flUgchaent. oL  adsfFV/K 19 ghigKcn o m i r o n w  gauged
by HC2.
Reduction in attachment of HC2-neutralized adpFPV/R to chicken erythrocytes 
paralleled the loss of inf activity down to 30% (Figure 9.4c). In contrast 
to tracheal organ cultures and B K  cells, there was no return to a normal 
level of attachment even at a log*HIU.HAU ratio of greater than ♦1.0. and 
there was no further decrease in attachment.
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9:2,4, NwtreliaUgfi Qt adriTV/B fir HQLQx
The lechaniaa of neutralization of adpfFV/R by HC10 was investigated with 
the protocol used for HC2. The HC10 neutralization profile is also shown in 
all relevant figures.
m , ! ,  tearratioo of rtPFTV/R swov l fir HC1Q,
The maximum average aggregate size was 4.5 virus particles and occurred at 
log»HIU.-HAU ratio of -2.3 (Figure 9.5.). The rise in aggregation occurred 
slightly before the HC10 concentration that caused neutralization. The 
amount of aggregation fell as the HC10 concentration was further increased. 
Above a log^HIU.HAU ratio of -1.0 no aggregation of the virus was found.
9^2,4,2. Reduction in attachment of adofPV/R to organ culture cells caused by HC10.
Reduction in attachment occurred at the same concentration of HC10 required 
to initiate neutralization of the vine (Figure 9.6a). As with HC2, the 
size of the reduction in attachment was always less than the reduction in 
inf activity. The maximum inhibition of attachment was 50% and this occurred 
at a log»HIU:HAU ratio of -1.2. The amount of HClO-neutralized virus able 
to attach to the organ culture cells increased when the amount of antibody 
was also increased. Attachment returned to 95* (compared to the 
non-neutralized controls) above a log^HIU.HAU ratio of 0.0.
2 0 4
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Fig.9.5. Aggregation of adpFPV/R due to HC10.
Dilutions of HC10 were added to equal volumes 
of adpFPV/R (1 000 HAU/m l), mixed and 
incubated for 60 min. at 2&C. The samples were 
then examined by EM and the degree of aggregation 
determined (  A  ) and compared to the non-neutralized
adpFPV/R controls ( --------). Also shown is the
HC10 neutralization profile ( -------- ) from Fig.9.2.
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Tracheal organ culture cells BHK cells
Chicken erythrocytes
Fig.9.6. Neutralization of adpFPV/R by HC10 and the
effect on attachment to various cells.
Dilutions of HC10 were added to equol volumes of 
■52 p adpFPV/R, mixed and incubated for 60 min. at 
25PC. The amounts of virus attaching were 
determined as previously described (section 6.5 .4.). 
Also shown is the HC10 neutrolizotion profile ( -------)■
2 0 68 ,2 ,4 ,3 ,  t e it lr t i « !  in  a t t a d l t n t  o f  «IcFPV/B to  EH< c» 11b caused by HC10
HC10 reduced attachment of adpfPV/R to EH< cells (Figure 9.6b). Maximum 
Inhibition of attachment was 40% and occurred at a log.HIU:HAU ratio of 
-1.5. Neutralized adpFFV/R attached to a similar extent as the 
non-neutralized controls (i.e. 100%) at a value greater than log^HIU.HAU
-0 .5 .
9*2.4 ,4-. Reduction in  attachment o f  adpFPV/R to  chicken erythrocytes caused 
by HC10.
A reduction in attachment of HClO-neutralized adpFPV/R to chicken 
erythrocytes was found (Figure 9.6c). Maximum inhibition was 00% of the 
non-neutralized controls. As with HC2, no return to normal amounts of 
attachment was observed at high HC10 concentrations and the amount of 
attachment remained at 20%.
2,2.5 , N w tr»lia U < ? n  9f « I pFPV^F fry N ^ l
The availability of HC61 was limited and three different preparations were 
used, each had a different undiluted activity, i.e. 4.888 ; 31,700 and 
141.250 HlU/ml. The dilution at which the first preparation (4.888 HlU/ml) 
caused 50% neutralization is shewn in Table 9.1.. the other two 
preparations caused neutralization at proportionally greater dilutions. The 
use of a relative concentration (log,HIU:HAU ratio), in preference to a 
simple dilution, allowed the results from the three preparations to be
combined.
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The HC61 neutralization profile is in all relevant figures.
2 ^ 5 ,1 ,  taqrwtttign vt ttflpfyv/R caugrt fry f l g l i
Figure 9.7. shews that aggregation of adpFPV/R by H061 did occur. A maximum 
aggregate size was difficult to deduce because one HC61 preparation caused 
sore aggregation than the other two preparations. The rise in aggregation 
occurred at a higher antibody concentration than neutralization, and 
reasons for this are discussed later. The range of HC61 concentrations that 
caused aggregation of adpFPV/R was greater than that seen for either HC2 or 
HC10. The amount of aggregation fell gradually as the HC61 concentration 
was increased. No aggregation was observed at above log^HIU:HAU ♦1.0.
9 ,2 .5 ,2 . Redaction in attachment of adnFPV/R to organ culture c e lls  caused
by HC61.
Attachment of HC61-neutralized adpfFV/R to organ culture cells was reduced 
and occurred at exactly the same concentrations required for neutralization 
(Figure 9.8a). Maximum inhibition of attachment was 70% of the control 
value and occurred at a log.HIU:HAU ratio of -2.0. Attachment of 
neutralized adpFPV/R remained low until the log»HIU:HAU ratio reached 40.6. 
The amount of neutralized adpFFV/R able to attach increased to 90% as the 
HC61 concentration increased to log^HIlhHAU +1.5.
Averag
e aggr
egate 
size
208
Fig.9.7. Aggregation of adpFPV/R due to HC61.
Dilutions of HC61 were added to equal volumes 
of adpFPV/R (1000 HAU/m l), mixed and incubated 
for 60 min. at 25 C. The stftnples were then 
examined by EM and the amount of aggregation
determined (--------) and compared to the non-neutralized
adpFPV/R controls ( -------- ). Also shown is the
HC61 neutralization profile ( ....... ) from Fig.9.2.
The data from 3 separate experiments are shown ( O  . A  , □  ) 
each with its respective control.
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9 . 2  5 - 3 .  Rodiictlon in « t h » c h » . n t  o f  « r t r J T V / H  l o  H »  c i l .  c . - M  b y  HC61.
Attachment of HC61-neutralizad adpFPV/R to BH< cells (Figure 9.0b) was 
similar to that previously found using organ culture cells. The maximum 
inhibition of attachment was 65% and occurred at a log.HIU:HAU ratio of 
-2.0. Attachment of neutralized virus at a log*HIU:HAU ratio of greater 
than +1.5 was 90% compared to the non-neutralized controls.
9.2-5,4. Reduction in attachment of adpfPV/R to chicken erythrocytes caused 
tv HC61.
HC61-neutralized adpFPV/R attached poorly (00% inhibition) to chicken 
erythrocytes (Figure 9.0c). and as with HC2 and HC10. there was no increase 
in attachment at high HCÓ1 HIU.HAU ratios.
BoTvfll vt f e l l  rtçreVarg fa - «dpfFV/R by n m H U a —  ami U » 
tliact on a t t a c h e n t .
The above experimente confirmed that the attachment of IgG-neutralized 
adpFFV/R to B *  and organ culture cells was unaffected at high IgG 
concentrations. In these situations it is possible that the neutralized 
virus attached to cells via a different cell receptor from that used by 
non-neutralized virus, as occurs with vesicular stomatitis virus (Schlegel 
& Wade. 1903). Antibody bound to neutralized virus may enable the virus to 
attach to the cells via Fc cell receptors as discussed in section 5.3.. To 
test this the cells were pre-treated with neuraminidase before the addition
of virus in order to remove the sialic acid cell receptors. Attachment of 
virus via an Fc cell receptor would not be affected by neuraminidase 
treatment.
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The results (Table 9.2.) show that pre-treatment of each of the three cell 
types with neuraminidase reduced the amount of virus able to attach. The 
attachment of infectious virus to cells was reduced showing that the 
neuraminidase did remove the sialic acid cell receptors. The attachment of 
IgG-neutralized virus was reduced by a similar amount demonstrating that 
the attachment of IgG-neutralized virus was also via a 
neuraminidase-sensitive cell receptor.
9 .2 .7 . In te rn a liz a tio n  o f  la g  m ut.raliaw l adcITV/R by « 1 1 » .
IgG-neutralized virus is able to attach to cells although the amount 
attaching is dependant on the HIU:HAU ratio. Internalization of attached 
neutralized virus was determined by treating the cells with neuraminidase 
at different times post-inoculation (section 6.5.S.). Virus remaining on 
the cell surface would remain sensitive to removal by neuraminidase, 
whereas virus being internalized would become progressively more resistant 
to removal fcy neuraminidase.
HC2 and HC61 were used. Table 9.3. shews that there was the same increase 
in neuraminidase resistance of neutralized and non-neutralized virus 
between 5 min. and 60 min. post-inoculation on either EH< or organ culture
cells.
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Two different IgG concentrations were used when studying internalization by 
B K  cells, the higher concentration causing little reduction in the 
attachment of virus and no aggregation, whilst the lower caused 
considerable aggregation and a large reduction in the attachment of virus.
The results demonstrate that antibody concentration used to neutralize the 
virus did not affect the internalization of virus that attached to these 
cells.
A similar set of experiments were performed using chicken erythrocytes (not 
shown). Less than 10* of the attached neutralized and infectious virus was 
neuraminidase resistant at either 5 min. or 60 sin. post-inoculation, 
indicating that minimal internalization of the attached virus took place in 
these cells.
9:3, Piggwai^n.
In this chapter I have investigated three mechanisms by which IgG 
antibodies could cause neutralization of influenza virus aggregation of 
the virus, inhibition of virus attachment to cells and prevention of virus 
entry into cells. In this discussion I shall examine the data for each of 
these stages separately before combining them into a more complete view of 
the neutralization process.
a.3,1. Igg-aadmted aggregation of aduTPV/R.
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If it is assumed that each aggregate represents a single infectious virus 
unit then aggregation of the virus reduces the number of infectious units 
within a virus population.
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The amount of aggregation caused by the binding of IgG molecules to 
influenza virus haemagglutinin was highly dependent on the antibody 
concentrât ion: virus concentration ratio and this confirms the findings of 
Taylor et al. (1967). My data are summarized in Table 9.4.. For HC2 a 
similar log^HIU:HMJ ratio of -1.5 caused both the initial loss of 
infectivity (50* neutralization) and the initial rise in aggregation 
(half-maximal average aggregate size).
The log^HIU:HAU ratio for H061 causing the initial rise in aggregation 
(-1.3) was higher than that retired for neutralization (i.e. log»HIU:HNJ 
-2.1). The fact that neutralization occurred at a HC61 concentration which 
did not cause appreciable aggregation of the virus suggests that 
aggregation contributed little to the overall process of neutralization.
The opposite situation was found with HC10 where the initial rise in 
aggregation (i.e. log^HIU:HAU -2.6) preceded neutralization (i.e. log„
HIU:HAU -2.0). This was surprising because the infectivity would be 
expected to diminish in proportion to the aggregate size. However more 
aggregation may occur on the EM grid than in solution as has been 
previously suggested by Taylor et al. (1967) or aggregates may be dispersed 
in solution by pipetting and vortexing. Obviously the specificity of the 
monoclonal antibody as well as the HIU:HAU ratio is a contributory factor 
to aggregation. This suggestion is supported by Wrigley et al. (1963) who 
demonstrated that the position of the antigenic site on the haemagglutinin 
affected the formation of aggregates of bromelain treated haemagglutinin in
2 1 6
Table 9.4. Sum m ary of aggregation of adpFPV/R by IgG monoclonal antibodies.
A ntibo dy ra tio  (log,fc<IU:HAU)
HC2 H C 1 0 HC61
50 %  neutralization ° - 1 . 5 - 2 . 0 -2 .1
H a lf -m a x im a l agg reg atio n  b - 1 . 6 - 2 . 6 - 1 . 3
M axim um  aggregation b - 1 . 0 - 2 . 3 - 0 .6
Return to m o no dispersio n  b + 0 .4 - 0 . 8 +  1.0
Max. ave ra ge  aggreg ate  size 6 .3 4 .5 1 1 .3  < - >  6 .0
M axim um  potential 
neutralization due to c 79% 71% 8 9 %  < - >  7 8 %
aggregation
a. Data fro m  Table  9 .1 .
b. Data fro m  Figures 9 .3 .,  9 .5 . ond 9 .7 . respectively .
c . If it is a ss u m e d  th at e o c h  aggregate rep re s en ts  a single 
infectious unit then a g g re g a tio n  of the v iru s  redu ces the 
num ber of infectious u n its  within a  v iru s  p o pu latio n . The  
m a x im u m  potential neutra lization  du e  to  a g g reg atio n  c a n  be 
ca lculated from  the m a x im u m  average a g g re g a te  size  e.g.
For HC2:
Infectious (c o n tro l) virus a g g reg ate  size  *  1 .3  p a rtic les /a g g reg ate  
.'. per 100  virions there a re  1 0 0 / 1 .3  a g g reg ate s  
.*. theoretical infectivity *  7 6 .9 2
For H C 2  neutra lized  v iru s  m a x. aggreg ate  s ize  =  6 .3  p a rtic les /a g g reg ate  
.*. per 100 virions there o re  1 0 0 / 6 .3  a g g re g a te s  
.’ . theoretical infectivity —  15.87
.*. rem aining infectivity *  1 5 .8 7 / 7 6 .9 2  X 1 0 0  —  2 0 .6 3 %
.'. neutralization =  7 9 .4 %
suspension by monoclonal IgG antibodies. All the Monoclonal antibodies used 
in this chapter were IgG2a and hence we are not considering variations in 
subclass properties.
All the monoclonal IgG antibodies caused a considerable amount of 
aggregation over a wide range of antibody concentrations. from ay data the 
maximum potential loss of infectivity due to aggregation is 70-90% (Table
9.4.). but this never fully accounts for the observed neutralization of 
greater than 99%.
Increasing the antibody concentration beyond that required for maximal 
aggregation resulted in a decrease in the amount of aggregation until 
eventually the virus was monodisperse. whilst there was no return in 
infectivity of the virus. Due to limitations in the availability of the 
monoclonal antibodies I could not assess the amount of antibody required 
for saturation of adpFPV/R. Taylor et al. (1987) demonstrated that 
saturation of A/TPV/P by either HC2. HC10 or HC61 label lad with m l. 
occurred at a constant log^HIU:HAU ratio of +0.9. Since the adpFFV/R strain 
is derived from and is still antigenically similar to the A/fPV/R strain 
(section 7.2.6.). it is likely that both viruses would be saturated by the 
same concentration of IgG. On the basis of this assumption, my data shew 
that IgG saturation of the virus did not always coincide with the antibody 
concentration at which aggregation was no longer apparent (Table 9.4.).
There was good agreement with HC61 and reasonable agreement with HC2 but 
there was a 50-fold difference with HC10. The reasons far this are not 
clear but again possibly may reflect the differences between the antigenic 
sites to which the antibodies bind (Wrigley et al.. 1983).
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A second possible mechanism by which IgG antibodies could neutralize 
influenza virus is by inhibiting its attachment to cells. A reduction in 
the capacity of the virus to attach would result in a proportional loss of 
virus infectivity. The infectivity assays (section 9.2.2.) were performed 
using CEF cells but parallel assays using EH< cells instead gave identical 
neutralization profiles (results not shown). The adpFFV/R virus could be
\
neutralized by each of the monoclones to an equal extent on either cell 
type. All three IgG monoclonals inhibited attachment of adpFTV/R to each of 
the cell types studied and the data are summarized in Table 9.5. In each 
case the initial inhibition of attachment (i.e. half-maximal) occurred at 
the same antibody concentration as that required for the initial loss of 
infectivity (i.e. 50% neutralization). This would suggest that at low IgG 
concentrations, the inhibition of attachment may be responsible for the 
loss of infectivity except for HC2 where at no point did the magnitude of 
such inhibition fully account for the amount of neutralization observed.
The magnitude of the reduction in attachment was dependent on the cell type 
used. For each antibody the largest reduction was found using chicken 
erythrocytes, intermediate reductions with tracheal organ culture cells and 
the least with EH< cells. The specificity of the antibody also influenced 
the size of the reduction: with tracheal organ culture or BH< cells HC61 
caused more inhibition of attachment than either HC2 or HC10. All three 
antibodies caused similar reductions in attachment of neutralized adpFTV/R 
to chicken erythrocytes.

2 2 0
When EH< cells were used, the attachment of virus returned towards 100% as 
the antibody concentration was increased whilst there was no return of 
virus infectivity. Earlier work had shown that IgG-neutralized A/fFV/R 
attached normally to CEF cells (Poesee et al.. 1962), mouse L929, human 
foreskin and BH< cells (Taylor & Dismock, 1965a; Taylor, 1966). None of 
these previous studies varied the concentration of IgG used to neutralize 
the virus and only high or saturating concentrations of neutralizing 
antibody were used. These workers isplied on the basis of these results 
that the attachment of IgG-neutralized influenza virus to cultured cells 
was unaffected regardless of antibody concentration. My data confirm their 
findings that with high or saturating IgG concentrations normal amounts of 
influenza virus attached to EH< cells, but show that with sub-saturating 
IgG concentrations this is not the case.
The attachment of IgG-neutralized adpFPV/R to tracheal organ culture cells 
and EHC cells proved to be similar and attachment returned towards 100% as 
the antibody concentration was increased. It would therefore appear that 
EH< cells are a good model of the in vivo situation but the amount of 
IgG-neutralized virus attaching to tracheal organ culture cells was always 
lower (by roughly 20%) than that attaching to EH< cells.
At high IgG concentrations, where maximum amounts of attachment occurred, 
it was possible that the IgG-neutralized virus was attaching to the cells 
via an Fc receptor and not via sialic acid as used by infectious virus. My 
data shew that this was not the case because removal of sialic acid from 
cells using neuraminidase affected equally the attachment of both 
infectious and neutralized virus (Table 9.2.). Hence IgG antibody does not 
necessarily block attachment of virus to the receptor.
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The question arises as how virus that is coated or saturated with IgG 
molecules attach in normal amounts to cells?. The receptor binding pocket 
on the haemagglutinin does not constitute an antigenic site far antibody 
binding (Wiley et al.. 1961; Weis et al.. 1968). It was proposed by Diamock 
(1967) that the antibody 'footprint' did not obscure the receptor binding 
pocket and that if the cell receptors are long enough to penetrate the 
fringe of IgG molecules bound to the virus then normal attachment could 
occur. On the other-hand. Weis et al. (1968) states that the binding of 
antibody would probably obscure the receptor binding pocket and that 
neutralization would result from an inhibition of virus attachment to 
cells. My data clearly demonstrate that this is not the case and support 
the view of Dinmock.
It is strange that virus with many IgG molecules bound attached to cells 
better than virus with only a few IgG molecules bound. Attached IgG 
antibodies are able to undergo axial rotation and flexing (Burton, 1986; 
Feinstein et al.. 1966; Pumphrey, 1986) and this may provide a possible 
explanation. It is conceivable that when only a few antibody molecules are 
bound then such molecules will have space to flex and rotate (Figure 9.9.). 
This movement will impede formation of the haemagglutinin-sialic acid 
linkage and lead to an overall lower level of virus attachment. When many 
antibody molecules are bound to the virus then the antibody molecules are 
more tightly packed and their movement and flexing will be reduced. 
Virus-cell attachment will not be impeded and greater amounts of 
neutralized virus will attach to the cells.
2 2 2
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Few IgG m o le c u le s  b o u n d  to v iru s  particles
Fig.9.9.Diagram of IgG binding to HA spikes of influenza particles and the limitations placed on antibody movement and flexing at high/saturating conditions.
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Tracheal organ cultures have been previously used as a model on which to 
study neutralization. It was shown that neutralization of avian infectious 
brooch it is virus (IBV) by IgG protected chick embryo tracheal organ 
cultures from cilioetasis (Cherry & Taylor-Robinson. 1970; Derbyshire 
al.. 1979). My results (Figure 9.1.) show that IgG neutralization of 
adpFPV/R occurred on mouse tracheal organ cultures and was apparent as a 
reduction in the amount of virus multiplication during the initial 24-36 
hours post-infection.
Chicken erythrocytes are a convenient but inappropriate cell type on which 
to study the infectious pathway of influenza virus because the attachment 
of virus to these cells does not lead to a productive infection although 
viral proteins are synthesized by the cells in small amounts (Cook et al.. 
1979; Dlsmock et al.. 1981). Attachment of neutralized adpPPV/R to chicken 
erythrocytes differed from that to either H *  or tracheal organ culture 
cells as the amount attaching remained low even when high antibody 
concentrations were used. This confirms the preliminary findings of Possee 
(1981) and would further support the view that chicken erythrocytes are a 
poor model on which to study the infectious route of influenza virus. The 
sialic acid-bearing cell receptor for influenza virus on chicken 
erythrocytes is probably glycophorin. This extends 5rm from the erythrocyte 
cell surface (Viitala & Jamefelt. 1985) and Dismock (1987) proposed that 
this was not long enough to penetrate the layer of IgG coating the virus 
particles and therefore the attachment of influenza virus to erythrocytes 
is sterically blocked by the IgG molecules bound to the virus 
haemagglutinin.
2 2 49 - 3 ,3 . In te rn a liz a tio n  o f IaG -o e u tralized  v iru s .
Resistance to removal by neuraminidase (Clostridiu perfnngens V) has been 
used by others to demonstrate the internalization of influenza virus by 
cells (Richman et a1.. 1966; Matlin et al.. 1961). The virus that is 
attached to the external surface of the cell can be removed by 
neuraminidase whereas internalized virus cannot as it is no longer 
available to the action of neuraminidase. Therefore internalization is 
measured by an increase in neuraminidase resistance with respect to time.
Table 9.3. shows that at 5 min. post-infection a mean of 33k of the 
attached infectious virus was resistant to neuraminidase. Probably some 
internalization has already occurred because on chicken erythrocytes, where 
little or no internalization occurs, less than 10% of the virus is 
resistant to neuraminidase. When the virus was incubated with cells for 60 
min. the proportion resistant to neuraminidase increased to over 64% 
indicating that the attached virus was being internalized.
The effect of IgG-neutralization on the internalization process is also 
shown in Table 9.3. Both HC2 and HC61 reduced the amount of virus attaching 
to EH< and tracheal organ culture cells. Neutralization by either HC2 or 
HC61 did not prevent the internalization of virus that had attached to 
either cell type. In all cases the increase in neuraminidase resistance 
observed was at least as large, and frequently greater, than that found 
using infectious virus. This suggests that neutralization by IgG antibodies 
does not prevent internalization of the virus that has attached to cells 
and may. in some cases (e.g. BhK cells), improve internalization. The data
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also show that while antibody had the capacity to aggregate virus neither 
the concentration of antibody nor the state of aggregation affected 
internalization of the virus that had attached to EH< cells.
IgG-neutralization of A/FTV/R does not to affect the amount of virion RNA 
accumulating in the nucleus ncr the rate at which it does so in CEF cells 
(Possee et al.. 1982) and EtK cells (Taylor & Dimsock. 1985a; Taylor,
1986). Therefore by implication, internalization of the neutralized virus 
must have occurred. Taylor (1986) also demonstrated that neutralization of 
A/FTV/R with saturating amounts of IgG did not prevent internalization by 
B-K cells when measured as the increase in resistance to removal of virus 
by proteinase K. The data in this thesis have advanced this concept by 
suggesting that (i) IgG-neutralized influenza virus is internalized by 
tracheal epithelial cells and (ii) IgG-neutralized virus is internalized 
regardless of whether it is neutralized by high or low concentrations of 
antibody.
With chicken erythrocytes the majority (more than 90*) of the attached 
infectious adpFPV/R was removed by neuraminidase treatment at both 5 min. 
and 60 min. post-infection. Very small amounts of virus appeared to be 
internalized but too little radioactivity remained after neuraminidase 
treatment to allow accurate assessment (data not shewn). It has been 
previously shown that small amounts of influenza virus are internalized and 
viral proteins are synthesised by chicken erythrocytes but no productive 
infection results (Cook et al.. 1979; Dimmock et al.. 1981) and my findings 
support this.
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When high IgG concentrations were used the virus was not aggregated and 
attachment to B *  or tracheal organ culture cells was not inhibited. The 
IgG-neutralized virus that attached to cells did so via sialic acid 
receptors and was successfully internalized by the cells. The infectivity 
of the virus was neutralized by sore than 99.9% at these high IgG 
concentrations and therefore, under these conditions, the mechanism of IgG 
neutralization involved neither aggregation, inhibition in the attachment 
to cells nor inhibition of internalization of attached virus by cells. 
Neutralization must therefore occur at a later stage of the infectious 
pathway and this is reviewed in detail in the general introduction to this 
thesis.
I have shewn in this chapter that at low. sub-saturating, IgG 
concentrations nsutralized virus was aggregated and its attachment to cells 
was impaired. This was seen with each of the monoclonal IgG antibodies, 
irrespective of the antigenic site to which they are directed, and with 
both tracheal organ culture and 9 K  cells.
IgG-mediated aggregation and inhibition of attachment of influenza virus to 
cells will result in some loss of infectivity but if virus is neutralized 
when neither of these occurs, then the question arises as to whether 
aggregation or reduced attachment ever play any major role in
neutra1izat ion?
I would argue as follows, on the basis of ay findings and those of others, 
that aggregation of the virus and the inhibition of virus attachment, 
either separately or in combination, are important in the overall process 
of neutralization.
(i) If the binding of a single IgG molecule to the virus resulted in 
neutralization then it could be argued that only virus already neutralized 
was aggregated and failed to attach.
Taylor et al. (1987) demonstrated that at the concentration of antibody 
required for 50% neutralization of X/fTV/R there were approximately 50 IgG 
molecules bound per virion. Therefore the binding of a single IgG molecule 
did not automatically result in neutralization. To reconcile this finding 
with the single (or limited) hit kinetics of neutralization they proposed 
that there were neutralization'relevant' and 'irrelevant' haemagglutinin 
spikes on the virus surface. The binding of antibody to a 'relevant' spike 
lead to a loss of infectivity whereas binding to an 'irrelevant' spike did 
not. They assumed, on the basis of earlier work, that neutralization 
resulted solely from an impairment of a post-internalization stage of the 
infectious pathway, involving a specific communicative interaction between 
the 'relevant' haemagglutinin spike and the virus core, possibly involving 
the M2 protein. They concluded that there were 20-40
neutral ization're levant ’ haemagglutinin spikes per virion. Unfortunately 
these workers failed to account for any possible loss of infectivity 
resulting from either aggregation or inhibition of virus attachment, even 
though they did show that aggregation did occur at the point of 50%
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neutralization.
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At high IgG concentrations my data would support the proposal that 
neutralization occurred post-internalization but at lower IgG 
concentrations both aggregation and inhibition of attachment could greatly 
enhance neutralization. It is unlikely that aggregation and inhibition of 
attachment would require a specific interaction between the haeaagglutinin 
and the virus core. Therefore some loss of infectivity would be expected to 
remilt from the binding of antibody to the virus irrespective of whether it 
was bound to a 'relevant* or 'irrelevant* spike. From my data, the loss of 
odpFPV/R infectivity due to aggregation and inhibition of attachment 
together could be calculated (Figure 9.10.). For HC61 the calculated loss 
of infectivity very closely paralleled the actual loss of infectivity down 
to 95* neutralization. For HC2 the calculated loss paralleled the actual 
loss of infectivity to approximately 65* neutralization although there was 
a small difference between the antibody ratios. The problems with the 
aggregation data for HC10 (discussed above) resulted in a substantial 
difference between the calculated and actual losses of infectivity. As 
previously discussed, increasing the IgG concentration eventually resulted 
in a decrease in the amount of both aggregation and inhibition of 
attachment. At these higher concentrations mere antibody molecules are 
bound per virion and therefore the chances of an antibody binding to a 
neutralization 'relevant* spike is increased, the post-internalization 
mechanism of neutralization then becomes more probable and more 
significant.
(ii) If neutralization resulted solely from the binding of IgG to 
'relevant* haemagglutinin spikes, then the efficiency of neutralization 
(i.e. the amount of antibody required to neutralize a given amount of 
virus) should be largely independent of virus concentration. Increasing the
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Fig.9.10. Calculated loss of adpFPV/R infectivity due to
the combined effects of IgG-m ediated aggregation 
and inhibition of attachment to tracheal organ 
culture cells. Data from:
HC2; Fig.9.3. and Fig.9 .4a.
HC10; Fig.9.5. and Fig.9.6a.
HC61; Fig.9.7. and Fig.9 .8a.
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concentration of virus would not increase the proportion of neutralization 
'relevant' spikes per virion for a given virus preparation. At 50» 
neutralization only 50 of the 1000 haemagglutinin spikes (or 3000 antigen 
sites) have antibody bound (Taylor et al.. 1987) and therefore, as the 
antigen is in vast excess, an increase in virus concentration will have 
little effect on the antibody binding.
Table 9.1. demonstrates that the efficiency of IgG neutralization, in terns 
of the number virions neutralized per molecules of IgG. of adpFFV/R was 
highly dependent on the concentration of virus to be neutralized. An 
increase of more than 100.000 fold in the virus concentration retired only 
an increase of 10-50 fold in the antibody concentration to effect the sane 
degree of neutralization. The dependence of neutralization on the virus 
concentration could be partly explained by introducing the concept of virus 
aggregation as one of the causes of neutralization. An increase in virus 
concentration would facilitate aggregation of the virus by reducing the 
average distance between virions in solution. Aggregation would also reduce 
the average number of IgG molecules required far neutralization because 
antibodies will be able to bind and cross-link two virions per IgG 
molecule. Ibis cross-linking of two virions by a single IgG molecule would 
improve the probability of an IgG binding for to a neutralization 
'relevant' haemagglutinin spike.
The dependence of the efficiency of neutralization on virus concentration 
means that comparisons of data carried out on widely disparate virus 
concentrations should be treated with caution e.g. Taylor et al. (1987) 
used 13.000 pfu (less than 0.1 HAU) when studying the neutralization of 
A/FPV/R but used 20 HAU when studying the attachment of antibody to the
virus and 200 HAU for virus aggregation. All ay data on the neutralization, 
attachment and internalization of adpFPV/R has been obtained using a 
constant virus concentration i.e. a final inoculm concentration of 500 
HAU/al.
(iii) The contribution of additional mechanisms of neutralization at 
sub-saturating IgG concentrations can be seen in the data of Taylor et al. 
(1907). They found the neutralization of A/FPV/R by HC10 was more efficient 
at low. sub-saturating IgG concentrations, less than 200 IgG molecules 
bound per virion, than at high IgG concentrations, more than 300 IgG 
molecules bound per virion (data reproduced in Figure 9.11.). The binding 
of the first 200 IgG molecules to virions reduced the infectivity by over 
60-fold whereas the binding of a further 200 IgG molecules only reduced the 
infectivity by less than 3-fold.
I would argue that the improved efficiency of neutralization at 
sub-saturating IgG concentrations was the result of enhancement by 
aggregation and inhibition of attachment. Although aggregation and 
inhibition of attachment may be i■partant factors under experimental 
conditions used it is difficult to assess their importance in vivo as the 
relative concentrations of antibody and virus are not known.
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Fig.9.11. Reproduced from Toylor et ol.. 1987.
Reduction in the infectivity of 2 X 10 ^pfu A/FPV/R 
by HC10 IgG correlated with the number of IgG 
molecules binding per A/FPV/R particle.
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The results presented in this chapter are based on the use of constant 
concentration of virus which allows clear comparison of neutralization by 
IgG and the effects on virus aggregation, attachment and internalization.
The relative concentration of antibody to virus was shown to be crucially 
important in both the aggregation and inhibition of attachment. Markedly 
different situations were found between high, saturating IgG concentrations 
and lcwer, sub-saturating concentrations.
At high IgG concentrations the virus was monodisperse, attached to EH< and 
tracheal organ culture cells in similar amounts to infectious virus and was 
internalized. At lower IgG concentrations each of the IgG monoclones 
aggregated the virus and inhibited its attachment to cells but did not 
affect the internalization of the virus that attached to BH< or tracheal 
organ culture cells. The specificity of the antibody influenced the 
magnitude of these effects. HC61 caused the greatest aggregation and 
inhibition of attachment whereas HC10 caused the least. The cell type also 
affected the attachment of neutralized virus and the probable in vivo 
situation, modelled using tracheal organ culture cells, was similar to that 
found using cultured EH< cells rather than chicken erythrocytes.
2 3 3
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Taylor & Dimock (1965b) previously demonstrated that neutralization of 
A/FPV/R by rabbit polyclonal IgM reduced virus attachment to EH< cells by 
50* at 37*C. Attachment was temperature dependent and little or no virus 
attached when the temperature was lowered to 4*C. The IgM-neutralized virus 
that had attached was not internalized by the cell and could be largely 
removed using proteinase K; no virion RNA was found in the cell nucleus. 
These workers proposed that IgM neutralized influenza virus by sterically 
hindering virus attachment and internalization. One limitation of the 
Taylor & Dimmock work described above was that they used only H-K cells and 
a single, high concentration of IgM which produced 99* neutralization of 
the virus. In this chapter I aim to extend these findings by investigating 
the IgM-neutralization process by using a range of IgM concentrations and 
examining aggregation of virus, attachment to cells and subse<^ient 
internalization of attached virus by cells. The same three cell types will 
be used as previously for IgG-neutralization. including chicken 
erythrocytes because of their importance in the assay of influenza virus 
(i.e. haemagglutination) and antibody (i.e. haemagglutination-inhibition). 
It was also of interest to see if the interaction of IgM-neutra 1 ized virus 
and chicken erythrocytes was as different from other cell types as we had 
found previously using IgG.
10.2. Results.
Punfiw tw n <?f IaH fp?» k m o 9 gwvm,
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As a Monoclonal IgM was not available, polyclonal IgM neutralizing for 
adpFTV/R was prepared by inoculating C3H Bice with A/FPV/D (K7N7) which has 
a haemagglutinin closely related to the A/FPV/R (H7N1) and an unrelated 
neuraminidase (section 6.4.1.2.). The C3H Bice were the same strain free 
which tracheal organ cultures were derived. The antiserum was specific for y
the H7 haeaagglutinin glycoprotein and had a haemagglutination inhibition 
titre of 1/2560 and an anti-neuraminidase titre of less than 1/200 (section
6.4.4.).
IgM antibodies were purified using a Sephacryl S-300 column (section
6.4.2.). Initially IgM was precipitated using polyethylene glycol (PEC).
This was only partly satisfactory as it precipitated a significant (but 
variable) proportion of antibody from the serum. but was better than 
ammonium sulphate which precipitated only snail amounts of antibody (data 
not shown).
5m 1 aliquots of PED-precipitated serum were passed through the column 
(Figure 10.1.). The IgM eluted in the first protein peak with a good 
separation (60 min.) between the IgM and the other serum proteins. There 
was little HI activity eluting in the position expected of IgG. Increasing 
the amount of sample overloaded the column and resulted in a poor 
separation of antibody classes. Many aliquots of serum were run on the 
S-300 column and the fractions containing HI activity were pooled and 
concentrated using Centricon-10 tubes (section 6.4.2.) and stored at 4*C.
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Fig. 10.1. Isolation of H7-specific IgM from PEG-precipitated 
mouse serum  on a Sephacryl S -3 0 0  column.
5ml of PEG-precipitated C3H mouse serum was applied to 
the Sephacryl S -3 0 0  column and the proteins eluted in TBS. 
The fractions were collected at 15 min. intervals and 
assayed for haemagglutination inhibition (section 6.4 .5 .) 
and protein concentration (section 6.4.8.).
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10,2,2. V e r if ic a t io n  th a t the p u r ifie d  antibody wag I< * .
The antibody was confirmed as IgM by Ouchterlony analysis (section 6.4.5.). 
There was uamunoprecipitation with the goat anti-mouse (GAM) IgM but not 
with GAM IgG or GAM IgA (Figure 10.2.).
The purified antibody was further characterised by SDS-PAGE (section
6.4.6.). Under non-reducing conditions (Figure 10.3a) a strong band was 
seen which hardly entered the gel. Increasing the running time of the gel 
or reducing the polyacrylamide concentration did not significantly improve 
the mobility of the band. The high molecular weight of this protein was 
thus consistent with the expected large size of pen tamer i c  IgM. molecular 
weight (Mr) of 900.000. The contaminating smaller proteins were probably 
IgM-fcreakdown products as they increased when the antibody was stored over 
prolonged periods. Under reducing conditions (Figure 10.3b) a strong band 
with a molecular weight of 75-77.000 was seen and this agrees well with the 
expected Mr of mouse ^  heavy chain (Mr 75.000). No light chains (Mr roughly
25.000) were seen, nor was the J chain (Mr 15,000). The IgG gave a band at 
50-54.000 which corresponded with the expected mouse Jfheavy chain (Mr
50.000) , and again there was no evidence of light chains, even though the 
antibody was monoclonal and should have given better definition. The Mr of 
bovine serum albumin (BSA) was calculated as 69,000 which agreed well with 
the expected value (67.000).
239
6
Fig. 10.2.
Immunoprécipitation of purified pcIgM.
10ul of pcIgM was placed in the centre well and 
wells numbered 1 to 6 were loaded with 10ul of: 
GAM IgM 1/10; 1/30; 1/100; 1/300 (wells 1 -4 )  
GAM IgG 1/10; GAM IgA 1/10 (wells 5 -6 ) .
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Fig. 10.3. SDS-PAGE analysis of purified pcIgM. 
Method detailed in section 6.4.6.
a) Non— reduced samples run on 10— 30% gel. 
track #1 monoclonal IgG
track #2 pcIgM 
track #3 empty 
track #4 BSA
b) BME— reduced samples on 20% gel. 
track § 1 BSA
track #2 molecular weight markers
track #3 BSA
track #4 monoclonal IgG
track #5 pcIgM
2 * 11Q±2,3, N e u tra liza tio n  o f adPFTV/R by left by p la « ie  redu ctio n on CXT c e l l s .
Neutralization of adpFPV/R by IgM was determined by plaque assay using CEF 
cells only and parallel assays using EH< cells were not performed. I had 
previously found with IgG that changing the cell type fre* CEF to EH< did 
not alter the neutralization profile (section 9.3.) and I assume this also 
to be true for IgM. The decline in inf activity with increasing 
concentration of IgM (Figure 10.4.) was more gradual than that seen for IgG 
(section 9.2.2.) and 50* neutralization occurred at a log^HIU:HAU ratio of 
-0.5. It should be noted that the amount of neutralization found at a log* 
HIU:HAU ratio of above 0.0 was variable (00-99%) and it was often found 
that maximum neutralization of only 90% could be achieved at the highest 
IgM concentration.
With IgG. I found neutralization to be highly dependant on the 
concentration of virus to be neutralized, the neutralization of a large 
amounts of virus could be brought about by a relatively small increase in 
antibody concentration (section 9.2.2.). This was similarly investigated 
using IgM (Table 10.1.).
The IgM had a haemagglutination inhibition (HI) titre of 1/10,540. This is 
measured using 4 HAU of virus, which is écrivaient to 16 HAU/ml (section
6.4.3.). In comparison, experiments studying the attachment of virus to 
cells used 500 HAU/ml (virus plus antibody) inocula. These inocula were 
assayed far remaining ha «»agglutination activity (section 6.5.2.). It was 
found that 50% haemagglutination activity remained when a 1/100 dilution of 
IgM was used to neutralize the virus. The ability of IgM to neutralize two 
widely different concentrations of adpFPV/R was determined by plaque
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Fig. 10.4. Neutralization of adpFPV/R infectivity by pcIgM.
Dilutions of pcIgM were added to equal volumes of 
adpFPV/R (1 000 HAU/m l), mixed and incubated for 
60 min. at 2&C. The remaining infectivity was 
determined by plaque assay using CEF cells.
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reduction. When the concentration of virus was increased by 70.000 fold 
(from 0.014 HAU/ml to 1000 HAU/ml) then only twice the amount of IgM was 
required to cause 50» neutralization (1/200 to 1/110 dilution).
Therefore at high virus concentrations (500 HAU/ml) the same amount of IgM 
(1/100 dilution) was retired to inhibit both infectivity and 
haemagglutination by 50». At lower virus concentrations more than 50-fold 
less IgM was retired to inhibit the haemagglutination of 16 HAU/ml by 50» 
(1/10,540 dilution) than was required to neutralize 0.02 HAU/ml by 50» 
(1/200 dilution). It would appear that at lower virus concentrations the 
IgM inhibited haemagglutination far more readily than infectivity. Reasons 
for this are discussed latter.
in ; 4 nf «rtrjpv/R tv IcM on tracftaal oron culturw.
Neutralization found by plaque reduction on cultured cells was not taken as 
evidence that neutralization was necessarily occurring on the epithelial 
surface of tracheal organ cultures. The ability of the IgM to reduce 
adpFTV/R multiplication on tracheal organ cultures was investigated as 
before (section 9.2.1.).
Neutralization of the inoculum by IgM reduced the multiplication by 99» 
during the initial 12 hours incubation (Figure 10.5.). demonstrating that 
neutralization had occurred. Two concentrations of IgM were used, the 
higher (log^HIU.HAU ratio of *0.5) caused 75» neutralization by plaque 
assay and the lower (log»HIU:HAU ratio of -0.4) only 54» neutralization. 
Nevertheless there was little difference in their effectiveness in 
inhibiting multiplication on organ cultures. At the higher concentration.
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Fig. 10.5. Neutralization of adpFPV/R by pcIgM and the 
effect on virus multiplication on tracheal 
organ cultures.
adpFPV/R was diluted to 1000 HAU/m l before adding 
an equal volume of either (i) 1/10 non— neutralizing 
185/1 0 ) ,  ( « )  purified polyclonal IgM (pcIgM) diluted to 
either log,JHIU:HAU -*-0.5 0  ) or -0 .4  0  ). The virus plus 
antibody mixtures were incubated at 2 5 X  for 60 min.
200ul of each mixture were added to batches of 18 tracheal 
organ cultures. After 60 min. at 3 ^  C, the cultures were 
washed with PBS and seeded as individual cultures into 
wells of a microtitre tray and 50ul of medium added. The 
cultures were incubated at 37°C, the medium was regularly 
harvested and replaced with fresh medium. The infectivity 
of the pooled media was determined by plaque assay.
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by EM. the virus particles appeared completely coated with antibody and 
there was little aggregation (personal rnssnnication. Er. S . J . Armstrong). 
whereas at the lower concentration the virus was considerably aggregated. 
Note that IgM was not present in the culture sodium and maximal levels of 
virus multiplication were seen when cells were infected with 
non-neutralized progeny virus.
19:2=5; ftaarr a itiqn vt adriTV/B fry laH,
IgM aggregated virus (Figure 10.6.) to a similar degree to that found with 
IgG (section 9.). The initial rise in aggregation (half-maximal) occurred 
at a log.HIU.-HAU ratio of -1.4 and preceded the initial fall in infectivity 
(i.e. 50* neutralization) which occurred at a log.HIU:HAU ratio of -0.5. 
This suggests that either the EM technique enhanced aggregation or that the 
aggregates were dispersed by physical agitation (as previously discussed).
A maximum average aggregate size of 4.6 occurred at a log.HIU:HAU ratio of 
-0.9. Increasing the log^HIU:HAU ratio to 0.0 lessened the amount of 
aggregation and the virus was essentially monodisperae at a concentration 
of above log.HIU.HAU +0.5.
1 0 2 6. Attechwent of edW F V /R tg tragheel ™  culture w l l i  ana the 
effect of neutralization by law.
IgM reduced attachment of adpFW/R to organ culture cella (Figure 10.7a). 
The initial fall in attachment (half maximal) occurred at an IgM log,, 
HIUrHAU ratio of -0.3 which was close to that required for 50* 
neutralization i.e. log^HIU:HAU ratio of -0.5. The maximum inhibition of 
attachment (70*) was not as great as the maximum neutralization (greater
247
Log10HIU/HAU ratio
Fig. 10.6. Aggregation of adpFPV/R by pcIgM.Dilutions of pcIgM were added to equal volumes of adpFPV/R (1000 HAU/ml), mixed and incubated for 60 min. at 2!?C. The samples were then examined by EM and the amount o f aggregation determined (—A —) and compared to the non-neutralizedadpFPV/R controls £------). Also shown is thepcIgM neutralization profile (------- ) from Fig. 10.4.
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than 90%). Above a loc^HIU.-HAU ratio of 0.0. where the virus was coated 
with antibody and was not aggregated (section 9.2.5.). There was no 
accompanying increase in attachment as seen with IgG.
10.2,7, Attachment, ot adofTV/R to  a «  ce l!»  and ttw e ffe c t  of neutralization by IaH.
A reduction in attachment of IgM-neutralized adpFFV/R to EhK cells was 
found and occurred at the same IgM concentration as that required for 
neutralization (Figure 10.7b). The maximum inhibition of attachment was 70% 
and occurred at a log„HIU:HAU ratio of 0.0. The slight improvement in 
attachment at the highest IgM concentration was not significant and 
subsequent experiments using high IgM ratios (not shown) confirmed that no 
increase in virus attachment occurred.
IQ.i.O. Attachment of adnFPV/R to chicken erythrocytes and the effect ofnwitrelwrtion fcy
Inhibition of attachment of IgM-neutralized adpFPV/R to chicken 
erythrocytes was more than 95% (Figure 10.7c) and the fall again 
parallelled the loss of infectivity.
10-2-9. E3fret 91 to. IrtLsn tt* intw ngiiw U on 9t adpfPV/E-_
The capacity of cells to internalize IgM-neutralized adpFTV/R was 
determined (Table 10.2.) by their acquisition of resistance to release by 
neuraminidase.
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The neuraminidase resistance of infectious virus increased with time using 
either BH< or tracheal organ culture cells and this, as discussed 
previously (section 9.2.7.). was taken as a demonstration that 
internalization was occurring.
In agreement with the results above, neutralization by IgM reduced the 
amounts of virus attaching to cells (Table 10.2., column 4). The 
IgM-neutralized adpFPV/R that attached did not become resistant to the 
action of neuraminidase and hence was not internalized by the cells. Even 
when the IgM concentration was reduced to a log^HIU.HAU ratio of -0.43 
(Table 10.2.. rows 5 and 6), internalization by BKK cells was still 
impaired to the same extent.
IQ,3: Bigcuagisn,
10.3.1. Aggregation of adpfPV/R by IoM.
IgM antibodies might be expected to cause more aggregation than IgG because 
of their increased antigen binding capacity (i.e. valency of 10 compared 
with 2), but both caused comparable amounts of aggregation. In theory 
aggregation caused by IgM could have reduced inf activity by up to 70% 
(Table 10.3.). This calculated loss of infectivity has to be treated with 
caution as aggregation preceded neutralization, as discussed above (section 
10.2.5.). Increasing the IgM concentration abolished aggregation whilst the 
infectivity remained low, suggesting that aggregation was not the sole 
mechanism of neutralization. A similar situation was found by Thomas et al. 
(1906) who investigated the neutralization of poliovirus. They found the 
amount of IgM-mediated aggregation of poliovirus decreased under conditions 
of antibody excess.
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Table 10.3. Summary of data on the aggregation of adpFPV/R by purified IgM.
A n tib o d y ra tio  
( l o g ^ l U :H A U )
5 0 %  ne u tra lizatio n  a - 0 . 5
H a lf -m a x im a l a g g re g a tio n  b - 1 . 4
M axim u m  a g g re g a tio n  b - 0 . 9
R eturn to m o n o d is p e rs io n  b 4 0 .5
M ax. a ve ra g e  a g g re g a te  s ize 4 .6
M axim u m  p otential 
n e utra lizatio n  d u e  to c 6 7 .4 %
agg reg atio n
o . D a ta  fro m  Fig. 1 0 .4 .
b . D a ta  fro m  Fig . 1 0 .6 .
c . C a lc u la te d  fro m  th e  m a x im u m  a v e ra g e  a g g re g a te  s ize  e .g .
In fe c tio u s  (c o n tr o l) v iru s  a g g re g a te  s ize  =  1 .5 p a rtic le s  / a g g re g a te  
/ . p e r  1 0 0  virio ns th ere  a re  1 0 0 / 1 .5  a g g re g a te s
th e o re tic a l infectivity =  6 6 .6 7
F o r p c Ig M  n eutra lized  v iru s  m a x . a g g re g a te  s ize  =  4 .6  p o rtic le s / a g g re g a te  
p e r  1 0 0  virio ns th ere  a re  1 0 0 / 4 .6  a g g re g a te s  
th e o re tic a l infectivity —  2 1 .7 4
.'.  re m a in in g  infectivity =  2 1 .7 4 / 6 6 .6 7  X 100  =  3 2 .6 1 %
.'.  n e u tra liz a tio n  =  6 7 .4 %
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I unsuccessfully attempted to saturate adpFPV/R with [**1 ]-IgM but failed 
to find a concentration where antibody no longer continued to attach to the 
virus. However at a log,HIU:H\U ratio of «1.5 the binding of IgM began to 
tail-off. indicating that saturation was being approached (data not shown). 
Taylor (1966) also failed to find a satisfactory sharp saturation end-point 
for polyclonal IgM.
IQ -3 ,2 . A t U d » e n t  o f  adnfPV^R to  c e l l s  and th e e f f e c t  o f  IaM.
Taylor & Dimmock (1965b) demonstrated that neutralization of A/FPV/R by a 
high IgM concentration resulted in more than a 50% reduction in attachment 
of virus to EH< cells. They also showed that levels of attachment were 
lower if cells were inoculated and incubated at temperature of 25*C, while 
at 4#C attachment was negligible. They concluded that the IgM. because of 
its large size, was sterically hindering the attachment of virus to cells 
and that "at higher temperatures the increased thermal agitation could be 
responsible for bringing receptor and target molecules into the correct 
juxtaposition".
My attachment data are summarized in Table 10.4.. Like Taylor & Diamock 
(1965b) I found that IgM-neutralization reduced the attachment of adpFPV/R 
to EH< cells. IgM also reduced the attachment of virus to tracheal organ 
culture cells to a similar level which suggests that BH< cells are a 
suitable cell type on which to investigate neutralization. Fcr both cell 
types the inhibition of attachment paralleled loss of infectivity and 
occurred at approximately the same log^HIU:HAU ratio, suggesting that the
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inhibition of attachment played an important role in the neutralization 
process. Unlike IgG. increasing the log^HIlhHAU ratio to 40.5 did not 
restore attachment.
Neutralization by IgM resulted in a concomitant reduction in attachment of 
adpFPV/R to chicken erythrocytes and was over 5-fold more than found using 
EtK or tracheal organ culture cells. The magnitude of the reduction was 
greater than with IgG (section 9.) and this may be due to the greater size 
of IgM compared to IgG which would increase the steric hindrance. The 
amount of IgM-neutralized virus attached to the chicken erythrocytes 
remained low when the IgM was increased to a log*HIU:HAU ratio of 40.5.
Limitations in the availability of IgM prevented examination of attachment 
above a log,HIU:HAU ratio of 40.5. Hcwever EM and aggregation data showed 
that above a log,HIU:HAU ratio of 0.0 virus was coated with antibody and 
was monodisperse. It therefore seems likely that saturation of the virus 
with IgM was being approached at a log.HIU.-HAU ratio greater than 40.5 and 
that the amount of virus attachment found at this point would not have 
significantly altered if the IgM concentration could have been increased.
10 3-3- In tw T w lia tia i ot Ia(Hwutraliz«d adpfPV/B by rellg.
Taylor & Dimmock (1965b) reported that mere than 00» of IgM-neutralized 
virus that managed to attach to B *  cells remained susceptible to removal 
by proteinase K following 2 hours incubation at 25"or 37*C and that none of 
the virion RNA was found in the cell nucleus. They concluded that the
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majority of the attached IgM-neutralized virus remained on the outer- 
surface of the cells and that the IgM interfered with the endocytotic event 
responsible for internalization.
Using neuraminidase and various concentrations of IgM, I also found that 
neutralization of adpFPV/R by IgM not only reduced the attachment of virus 
to cells but also impaired the internalization of the virus that had 
attached. The large size of the IgM molecule may possibly be preventing the 
internalization process, which is not affected by the smaller IgG (section 
9.). The amount of neutralization caused by IgM tended to be more variable 
than that found for IgG and frequently as much as 10* original infectivity 
could remain even when the highest antibody concentration was used. Reasons 
far this are discussed later.
IQ,3,4, Hwhani« 9t ngutranzaUsn <3t irtflugn» virug by IqH,
IgK-mediated aggregation of the virus presumably results in the loss of 
scoe infectivity. However aggregation cannot be the sole cause of 
neutralization because increasing the antibody concentration decreased 
aggregation without any return of infectivity. Aggregation probably 
contributes to neutralization by enhancing the neutralizing activity of the 
antibody shifting the neutralization profile to the left (i.e. to a lower 
antibody concentration). At low relative IgM concentrations aggregation 
could be an important cause of neutralization as there may be insufficient 
antibody to neutralize the virus by other means.
2 5 7
On data based on a single concentration of IgM. Taylor & Dismock (1965b) 
proposed that the large size of the IgM molecules bound to the virus 
particles probably sterically hindered virus attachment and blocked 
internalization. I have confirmed this and shewn that the fall in virus 
attachment coincided with the loss of infectivity. The amount of 
IgM-neutra 11zed virus attached to EH< and tracheal organ culture cells 
remained low at high log HIU:HAU ratios and could account for most of the 
observed neutralization (70% out of a total 90-99%). Therefore inhibition 
of virus attachment appears to be a major mechanism by which IgM antibodies 
neutralize influenza virus. Although IgM greatly reduced the attachment of 
virus to cells, approximately 30% of the virus did attach. Thus inhibition 
of attachment does not fully account for neutralization but impairment of 
internalization of this attached IgM-neutralized virus may explain the 
additional loss of infectivity.
Results here suggest a different explanation of the findings of Caseino 
al. (1966). They produced a human IgM monoclonal (ITT 17.9) which bound to 
the H3 haemagglutinin, caused haemagglutination inhibition (HI) but did not 
neutralize the virus. They proposed that "the epitope for neutralization 
overlaps with, but is smaller than, the epitope for /neneg?t;l»W)tM or that 
it only partially overlaps with the latter". They argued that simple steric 
hindrance which caused HI differed from neutralization and that 
neutralization must in some way be related to the antigenic site against 
which the antibody was directed. However erythrocytes are a poor model for 
the study of neutralization (discussed in section 9.) and therefore the 
conclusions of Caseino et al. (1966) about neutralization, which are based 
on the use of erythrocytes, need to be treated with caution. Also their 
monoclonal IgM. ITT 17.9. had a very low haemagglutination inhibition (HI)
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titre (1/32) and it is possible that they failed to detect neutralization 
because the HI activity was too low. My data (Table 10.1.) would support 
this interpretation and showed that HI was a such sore sensitive test than 
neutralization when low virus concentrations are used.
By EM examination Dr.S .J .Armstrong (personal communication) has detected 
bound IgM using anti-IgM linked to colloidal gold. The amount of antibody 
used shews that neutralization does not result simply from the binding of 
one IgM molecule to the influenza virus particle but was dependant on the 
number of IgM molecules bound. Maximum aggregation and 30k neutralization 
required 31 and 172 molecules of IgM per virion respectively, using CEF 
cells for the latter. The lowest concentrations of IgM bind to the virus 
particles but fail to neutralize or reduce the attachment to CEF cells and 
only caused a small amount of aggregation.lt was also found that the 
distance between the viral envelopes of aggregated virus particles was the 
same for virus with a few IgM molecules bound as for infectious virus and 
therefore it did not appear that IgM would sterically hinder virus 
attachment. In contrast when higher concentrations of IgM were used, the 
attachment of virus to CEF cells was reduced and neutralization resulted. A 
significant increase in distance between the viral envelopes within 
aggregates was also found, this would suggest that the IgM molecules are 
sterically hindering virus attachment at these higher, neutralizing IgM 
concentrations. Efc-.Armstrong proposes that the conformation the bound IgM 
adopts affects the attachment and neutralization of the virus (illustrated 
in Figure 10.8.). At low. non-neutralizing concentrations the IgM binds to 
the virus in the 'staple' conformation (Feinstein et al.. 1906) and this 
conformation does not aggregate the virus or reduce either the attachment, 
internalization or infectivity. At high concentrations more IgM molecules
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- igM molecule
Hoemogglutinin
spike
Many IgM molecules bound to virus porticles 
with th e  IgM  a d o p tin g  'p la n a r ' c o n f o r m a t io n .
Few IgM molecules bound to virus particles
w ith  th e  IgM  a d o p tin g  th e  's ta p le ' c o n f o r m a t io n .
Fig. 10.8.Diagram of IgM binding to HA spikes of influenza particles and the limitations placed on antibody conformation at differing antibody concentrations.
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bind to the virus particles. They are unable to adopt the 'staple' 
conformation and instead adopt the 'planar' conformation. Dr.Armstrong 
proposes that the 'planar' conformation aggregates the virus particles, 
sterically hinders the attachment and blocks the internalization process of 
any virus which does attach.
The conformation adopted by the bound IgM molecules may explain ay 
observation that haemagglutination can be more readily inhibited than 
infectivity. The depth of antibody surrounding the virus particles is 
relatively small when IgM is bound in the 'staple' conformation compared to 
the 'planar' conformation. Both the 'planar' and 'staple' conformations may 
sterically hinder the interaction of the virus haemagglutinin with the 
short erythrocytes receptor (Viitala & Jamefelt, 1905; Diamock. 1907). I 
previously found that the smaller IgG molecule was capable of blocking this 
interaction and reduced the attachment of virus to chicken erythrocytes 
(discussed in section 9.). In comparison, it would seem that the length of 
the receptor on BH< and organ culture cells is sufficiently long to 
penetrate the antibody layer surrounding the virus when either IgG 
molecules are bound or when IgM is bound in the 'staple' conformation. When 
more IgM molecules bind to the virus, and the 'planar' conformation is 
adopted, the depth of the antibody layer becomes sufficiently deep to block 
the attachment of virus to BhK and organ culture cells, resulting in
neutralization.

2621 1 ,1 , I ntrefluctigrL
The neutralization of influenza virus by IgA was investigated in the sane 
manner as previously reported for IgG (section 9.) and IgM (section 10.). 
Secretory IgA (slgA) is the predcoinant antibody class found in external 
secretions and is a principal nodi at or of humoral immunity against 
infections of the respiratory tract (reviewed by Underdown & Schiff. 1966; 
Mestecky, 1907). Therefore the mechanisms by which this immunoglobulin 
class neutralizes respiratory tract pathogens are of considerable interest. 
My use of epithelial cells from mouse tracheal organ cultures in 
conjunction with murine IgA was designed to create a model system within 
one species of animal with which to study influenza virus infection. As it 
used natural differentiated target cells, the system was also capable of 
determining if there were significant differences between in vivo 
mechanisms of neutralization and the in vitro mechanisms of neutralization 
which have been previously reported.
Taylor & Dimmock (1965a) found that secretory IgA (slgA). prepared from rat 
bile, reduced the attachment of A/FPV/R to B *  cells at 37*C by roughly 
60k. The inhibition of attachment was shewn to be temperature dependant, 
with negligible amounts of neutralized virus attaching at 4*C. The majority 
of virus that attached remained susceptible to proteinase K removal and the 
RNA of any virus remaining attached to the cells did not migrate to the 
cell nucleus. It was also found that IgA monomers, prepared from the same 
slgA by differential reduction, neutralized but did not inhibit virus 
attachment or its internalization by the cells. Taylor & Dismock concluded 
that the mechanism of neutralization of influenza virus was dependant on 
the character of the antibody used. Monomeric antibodies. IgG and monomeric
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IgA, did not block virus attachment or internalization by cells and 
therefore must neutralize infectivity at a intracellular stage of 
infection. On the other hand the polymeric antibodies slgA and later IgM 
(Taylor & Dimmock, 1965b) inhibited both virus attachment and 
internalization.
11.Z- R w i a ,
11,2,1, Purification of IaA from culture medium.
Taylor (1966) prepared polyclonal slgA by directly inoculating the Peyers 
patches of Wistar rats with BPL-treated A/PTV/D and at 7-9 days 
post-inoculation cannulating the bile ducts and collecting bile. Bile salts 
were removed by dialysis and the slgA purified by either affinity 
chromatography or gel filtration. I unsuccessfully attempted to adapt this 
method for use with mice: BPL-treated A/FPV/D was administered to C3H mice 
by either intranasal, intragas trie or intravenous inoculation and the bile 
collected from mice sacrificed 7 days post-inoculation. The methodology and 
results are not presented because in all cases the
haemagglutination-inhibition titre of the harvested bile was low (less than 
16 HlU/ml) and the small amount of bile per mouse (less than 20ul) made 
this an impractical source of slgA.
Er.W.Gerhard (Philadelphia, USA) kindly supplied a hybidoma cell-line 
(437-66-1) that produced monoclonal IgA directed against the haemagglutinin 
of A/PR/8 (H1N1). The culture medium harvested from these cells 
(tef«37-66-1) had a high haemagglutination-inhibition titre against A/PR/8
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(sore than 28. (XX) HIU/ml ). and did not cross-react with other 
haemagglutinin sub-types or with the HI haemagglutinin of A/WSN (results 
not shown).
The antibody in tcf*37-66-1 failed to bind to protein-A beads which had 
previously been reported to bind human IgA2 in addition to IgG antibodies 
(Archibald et al.. 1987). This may reflect the fact that Burine 
immunoglobulin A has only one subclass, whereas man has two subclasses 
(IgAl and IgA2) and rabbits possibly three subclasses (Underdown & Schifi. 
1966).
I initially attempted to purify the IgA from tcf§37-66-1 using Jacalin. a 
lectin isolated from the jackfruit Artocanxis integri folia. Jacalin has an 
IgA-binding specificity and has been previously used to purify human serum 
and secretory IgA (Roque-Barreira & Campos-Neto. 1985) and hamster IgA (Ray 
et al.. 1988). Jacalin failed to bind any of the HI activity in 
tcf 037-66-1.
Immune precipitation followed by gel filtration has been used to purify IgA 
from human serum (Mestecky et al ■. 1971). I loaded 5ml batches of 
tcf§37-66-l culture medium directly on to a Sephacryl S-300 column and 
eluted with TBS (section 6.4.2.). I did not include an immune precipitation 
step because I was working with hybidooa cell culture medium which would 
not contain any other immunoglobulins specific for influenza virus. PEE 
precipitation was not used as it failed to precipitate significant amounts 
of antibody and as culture meditai was used instead of serum it was found 
that the column did not become blocked. A typical elution profile is shown 
in Figure 11.1. HI antibody eluted with the first peak and good separation
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Fig. 11.1. Isolation of presumptive IgA from the culture medium 
of the hybridoma #37— 6 6 — 1.
5ml of undiluted tc f# 3 7 -6 6 -1  was applied to the 
S -3 0 0  column and the IgA eluted with TBS (section 6.4.2.). 
Fractions were collected at 15 min. intervals and assayed for 
haemagglutination inhibition against A /PR /8 and 
protein concentration (section 6.4.3. and 6.4 .8 .).
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was found between this and the other eajcr proteins of the culture nedium. 
The fact that the HI antibody eluted in the first peak and at a time 
similar to that previously found for IgM rather than IgG (section 10.2.1.) 
suggested that the IgA was in a polymeric rather than a monomeric form.
Repeated attempts were made, without much success, to prepare monomeric IgA 
using the differential reduction method of Taylor & Dimmock (1985a). I 
found that if 0.12M iodoacetamine was added as a blocking agent following 
the reduction by beta-mercaptoethanol, then small amounts of monomer were 
obtained.
11.2.2. Verification that the purified antibody was IaA.
The fractions obtained from the S-300 column were characterised by SD6-PAGE 
using non-reducing conditions (Figure 11.2a). A band was found (tracks 3,
4. 5) with a higher molecular weight than IgG (track 11) and was only 
observed in the fractions which contained HI activity, suggesting that this 
was the putative IgA. fractions from the second large protein peak of the 
S-300 purification (tracks 6 to 10) appeared to be mainly composed of 
albumin. Determination of the molecular weight (Hr) of the putative IgA 
antibody using this gel system proved difficult, so the PAA gel system was 
used instead and is reported below. The putative IgA antibody was also run 
on SE6-PAGE gels using reducing conditions (Figure 11.2b). The Mr of the 
IgA heavy chain (track 3) was 67,000; heavier than found for IgG (track 4) 
(Mr 60,000) but less than IgM (track 1) (Mr 76.000). A second minor band 
can be seen in this IgA preparation which had a slightly lower Mr (58.000). 
The IgA had been stored at 4#C for approximately 1 week and possibly the 
IgA antibody undergoes some degradation upon storage similar to that found
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for IgM (section 10.2.2.). With a different IgA preparation (track 2). 
bands were observed with higher Mr values and these possibly result fro® 
incomplete reduction of the antibody. The J chain was not visible for 
either IgA preparation. Light chains can be seen with Mr of 27.000 (IgG), 
28.000 (IgM) and 29.000 (IgA).
The IgA was further characterised on PAA gels using non-reducing, 
non-denaturing conditions (Figure 11.2c). The IgG (track 2) had a Mr of 
210.000, which was higher than the expected value of approximately 160,000. 
The reasons for this are not clear. The IgM (track 1) had been stored for 
more than 2 months and gave a series of bands with high Mr values. These 
probably represent IgM degradation products. The IgA (track 3) gave 4 
visible bands. The smallest band had a Mr of 470,000 which agrees with that 
expected far a dimeric structure. The Mr values of the other IgA bands were 
greater than thyroglobulin (Mr 669.000), the largest molecular weight 
marker used. These bands probably represent larger polymers of IgA i.e. 
trimers, tetramers and pentamers. Underdown & Schiff (1986) have reported 
the presence of large polymers of human IgA in preparations of secretory 
IgA.
The antibody was confirmed as IgA by Ouchterlony analysis (Figure 11.3.), 
inounoprecipitation was found against the GAM anti-IgA and not against GAM 
anti-IgG or GAM anti-IgM.
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Fig. 11.3. Immunoprécipitation of purified IgA.
10ul of purified IgA was placed in the centre well and 
wells numbered 1 to 6 were loaded with 10ul of:
GAM IgA 1/10; 1/30; 1/100; 1/300; GAM IgG 1/10; 
GAM IgM 1/10. Method described in section 6.4.5.
2 7 0
11.2.3. Neutralization of A/PR/8 with purified IaA by plaque reduction.
The specificity of the IgA antibody isolated frcs tcf#37-66-l scant that I 
had to change fros using the adpFPV/R strain of influenza virus to the 
A/PR/8 strain, which also sultiplied well on souse tracheal organ cultures 
(section 7.2.3.).
The neutralization profile of the purified IgA versus A/PR/8 determined by 
plaque reduction on M X K  cells is shown in Figure 11.4. A 50% loss of 
infectivity was found at a logy HIlhHAU ratio of -1.3. Increasing the 
antibody ratio to above -1.0 caused greater than 99.9% neutralization.
1 1 .2 .4 . N e u tra liza tio n  o f  A/PR/8 on tra c h e a l c r « n  c u ltu re s
The ability of the IgA to reduce A/PR/8 sultiplication on tracheal organ 
cultures was investigated as described previously for IgG and IgM 
antibodies. The multiplication of IgA-neutralized A/PR/8 was reduced during 
the initial 24 hours post-inoculation (Figure 11.5.) again demonstrating 
that neutralization had occurred. Further incubation of the cultures, in 
the absence of antibody, resulted in normal amounts of virus 
multiplication, the progeny virus could still be neutralized by the IgA and 
did not result from neutralization-escape mutations. I used two different 
IgA concentrations to neutralize the virus and found that both reduced the 
multiplication of virus to a similar degree.
remain
ing inf
ectivity
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Fig. 11.4. Neutralization of A /PR /8 infectivity by IgA.
Dilutions of IgA were added to equal volumes of 
A /PR /8 (1000 H AU/m l), mixed and incubated for 
60 min. at 2fPC. The remaining infectivity was 
determined by plaque assay using MDCK cells.
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Fig. 11.5. Neutralization of A /P R /8 by IgA and the 
effect on virus multiplication on tracheal 
organ cultures.
A /P R /8  was diluted to 1000 HAU/ml before adding an 
equal volume of either (i) 1/10 non— neutralizing 185/1 ( O ) . or IgA; (ii) logH/H +1.28 (A ), or logH/H +0.28 
( □  ). The virus/antibody mixtures were incubated at 
2 5 ^ t  for 60 min.. 20Qul of each virus/antibody mixture 
were added to batches of 18 tracheal organ cultures. 
After 60 min. at 3~PC, the cultures were washed with 
PBS and seeded as individual cultures into wells of 
a microtitre tray and 50pl of medium added. The cultures 
were incubated at 37°C, and the medium was regularly 
harvested and replaced with fresh medium. The infectivity 
of the pooled medium was determined by plaque assay.
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11.2.5. Aggregation of A/PR/8 tv loA,
A/PR/8 was aggregated by IgA (Figure 11.6.) with the initial rise in 
aggregation (half-maximal) occurring at a log^HIU:HAU ratio of -1.5. This 
coincided with the initial fall in infectivity. The maximum average 
aggregate size of IgA-neutralized virus was 3.4 and occurred at a log.
HIU:HAU ratio of -1.2. Increasing the IgA concentration beyond a log,.
HIU: HAU ratio of -1.2 reduced the amount of aggregation and the virus was 
essentially monodisperse at a log.HIU:HAU ratio of above -0.7.
The maximum potential loss of infectivity due to IgA aggregation was 41* 
whereas virus was neutralized by more than 99*.
1 1 .2 .6 . A t t a c f e n t  of A/PR/S to  tractw al organ c u ltu r e  c e l l s  and t i n  tiltst  o f  n e u tr a lis a tio n  tV IgA-
The results of two separate experiments are shewn in Figure 11.7. In both 
cases a significant reduction in attachment of A/PR/8 to organ culture 
cells was found and the initial fall in attachment (half maximal) occurred 
at an IgA log.HIU:HAU ratio of -1.2 which is close to that required for 50* 
neutralization and the same as for maximum aggregation i.e. log.HIU:HAU 
ratio of -1.5. In both cases the maximum reduction in virus attachment was 
between 00-90* and occurred at an IgA log*HIU:HAU ratio of approximately 
-0.8. Variations were seen between the two separate experiments; in one 
(solid line) the rise in attachment became apparent at a log»HIU:HAU ratio 
of +0.4 and at a ratio of +1.1 attachment had returned to 105*. whereas in
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Fig. 11.6. Aggregation of A /PR /8 by IgA.
Dilutions of IgA were added to equal volumes 
of A /PR /8 (1000 HAU/m l), mixed and incubated 
for 60 min. at 2 ^ C .  The samples were then 
examined by EM and the amount of aggregation 
determined (— A — ) and compared to the non-neutralized
A /PR /8 controls ( --------- ). Also shown is the IgA
neutralization profile (--------- )  from Fig .11.5.
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Fig. 11.7. Neutralization of A/PR /8 by IgA and the 
effect on attachment to epithelial cells of 
mouse tracheal organ cultures.
Dilutions of IgA were added to equal volumes 
of “ P A /PR /8 (1122 HAU/ml, CPM:HAU 82/516), 
mixed and incubated for 60 min. at 25°C.
Batches of 26/40 organ cultures were inoculated with 
400ul virus/antibody. The levels of virus attachment 
were determined as previously described (section 6.5 .4.). 
Each organ culture batch yielded 2.11/10.0 X 10 cells.
Also shown is the IgA neutralization profile (-------- )
from Fig. 1 1.4.
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the other (dotted line) the rise in attachment occurred at a log^HIU:HAU 
ratio of -0.3 and rose to 250» at a ratio of +1.2. The reasons for these 
differences will be discussed later.
11.2.7, AttftdiMnt <jt A/PR/9 ^  BK m I I b and tfn M a n  <A no u tra lia U g )
by IqA.
A reduction in attachment of IgA-neutralized A/PR/8 to 9 K  cells was found 
(Figure 11.8.). The fall in attachment paralleled the loss in infectivity 
and the maximum inhibition of attachment was 70» and occurred at log«» 
HIU.HAU ratio of -1.5. In contrast to my findings using tracheal organ 
culture cells, increasing the IgA concentration did not increase attachment 
which remained low even at a lo$,HIU:HAU ratio of +1.0. These data agree 
with Taylor & Diamock (1985a) even though they used slgA whilst I used 
polymeric IgA lacking secretory component (discussed later).
11.2.8. Attachment of A/PR/8 to chicken erythrocytes and the effect of
M utallaUflD by IgA.
Neutralization of A/PR/8 by IgA reduced the attachment of the virus to 
chicken erythrocytes by more than 90» (Figure 11.9.). The fall in 
attachment parallelled the loss of infectivity and remained low at a log» 
HIU.HAU ratio of greater than +1.0.
% viru
s ottoc
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Fig. 11.8. Neutralization of A/PR /8 by IgA and the 
effect on attachment to BHK cells.
Dilutions of IgA were added to equal volumes 
of “ P A /PR /8 (1 125 HAU/ml, CPMrHAU 79). 
mixed and incubated for 60 min. at 25°C.
100ul of virus/antibody was inoculated onto each 
confluent BHK monolayer (1 .5 X 1c£ cells). The levels 
of virus attachment were determined as previously 
described (section 6.5 .4 .).
Also shown is the IgA neutralization profile (---------).
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Fig. 11.9. Neutralization of A /PR /8 by IgA and the
effect on attachment to chicken erythrocytes.
Dilutions o f IgA were added to equal volumes 
of “ P A /P R /8  (1124 HAU/ml, CPM.HAU 93). 
mixed and incubated for 60 min. at 25°C.
100ul of virus/antibody was inoculated into suspensions 
of chicken erythrocytes (1 X 10® cells). The levels 
of virus attachment were determined as previously 
described (section 6 .5 .4 .).
Also shown is the IgA neutralization profile (-------- ).
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11.2.9. Pr«-treatment of cell» wiUi nw jrm nldw  and ttiert sn VTR/6 
attachment.
The enhanced attachment of IgA-neutralized virus to organ culture cells say 
result from attachment to a different cell receptor, «ich as an IgA Fc cell 
receptor (discussed later). To test this, cells were pre-treated with 
neuraminidase before the addition of virus. Table 11.1. show that 
pre-treatment of both organ culture and BH< cells with neuraminidase 
reduced the attachment of infectious virus.
Pre-treatment with neuraminidase reduced the attachment of IgA-neutralized 
A/PR/8 and infectious virvm to B K  cells to a similar extent. In contrast 
the attachment of IgA-neutralized virus to organ culture cells was not 
greatly affected by neuraminidase pre-treatment. Apparently IgA-neutralized 
virus could attach to organ culture cells via a neuraminidase-resistant 
cell receptor which is clearly different from the sialic acid receptor used 
by infectious virus. This will be discussed below.
11 .2 .10. E ffect of neutralization by IgA on the in tern a lira tio n  9t A/PR/8,
It was of interest to investigate tfiether the virus that had attached to 
the cells remained external to the oell (i.e. sensitive to removal by 
neuraminidase) or was internalized (i.e. resistant to removal by 
neuraminidase).
Table 11.2. shows that the resistance of attached infectious virus to 
neuraminidase, using either B K  or tracheal organ culture cells, increased 
with time and internalization of virus had occurred.
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Neutralization of the virus by IgA reduced the amounts of virus attaching 
to EH< cells as expected. Neuraminidase resistance of attached 
IgA-neutralized A/PR/8 did not increase with time, unlike infectious virus, 
thus neutralization by IgA impairs the internalization of the virus. It was 
also found that the two different IgA concentrations used to neutralize the 
virus both affected internalization on these cells.
The internalization of IgA-neutralized A/PR/8 by organ culture cells was 
less clear. A high IgA concentration used to neutralize the virus resulted 
in enhanced attachment (595%) and confirmed data in Figure 11.7. Not 
surprisingly at 60 min. p.i. the majority of IgA-neutralized virus was not 
detached by neuraminidase, either it was still attached by a 
neuraminidase-resistant receptor or had been internalized. However after 5 
min. p.i. the IgA-neutralized virus was detached by neuraminidase. This was 
surprising as I had earlier demonstrated that the pre-treatment of organ 
culture cells with neuraminidase did not affect the attachment of 
IgA-neutralized virus (Table 11.1.). The possible reasons for this are 
discussed later (section 11.3.4.).
ll-2.il. Neutralization of A/TR/8 tv moncmanc IgA and the attact on 
attachment to EH( cell».
The differential reduction of the IgA to monomeric IgA was too inefficient 
to allow a full range of experiments to be performed. Therefore only a 
preliminary investigation into neutralization and the effect on attachment 
of virus to EtK cells was carried out (Figure 11.10.).
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Fig. 11.10. Neutralization of A /PR /8 by monomeric IgA and 
the effect on attachment to BHK cells.
Dilutions of mlgA were added to equal volumes 
of “  P -A / P R / 8  (942 HAU/ml. CPM:HAU 89). 
mixed and incubated for 60 min. at 25°C.
100ul of virus/antibody was inoculated onto each 
confluent BHK monolayer (5.8 X 10^ cells). The levels 
of virus attachment were determined as previously 
described (section 6 .5 .4 .). Also shown is the mlgA 
neutralization profile determined by plaque reduction 
using MDCK cells {---------).
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The monomeric IgA efficiently neutralized A/PR/8 by plaque reduction; 50% 
neutralization occurred at a log*HIU:HAU ratio of -2.1 and more than 95% 
neutralization was achieved at the highest log,HIU:HAU ratio. The 
attachment of virus neutralized by monomeric IgA to BhK cells was reduced 
and the fall in attachment paralleled the loss of infectivity. At the 
highest log^HIU:HAU ratio (-1.6) the attachment of virus was low (80%) but 
the lack of available monomeric IgA prevented me from determining if 
attachment increased at high concentrations as described by Taylcr & 
Dimmock (1985a) using rat moncmeric IgA.
1 1 ,3 , Pireuggipn ,
My data are summarized in Table 11.3.. Direct comparisons between the data 
presented in this chapter with those presented earlier in the thesis need 
to be treated with caution because two different influenza virus strains
1 1 , 3 1, h n r v n U m  9f  ¿ 4 * / ? .,  to  I f lg t
Infectious A/PR/8 was slightly more aggregated (average 2.0 
virions/aggregate) compared to adpFPV/R (average <1.5 virions/aggregate). 
The rise in IgA-mediated aggregation of A/PR/8 coincided with 
neutralization but IgA caused less aggregation of A/PR/8 than previously 
found when examining IgG- or IgM-mediated aggregation of adpFPV/R. This was 
surprising, polymeric IgA would have been expected to cause more 
aggregation than IgG because of its greater valency. I can offer no reason 
as to why the IgA failed to substantially aggregate the virus.
Table 1
1.3. S
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A Inhib
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11.3.2. Attachment of A/PR/8 to chicken erythrocytes and the effect of IaA.
IgA reduced attachment of A/PR/8 to chicken erythrocytes by 90% and the 
fall in attachment occurred at the same log,HIU:HAU ratio required for 
neutralization. The amount of virus attaching remained low when the IgA 
concentration was increased to a log»HIU:HAU ratio of more than +1.0. The 
magnitude of the reduction was similar to that found using adpFFV/R and IgM 
(section 10.). and greater than seen using adpFPV/R and IgG (section 9.). 
The size of the polymeric IgA antibody molecules (dimers, trimers, 
tetramers etc.) are larger than IgG molecules and would result in more 
steric hindrance of attachment.
U.3,3. Attachment of K/PR/e to EH< cell» ana the effect of IgA.
Taylor & Dinnock (1985a) found that polymeric rat slgA, when used at a 
concentration sufficient to neutralize the virus by 96.5%. reduced 
attachment of A/FPV/R to EH< cells by 60% at 37*C. They also found that the 
virus that did attach to the cells was not internalized and remained 
susceptible to removal using proteinase K. They concluded that the 
polymeric slgA sterically hindered both the attachment and the 
internalization stages of infection and that neutralization resulted from a 
combination of these two effects.
My data confirm the findings of Taylor & Dunmock (1985a) and extend them by 
using a range of antibody:virus ratios. I found the initial inhibition of 
attachment of A/PR/8 to BKK cells by the polymeric IgA occurred at the same 
log^HIU:HAU ratio (-1.5) as required for neutralization (Table 11.3.). This 
strengthens the proposition that the inhibition of attachment is largely
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responsible for the loss of infectivity. The reduction In attachment cannot 
be the sole mechanism of neutralization because attachment was inhibited by 
a maximum of 70% whereas the virus was neutralized by 99.9%. The additional 
loss of infectivity probably results from impairment of the internalization 
process. IgA-neutralized virus that did attach to BH< cells was not 
internalized but remained on the cell surface and was susceptible to 
removal using neuraminidase (Table 11.2.). Therefore polymeric IgA 
neutralized influenza virus on EH< cells by a similar mechanism to IgM; 
i.e. by inhibiting virus attachment and impairing internalization.
Taylor & Dimmock (1965a) found that monomeric rat IgA failed to inhibit the 
attachment of A/FFV/R to BhK cells and they proposed that monomeric IgA 
behaved in a manner similar to monomeric IgG which also failed to reduce 
virus attachment. I have previously demonstrated that IgG used at high log 
HIU:HAU ratios, failed to inhibit the attachment of adpFFV/R to EH< cells 
tut at lower ratios the attachment of virus to B *  cells was reduced 
(section 9.). If monomeric IgA and IgG act in a similar manner then one 
would expect an inhibition in the attachment of virus to EH< cells to occur 
at low. sub-saturating log.HIU.HAU ratios. I found that low concentrations 
of monomeric IgA reduced the attachment of A/PR/8 to EH< cells by 80% and 
the fall in attachment coincided with neutralization. If influenza virus is 
neutralized by monomeric IgA via the same mechanisms as IgG one would 
predict that (i) increasing the log^HIU.-HAU ratio would result in virus 
attachment returning towards 100% and (ii) monomeric IgA-neutralized virus 
that had attached would be internalized by EH< cells. Unfortunately these 
experiments could not be performed because of limitations in availability 
of monomeric IgA.
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Taylor & Dimmock (1965a) found that 96ug of rat slgA yielded 47ug of 
monomeric IgA by differential reduction and there was negligible loea of HI 
activity. In contrast, using the same technique, I found no differential 
reduction of souse polymeric IgA to monomeric IgA units, and only by adding 
lodoacetasine could any reduction be achieved which even then was 
inefficient (only 15* of the HI activity was recovered). The reasons for 
this are not clear; rat polyclonal slgA seems inherently sore susceptible 
to reduction by EKE than souse monoclonal IgA, and possibly the lack of a 
secretory component on the latter say somehow confer increased resistance 
to BME reduction.
1 1 ,3 .4 , Attachment of A/PR/8 to  tr a c h e a l organ cu ltu re  c e l l s  and the e f fe c t  o f  IaA .
The attachment of IgA-neutralized virus to differentiated tracheal organ 
culture cells was very different to that found using the relatively 
dedifferentiated EH< cells. When low log^HIU.-HAU ratios of IgA were used, 
the attachment of A/PR/8 to tracheal organ culture cells was reduced by 
80*. The fall in attachment paralleled the loss of infectivity and both 
occurred at a similar log^HIU:HAU ratio, again suggesting cause and effect. 
In contrast to ay findings with BhK cells, increasing the concentration of 
IgA remlted in increased attachment of virus to tracheal organ culture 
cells and at the highest log»HIU:HAU ratios attachment was enhanced 
compared to infectious virus. As there was no concomitant return in 
infectivity. the inhibition of attachment cannot account for the 
neutralization observed at these high IgA concentrations and therefore 
additional mechanises must apply.
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Others have demonstrated that IgA enhanced the attachment of virus to 
cells. Nguyen et al. (1966) used slgA purified from porcine milk to 
neutralize transmissible gastroenteritis virus (TGEV) and found enhanced 
attachment of virus to both swine testis and pig kidney cells. The 
enhancement of attachment by slgA was concentration dependant: there was no 
inhibition of attachment at low (0.2ug/ml) concentrations but attachment 
increased three fold at high (llug/ml) concentrations. Incubation of the 
cells with slgA prior to addition of virus did not enhance virus 
attachment. They argued on the basis of this finding that the increased 
attachment was not due to sIgA-neutralized virus binding via an Fc receptor 
but instead resulted from aggregation, such that the attachment of one 
virus particle carried along with it many more virions. I feel this 
particular conclusion needs to be treated with caution as they merely 
titrated the residual inf activity of the supernatants instead of measuring 
radioactive counts attaching, which would have been the more logical and 
sensitive assay. The a IgA-neutral lzed TGEV that had attached to the cells 
remained susceptible to proteinase K removal following incubation at 37 C 
for 60 min. and therefore was not internalized.
I found the removal of the sialic acid by treating the cells with 
neuraminidase before inoculation failed to reduce the attachment of IgA 
neutralized virus (Table 11.1.). suggesting that the virus was binding via 
a neuraminidase resistant receptor. Possible explanations are that: (i) 
Treatment of the cells with neuraminidase altered the charge on the cells 
which resulted in spurious interactions between the IgA-neutralized virus 
and the cells. This explanation is unlikely because a non-specific charge 
effect would be expected to apply to other cell types and no such effect 
was noted with BHC cells, (ii) The IgA-neutralized virus may have attached
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to the poly-Ig receptor present on epithelial cells which selectively 
transports polymeric IgA to the mucosal lumen (reviewed by Underdown & 
Schiff, 1986) . This explanation is unlikely because the poly-Ig receptor is 
cleaved during the course of transport, although the cellular location of 
cleavage is not known. The IgA transport pathway is constitutive and 9C 
component is found to be secreted in a free form even if IgA had not bound 
to the poly-Ig receptor. Therefore, if receptor cleavage occurred 
intracellularly then IgA-neutralized virus would not attach to the cells.
If receptor cleavage occurred at the apical surface of cells then 
IgA-neutralized virus would attach but would probably be released 
immediately by protease action together with 9C component, (iii) The 
IgA-neutralized virus may have attached to the cells via a Fc receptor. The 
incidence and functions of Fc receptors for IgA are poorly understood 
compared to receptors specific far I&S (reviewed Unkeless et al.. 1988) .
IgA Fc receptors have been found on cells of the immune system (reviewed by 
Kilian et al.. 1988; Underdown & Schiff. 1986) .  Altrechtsen et al. ( 1988) 
found a receptor (Mr 60 . 000 ) on human blood PMN cells that bound monomeric 
serum IgAl. Garter et al. ( 1988 ) demonstrated that the binding of serum IgA 
to rat peritoneal macrophages was isotype specific and could not be blocked 
using either IgG or IgM antibodies. Briere et al. ( 1988) showed that human 
slgA bound to and induced expression of IgA-specific receptors on T cells 
(both CD4+ and CD6+) isolated from the tonsils but not from peripheral 
blood. The induction of receptors did not occur if serum IgA was used, 
suggesting that the polymeric structure of IgA or presence of the 9C 
component was an important factor. The presence of an IgA Fc receptor on 
cells prepared from tracheal organ cultures could also explain the 
variations I found both in the amount of enhanced attachment achieved 
( 105- 250%) .  and in the concentration of IgA required for increased
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attachment (loq,HIU.HAU ratio of -0.3 to +0.4) (Figure 11.7.). The 
variation may be due to the number of IgA receptors present on different 
tracheal organ culture cell preparations because in both experiments the 
same virus and antibody were used. Unfortunately I lacked the time to 
investigate the possible Fc-mediated mechanism of attachment. This 
mechanism could have been investigated using the techniques employed by 
Feiris et al. (1962) to examine ADE of flavivirus infection of macrophages: 
i.e. by blocking Fc-mediated attachment using anti-Fc receptor antibodies 
and by papain treating the IgA to give monovalent Fab' fragments, which are 
unable to interact with Fc-receptors. Another approach would have been to 
examine whether radiolabel led IgA bound to tracheal organ culture cells.
I attempted to determine if the IgA-neutralized virus that had attached to 
the organ culture cells was internalized. If the IgA-neutralized virus 
attached to a different (neuraminidase-resistant) receptor, it would have 
been expected that treatment with neuraminidase of cells to which 
IgA-neutralized virus had already attached would be ineffective. I found 
this not to be the case, both infectious and IgA-neutralized A/PR/8 that 
had attached to organ culture cells were susceptible to removal by 
neuraminidase (Table 11.2.). If the IgA-neutralized virus had attached to a 
sialic acid cell receptor, then removal of virus by neuraminidase would 
only result in re-attachment via the neuraminidase resistant cell receptor. 
Possible explanations for my findings include: (i) release by neuraminidase 
into the medium of a population of IgA-neutralized virus that had bound to 
sialic acid receptors. The released virus may have reattached to 
neuraminidase-resistant receptors but the rate of reattachment was reduced 
because the addition of the neuraminidase solution diluted the medium, or 
(ii) the receptor to which the IgA-neutralized virus attached was sensitive
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to the action of neuraminidase only after virus had bound and not before. 
This could be possible because in man the IgA Fc receptor is heavily 
glycosylated (Albrechtsen et al.. 1908). If the situation in the mouse is 
similar then this explanation could be tested by attaching radiolabel led 
IgA antibodies to the cells prior to the treatment with neuraminidase. If 
the above explanation is correct, then the bound IgA should be eluted from 
the cell surface into the medium following neuraminidase treatment. It 
should be noted that the hinge region of the human IgA molecule (Garter e£. 
al.. 1988) and the 9C component (Kilian et al.. 1988) are also heavy 
glycosylated and therefore may be the targets for neuraminidase action.
The fact that the neuraminidase resistance of attached IgA-neutralized 
virus increased by two-fold with time indicated that the virus was 
internalized. This suggestion should be treated with caution until further 
investigations into receptor-mediated IgA-neutralized virus attachment have 
been carried out.
11.3.5. Hecframa» of neutralization of influenza virus tv IaA.
Polymeric IgA caused little aggregation of A/PR/8 (compared with adpFTV/R 
and IgG or IgM sections 9.3.1. and 10.3.1.) suggesting that this plays only 
a miner role in neutralization. My data show that at all ratios of 
antibody.vir-us the mechanism of neutralization of influenza virus by 
polymeric IgA on EH< cells involves both the inhibition of attachment of 
virus to cells and its subsequent internalization and support the more 
limited data of Taylor & Dimmock (1985a). The large molecular sizes of the 
polymeric IgA molecules (which range from dimeric to larger polymeric 
units) probably hinder the attachment and internalization of A/PR/8
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sterically in Banner similar to that found using adpFPV/R and IgM (section
10.3.4.). Problems in its preparation prevented any conclusions concerning 
monomeric IgA from being made and further work needs to be done in this 
area.
Reduction in attachment of A/PR/8 to tracheal organ culture cells and 
neutralization occurred at the same IgA concentration suggesting that the 
inhibition of virus attachment is a mechanism of IgA neutralization. 
Increasing the amount of antibody resulted in an enhancement of attachment 
but no return of infectivity. It was possible that this was mediated 
through Fc receptors. If so then the binding of sub-neutralizing amounts of 
antibody to the virus should enhance virus attachment and infectivity 
(ADE). as with other viruses (section 5.3.). This was not found; 
sub-neutralizing amounts of IgA did not enhance A/PR/8 attachment and 
sub-saturating amounts of IgA neutralized the virus and substantially 
reduced attachment. The reasons why enhanced attachment was only apparent 
using high IgA .virus ratios are not clear. Further work, as described 
above, has to be done to examine the mechanism by which IgA-neutralized 
virus attaches to tracheal organ cultures cells, and to determine whether 
or not it is mediated by an IgA-specific Fc receptor. To my knowledge this 
would be the first report of an IgA-specific Fc receptor on a cell which 
does not belong to the immune system. Unti 1 this work is done no firm 
conclusions can be drawn relating to internalization of IgA-neutralized 
virus by tracheal organ culture cells or the mechanism of neutralization 
operating at high IgA:virus ratios.
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